Iso3,Location Name,AMRO subregions,Causename Eng,Year,Sex,Age group,Measure Name En,Metric Name En,Value,Value Low,Value Up
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.13,0.22,4.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.13,0.22,4.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,9.64,3.16,19.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,9.52,3.1,19.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.12,0.06,0.19
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.13,5.3,32.34
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,15.94,5.19,32.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.19,0.11,0.32
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,8.72,0.88,20.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,8.72,0.88,20.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.52,8.05,49.15
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,24.23,7.89,48.66
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.29,0.16,0.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.29,15.21,77.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,39.7,14.88,76.94
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.59,0.33,0.97
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,40.12,16.78,73.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,39.34,16.34,71.83
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.79,0.44,1.29
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.35,6.17,36.2
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,17.88,5.91,35.45
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.46,0.26,0.75
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,21.68,6.42,44.36
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,20.94,6.01,43.21
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.73,0.41,1.15
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,11.98,2.19,26.07
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,11.74,2.05,25.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.24,0.14,0.37
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.37,0.69,17.95
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,7.13,0.56,17.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.24,0.13,0.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.45,2.87,9.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.22,2.74,9.53
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.23,0.14,0.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.02,1.9,7.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.69,1.7,6.85
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.33,0.19,0.53
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.93,1.4,5.47
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,2.81,1.33,5.28
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.19
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.66,1.27,5.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,2.66,1.27,5.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.91,0.96,3.55
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,1.91,0.96,3.55
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.7,0.87,3.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.43,0.71,2.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.27,0.16,0.43
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,0.73,2.63
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.27,0.64,2.39
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.15,0.09,0.24
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.08,0.55,1.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.08,0.55,1.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.56,1.92
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.79,0.39,1.46
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.3,0.17,0.45
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.63,2.21
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.05,0.51,1.89
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.21,0.12,0.32
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.78,0.35,1.47
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.78,0.35,1.47
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.34,1.17,4.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.05,1.03,3.52
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.29,0.14,0.48
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,11.07,3.77,21.9
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,10.82,3.63,21.51
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.25,0.14,0.4
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,10.97,3.74,21.71
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,10.73,3.6,21.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.25,0.14,0.4
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,0.11,3.67
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.43,0.11,3.67
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.23,1.81,12.56
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,6.18,1.78,12.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,10.41,3.02,20.99
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,10.34,2.98,20.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.07,0.04,0.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.84,0.45,14.95
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,5.84,0.45,14.95
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.75,4.58,31.78
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,15.65,4.52,31.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.11,0.06,0.16
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,25.59,8.67,48.46
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,25.38,8.55,48.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.21,0.12,0.32
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,23.86,8.46,46.75
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,23.24,8.1,45.79
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.62,0.36,0.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.38,3.1,21.54
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,10.22,3.01,21.3
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.16,0.09,0.25
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.6,2.09,25.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,11.6,2.09,25.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,0.51,16.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.46,0.51,16.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.36,2.22,7.83
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.36,2.22,7.83
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.01,1.51,5.48
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.88,1.43,5.27
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.13,0.08,0.21
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.0,0.9,3.97
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.87,0.82,3.78
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.13,0.08,0.19
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.72,2.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.47,0.67,2.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.07,0.05,0.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.63,2.69
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.38,0.63,2.69
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.2,0.61,2.18
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.11,0.55,2.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.98,0.49,1.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.89,0.44,1.74
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.43,1.63
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.39,1.53
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.07,0.04,0.1
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.73,0.36,1.34
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.69,0.34,1.29
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.04,0.02,0.05
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.23,0.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.51,0.23,0.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.6,0.26,1.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.59,0.26,1.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.18,0.87
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.43,0.17,0.85
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.89,0.4,1.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.88,0.39,1.54
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,6.58,1.98,13.48
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,6.49,1.93,13.34
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.09,0.05,0.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,6.23,1.9,12.75
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,6.15,1.85,12.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.09,0.05,0.13
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.21,0.16,5.59
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.16,0.13,5.5
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.05,0.02,0.09
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,9.87,3.47,20.29
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,9.7,3.38,20.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.16,0.09,0.28
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.29,5.73,33.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,16.02,5.58,33.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.27,0.14,0.46
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,8.91,0.64,22.55
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,8.72,0.54,22.2
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.19,0.1,0.35
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.86,8.74,51.1
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,24.44,8.52,50.39
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.41,0.22,0.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.84,16.86,79.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,40.2,16.51,78.66
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.64,0.34,1.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,39.08,16.64,71.26
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,39.08,16.64,71.26
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.07,6.44,35.32
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,17.69,6.23,34.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.37,0.21,0.6
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,21.42,7.46,42.46
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,20.41,6.9,40.84
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.02,0.56,1.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,12.09,2.64,26.69
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,12.09,2.64,26.69
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.66,0.72,17.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,7.0,0.36,16.87
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.66,0.36,1.09
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.48,2.91,9.71
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.31,2.81,9.43
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.17,0.1,0.29
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.16,2.06,7.77
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.73,1.8,7.08
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.44,0.26,0.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.06,1.48,5.79
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,2.83,1.35,5.41
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.24,0.14,0.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.9,1.36,5.58
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,2.67,1.24,5.22
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.23,0.13,0.37
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.9,0.92,3.61
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,1.9,0.92,3.61
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.42,0.69,2.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.42,0.69,2.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.69,2.56
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.27,0.63,2.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.19
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.34,0.7,2.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.07,0.55,1.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.27,0.16,0.43
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.04,0.02,0.05
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.72,2.37
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.79,0.39,1.45
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.6,0.34,0.92
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.03,0.01,0.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.42,0.72,2.48
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.05,0.51,1.89
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.37,0.2,0.59
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.79,0.37,1.5
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.79,0.37,1.5
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.05,0.02,0.08
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.41,1.19,4.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.06,1.03,3.51
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.35,0.16,0.6
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,11.08,4.0,22.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,10.83,3.86,21.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.25,0.14,0.41
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,11.0,3.98,21.86
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,10.75,3.84,21.44
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.25,0.14,0.42
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.09,3.81
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.38,0.09,3.81
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.14,1.82,12.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,6.14,1.82,12.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,10.12,3.0,20.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,10.12,3.0,20.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.55,0.36,15.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,5.55,0.36,15.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.39,4.56,31.51
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,15.39,4.56,31.51
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,25.19,8.75,47.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,25.19,8.75,47.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,23.94,7.45,44.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,23.94,7.45,44.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.35,2.86,20.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,10.32,2.85,20.87
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.02,0.01,0.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.6,2.0,24.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,11.6,2.0,24.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.4,0.54,16.74
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.4,0.54,16.74
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.5,2.27,8.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.38,2.21,7.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.18
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.88,1.44,5.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.88,1.44,5.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,0.9,3.82
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.86,0.84,3.68
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.09,0.05,0.13
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.5,0.7,2.89
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.47,0.68,2.84
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.63,2.68
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.38,0.63,2.68
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.53,2.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.11,0.53,2.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.14,0.56,2.08
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.9,0.41,1.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.25,0.15,0.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.97,0.48,1.75
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.37,1.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.17,0.1,0.25
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.38,1.36
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.69,0.33,1.25
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.07,0.05,0.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.55,0.26,1.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.5,0.23,0.97
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.62,0.27,1.15
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.59,0.26,1.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.18,0.9
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.42,0.16,0.86
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.89,0.39,1.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.88,0.39,1.56
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,6.52,1.9,13.23
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,6.5,1.88,13.2
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,6.19,1.82,12.53
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,6.16,1.8,12.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.68,2.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.25,0.68,2.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.05,6.09,16.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,10.05,6.09,16.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.31,8.34,23.36
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,14.31,8.34,23.36
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.7,2.01,6.06
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.7,2.01,6.06
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,23.96,13.97,39.11
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,23.96,13.97,39.11
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,37.28,22.82,59.35
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,37.28,22.82,59.35
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,34.49,20.18,56.28
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,34.49,20.18,56.28
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.7,17.55,53.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,31.7,17.55,53.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,18.11,9.25,31.48
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,18.11,9.25,31.48
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.93,4.46,17.9
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,9.93,4.46,17.9
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.57,5.38,20.67
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,11.57,5.38,20.67
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,7.93,2.77,14.55
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,7.93,2.77,14.55
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.81,1.84,11.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.81,1.84,11.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.12,2.0,7.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.12,2.0,7.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.81,1.41,4.65
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.81,1.41,4.65
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.11,0.99,3.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,2.11,0.99,3.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.96,0.89,3.62
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.96,0.89,3.62
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.45,0.58,2.8
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,1.45,0.58,2.8
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.36,2.24
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.09,0.36,2.24
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.96,0.38,1.91
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.96,0.38,1.91
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.79,0.39,1.48
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.79,0.39,1.48
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.24,1.03
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.56,0.24,1.03
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.2,0.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.45,0.2,0.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.4,0.18,0.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.4,0.18,0.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.11,0.5
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.26,0.11,0.5
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.95,5.29,16.89
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,9.95,5.29,16.89
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.69,5.13,16.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,9.69,5.13,16.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.61,0.29,1.08
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.61,0.29,1.08
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.07,2.5,8.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.07,2.5,8.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.99,3.39,12.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,6.99,3.39,12.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.83,0.88,3.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.83,0.88,3.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.68,5.66,20.13
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,11.68,5.66,20.13
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,18.75,9.29,31.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,18.75,9.29,31.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.74,8.12,28.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,16.74,8.12,28.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.74,6.95,26.67
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,14.74,6.95,26.67
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.88,2.87,15.51
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,7.88,2.87,15.51
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.4,1.71,8.34
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.4,1.71,8.34
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.07,1.43,10.14
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.07,1.43,10.14
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.67,1.94,6.06
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.67,1.94,6.06
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.72,1.26,4.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,2.72,1.26,4.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,1.87,0.8,3.62
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,1.87,0.8,3.62
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.23,0.51,2.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.23,0.51,2.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.95,0.39,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,0.95,0.39,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,0.9,0.29,1.77
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,0.9,0.29,1.77
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.69,0.36,1.24
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.69,0.36,1.24
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.49,0.23,0.91
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.49,0.23,0.91
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.18,0.78
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.41,0.18,0.78
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.12,0.63
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.31,0.12,0.63
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.07,0.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.19,0.07,0.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.05,0.31
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.14,0.05,0.31
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.13,0.05,0.29
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.13,0.05,0.29
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.08,0.03,0.18
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.08,0.03,0.18
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.68,2.11,8.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,4.68,2.11,8.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.32,1.94,7.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,4.32,1.94,7.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.3,0.67,2.12
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.3,0.67,2.12
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.27,6.02,16.25
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,10.27,6.02,16.25
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.55,8.09,23.5
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,14.55,8.09,23.5
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.74,1.94,6.13
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.74,1.94,6.13
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.01,13.35,38.79
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,24.01,13.35,38.79
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,37.48,22.24,59.1
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,37.48,22.24,59.1
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,34.67,19.34,55.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,34.67,19.34,55.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.86,16.44,52.83
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,31.86,16.44,52.83
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,17.94,8.79,30.71
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,17.94,8.79,30.71
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.84,4.34,18.16
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,9.84,4.34,18.16
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.57,5.11,21.46
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,11.57,5.11,21.46
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.02,3.31,16.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,8.02,3.31,16.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.64,1.62,11.69
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.64,1.62,11.69
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.12,1.91,7.45
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.12,1.91,7.45
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.76,1.33,4.87
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.76,1.33,4.87
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.11,0.98,3.83
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,2.11,0.98,3.83
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.01,0.95,3.68
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,2.01,0.95,3.68
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,0.61,2.71
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,1.43,0.61,2.71
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.38,2.11
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.11,0.38,2.11
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.97,0.38,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.97,0.38,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.8,0.38,1.46
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.38,1.46
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.25,1.07
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.56,0.25,1.07
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.46,0.2,0.86
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.46,0.2,0.86
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.17,0.76
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.41,0.17,0.76
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.1,0.51
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.26,0.1,0.51
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.97,5.11,16.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,9.97,5.11,16.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.72,4.96,16.59
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,9.72,4.96,16.59
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.63,0.29,1.15
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.63,0.29,1.15
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.05,2.63,8.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.05,2.63,8.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.95,3.41,12.43
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,6.95,3.41,12.43
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.82,0.83,3.33
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.82,0.83,3.33
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.46,5.63,20.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,11.46,5.63,20.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,18.4,9.68,32.6
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,18.4,9.68,32.6
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.47,8.13,29.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,16.47,8.13,29.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.54,6.58,26.26
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,14.54,6.58,26.26
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,8.03,2.88,14.87
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,8.03,2.88,14.87
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.42,1.77,8.17
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.42,1.77,8.17
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.09,1.71,10.23
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.09,1.71,10.23
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.63,1.84,6.25
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.63,1.84,6.25
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.76,1.35,4.61
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,2.76,1.35,4.61
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,1.87,0.82,3.53
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,1.87,0.82,3.53
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.23,0.45,2.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.23,0.45,2.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.94,0.38,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,0.94,0.38,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.34,1.7
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,0.87,0.34,1.7
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.68,0.35,1.16
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.68,0.35,1.16
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.49,0.23,0.88
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.49,0.23,0.88
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.18,0.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.41,0.18,0.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.12,0.6
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.31,0.12,0.6
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.07,0.41
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.2,0.07,0.41
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.05,0.31
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.14,0.05,0.31
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.05,0.28
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.14,0.05,0.28
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.08,0.02,0.18
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.08,0.02,0.18
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.65,2.12,8.43
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,4.65,2.12,8.43
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.3,1.96,7.8
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,4.3,1.96,7.8
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.55,1.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.06,0.55,1.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,28.68,14.41,50.27
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,28.68,14.41,50.27
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,47.56,23.97,82.15
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,47.34,23.84,81.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.22,0.13,0.36
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.63,5.55
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.16,1.63,5.55
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,79.64,40.13,137.55
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,79.26,39.91,136.95
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.37,0.22,0.6
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,114.08,57.27,199.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,114.08,57.27,199.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,119.39,60.14,206.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,118.82,59.81,205.25
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.57,0.33,0.91
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,124.68,63.0,212.32
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,123.54,62.34,210.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.14,0.66,1.82
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,97.13,49.52,163.28
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,95.74,48.68,161.12
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,1.39,0.83,2.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,0.02,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,72.18,36.74,122.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,71.23,36.16,121.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.95,0.58,1.46
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,79.62,40.33,137.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,77.9,39.26,135.21
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.72,1.07,2.62
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,66.51,32.41,109.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,66.06,32.13,108.63
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.45,0.28,0.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,57.96,30.43,99.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,57.49,30.15,98.29
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.47,0.28,0.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,52.77,27.65,92.14
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,52.22,27.33,91.28
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.55,0.32,0.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,45.64,21.19,79.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,44.92,20.72,78.27
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.72,0.46,1.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,40.19,19.3,70.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,39.92,19.13,69.71
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.26,0.17,0.39
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,38.76,19.89,68.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,38.76,19.89,68.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.21,16.36,61.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,35.21,16.36,61.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,30.87,14.75,52.93
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,30.18,14.31,51.9
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.69,0.44,1.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.12,13.44,51.44
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,28.73,13.19,50.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.39,0.25,0.58
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,26.85,11.74,49.52
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,26.85,11.74,49.52
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,0.05,0.04,0.08
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,25.32,10.6,43.8
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,24.4,9.98,42.48
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.92,0.62,1.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,0.07,0.04,0.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,23.86,9.92,42.68
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,23.09,9.45,41.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.77,0.47,1.18
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,22.85,9.31,42.74
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,22.85,9.31,42.74
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.2,0.11,0.34
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,21.75,9.14,39.88
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,20.26,8.35,37.37
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,1.49,0.78,2.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.45,26.8,91.78
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,52.94,26.49,90.99
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.51,0.31,0.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.26,26.68,91.47
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,52.75,26.37,90.67
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.52,0.32,0.8
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.53,0.24,1.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.53,0.24,1.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.92,5.73,27.34
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.92,5.73,27.34
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.29,9.57,42.92
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,22.2,9.51,42.78
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.59,0.72,3.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.59,0.72,3.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,37.26,16.0,71.74
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,37.11,15.9,71.51
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.15,0.1,0.23
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,55.06,22.59,108.25
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,55.06,22.59,108.25
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,55.6,23.85,107.05
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,55.36,23.71,106.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.23,0.15,0.35
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,56.12,25.1,105.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,55.65,24.81,105.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.47,0.29,0.69
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,42.32,19.2,78.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,40.91,18.36,76.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.41,0.84,2.19
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.26,11.79,55.24
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,28.85,11.54,54.59
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.41,0.25,0.65
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,32.06,12.16,60.36
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,32.06,12.16,60.36
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,25.9,10.93,50.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,25.9,10.93,50.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,22.89,8.07,44.35
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,22.89,8.07,44.35
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,20.26,7.05,37.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,19.66,6.68,36.92
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.6,0.37,0.95
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,17.59,5.39,32.92
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,17.17,5.13,32.29
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.42,0.26,0.63
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,15.26,4.72,29.67
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.94,4.52,29.19
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.32,0.2,0.48
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,14.61,4.43,28.59
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,14.61,4.43,28.59
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,13.28,4.28,27.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.73,3.93,26.3
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.55,0.35,0.82
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,11.69,3.45,22.71
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,11.12,3.09,21.89
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.56,0.36,0.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.04,3.15,22.21
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,10.53,2.82,21.45
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.51,0.32,0.75
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.28,2.79,21.61
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,9.84,2.5,20.94
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.45,0.28,0.67
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,8.96,2.23,19.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,8.96,2.23,19.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,8.81,2.13,18.97
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,8.43,1.9,18.39
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.38,0.23,0.59
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,8.95,2.0,19.34
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.55,1.75,18.71
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.41,0.25,0.63
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.12,0.08,0.19
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.46,2.13,17.55
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,7.56,1.59,16.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.91,0.54,1.38
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,22.73,9.1,43.52
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,22.47,8.94,43.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.27,0.16,0.41
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,22.01,8.7,42.22
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,21.72,8.53,41.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.28,0.17,0.43
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.57,1.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.11,0.57,1.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,29.33,14.34,52.47
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,29.27,14.31,52.37
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.06,0.03,0.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,48.33,23.78,84.58
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,48.05,23.62,84.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.28,0.15,0.48
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.2,1.64,5.73
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.2,1.64,5.73
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,79.77,39.25,139.61
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,79.31,38.99,138.82
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.46,0.26,0.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,114.93,56.12,205.62
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,114.69,55.98,205.21
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.24,0.13,0.41
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,120.03,59.03,210.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,119.32,58.64,208.81
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.71,0.39,1.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,125.14,61.94,214.42
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,123.97,61.3,212.42
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.17,0.65,2.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,96.81,54.4,169.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,96.81,54.4,169.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,72.17,38.08,124.18
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,71.37,37.59,122.94
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.8,0.49,1.23
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,80.45,42.55,134.74
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,78.13,41.14,131.18
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,2.31,1.41,3.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,66.47,33.91,114.54
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,66.47,33.91,114.54
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,0.02,0.02,0.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,59.37,29.08,100.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,58.11,28.31,98.78
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,1.25,0.76,1.92
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,51.18,26.49,90.89
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,50.78,26.26,90.26
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.39,0.23,0.63
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,45.46,23.52,78.6
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,44.54,22.94,77.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.92,0.58,1.4
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,40.42,19.39,68.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,39.9,19.07,68.07
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.52,0.32,0.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.02,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,39.77,18.14,66.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,39.23,17.81,65.48
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.53,0.33,0.84
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.01,15.75,59.81
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,35.01,15.75,59.81
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,30.69,14.93,53.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,30.69,14.93,53.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.54,14.15,50.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,29.14,13.89,50.38
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.39,0.26,0.6
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,28.04,13.14,48.24
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,27.14,12.55,46.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.9,0.6,1.38
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,0.1,0.07,0.15
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,26.46,12.11,44.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,24.74,10.98,42.42
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.73,1.13,2.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.1,0.06,0.15
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,24.37,10.82,42.14
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,23.16,10.07,40.27
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,1.22,0.75,1.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,22.58,9.44,39.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,22.58,9.44,39.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,0.24,0.12,0.39
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,21.84,9.63,38.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,20.14,8.74,35.85
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,1.7,0.89,2.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.66,27.21,92.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,53.13,26.89,92.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.53,0.32,0.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.69,27.2,92.88
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,53.15,26.88,92.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.54,0.33,0.85
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.54,0.25,0.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.54,0.25,0.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.98,5.74,26.88
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.98,5.74,26.88
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.17,9.36,41.17
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,22.17,9.36,41.17
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.55,0.72,2.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.55,0.72,2.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.56,15.43,67.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,36.56,15.43,67.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,54.57,22.34,105.13
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,54.57,22.34,105.13
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.77,23.09,101.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,54.77,23.09,101.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.97,23.83,98.32
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,54.97,23.83,98.32
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,40.65,17.5,72.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,40.65,17.5,72.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.17,11.77,53.39
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,29.05,11.7,53.21
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.18
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,32.01,13.34,58.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,32.01,13.34,58.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,26.77,9.88,48.29
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,26.77,9.88,48.29
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,24.17,9.69,45.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,23.56,9.32,44.3
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.61,0.37,0.9
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,19.7,7.21,38.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,19.7,7.21,38.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,16.95,6.55,33.42
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,16.65,6.37,32.96
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.3,0.18,0.46
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.85,5.25,29.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.75,5.19,29.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.11,0.07,0.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,14.82,4.65,28.47
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,14.82,4.65,28.47
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,12.46,4.4,25.08
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.46,4.4,25.08
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,12.44,3.87,24.8
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,10.9,2.91,22.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.54,0.95,2.3
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.05,0.03,0.08
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.62,3.55,23.37
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,10.37,2.76,21.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.25,0.78,1.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.66,3.18,21.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,9.75,2.59,20.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.9,0.59,1.37
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.02,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.09,2.42,19.76
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,8.82,2.25,19.35
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.27,0.17,0.41
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,8.82,2.21,19.28
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,8.35,1.93,18.57
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.46,0.28,0.71
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.07,0.04,0.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.35,2.35,20.3
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.49,1.82,18.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.86,0.52,1.32
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,7.88,1.77,17.54
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,7.54,1.57,17.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.34,0.2,0.52
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,22.55,9.07,41.99
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,22.41,8.99,41.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.14,0.08,0.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,21.91,8.72,40.96
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,21.73,8.61,40.69
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.18,0.11,0.27
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.31,1.23,3.91
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.31,1.23,3.91
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,46.22,22.27,82.03
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,46.22,22.27,82.03
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,98.27,47.27,170.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,95.99,45.79,167.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,2.28,1.48,3.34
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.86,3.64,11.61
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,6.86,3.64,11.61
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.05,0.04,0.08
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,164.53,79.15,286.25
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,160.72,76.67,280.67
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,3.81,2.48,5.58
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,182.04,87.35,323.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,182.04,87.35,323.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,246.48,118.39,429.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,240.69,114.63,420.51
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,5.79,3.76,8.49
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.16,0.11,0.24
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,310.76,149.35,534.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,299.2,141.83,517.14
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,11.57,7.51,16.95
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.23,0.15,0.34
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,293.16,152.62,486.44
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,277.92,142.72,463.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,15.24,9.89,22.48
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.13,0.09,0.19
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,187.92,92.41,320.42
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,180.05,87.26,308.88
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,7.87,5.15,11.54
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.19,0.13,0.28
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,223.31,108.38,378.94
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,211.79,100.77,362.17
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,11.52,7.61,16.77
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.07,0.04,0.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,161.82,75.25,274.73
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,158.19,72.86,269.38
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.62,2.38,5.35
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,125.54,58.19,225.89
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,122.04,55.89,220.8
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.5,2.3,5.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,106.43,52.22,189.42
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,102.83,49.84,184.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.6,2.38,5.29
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.09,0.06,0.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,89.32,39.39,159.32
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,85.5,36.81,153.91
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,3.82,2.58,5.42
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,73.21,31.86,133.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,71.83,30.93,131.69
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.38,0.94,1.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,69.77,31.61,129.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,69.77,31.61,129.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,57.67,23.08,107.21
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,57.67,23.08,107.21
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.14,0.1,0.2
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,51.74,21.44,94.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,48.04,18.87,89.38
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,3.69,2.57,5.25
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.08,0.06,0.11
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,46.97,18.52,87.67
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,44.88,17.07,84.71
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,2.09,1.45,2.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,40.79,14.73,78.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,40.79,14.73,78.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.27,0.19,0.38
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,40.96,16.63,74.64
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,36.23,13.41,68.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,4.73,3.22,6.53
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,0.41,0.25,0.61
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,39.14,17.17,69.76
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,34.78,14.43,63.41
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,4.36,2.75,6.35
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,34.54,15.7,61.43
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,34.54,15.7,61.43
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,1.33,0.76,2.07
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,41.33,20.59,69.87
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,31.62,15.04,54.84
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,9.71,5.55,15.03
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,121.77,58.59,210.74
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,117.58,55.84,204.61
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,4.19,2.75,6.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,0.09,0.06,0.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,121.29,58.28,210.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,117.08,55.52,203.85
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,4.21,2.76,6.15
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.15,0.54,2.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.15,0.54,2.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.33,10.0,51.19
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,26.33,10.0,51.19
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.9,27.53,115.08
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,62.06,26.99,113.87
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.84,0.54,1.21
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.41,1.6,6.26
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,3.41,1.6,6.26
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,105.13,46.01,192.34
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,103.73,45.11,190.31
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.4,0.91,2.02
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,103.74,39.11,202.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,103.74,39.11,202.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,157.41,68.84,287.98
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,155.29,67.47,284.91
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,2.12,1.38,3.06
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,210.62,98.32,373.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,206.4,95.58,367.02
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,4.22,2.74,6.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.19,0.12,0.27
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,227.29,117.95,385.42
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,215.01,109.81,367.69
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,12.28,8.14,17.73
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.05,0.04,0.08
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,151.4,71.63,260.33
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,148.08,69.44,255.54
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,3.31,2.19,4.79
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,179.07,81.5,304.84
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,179.07,81.5,304.84
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,138.64,64.37,241.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,138.64,64.37,241.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,105.51,46.1,183.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,105.51,46.1,183.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.08,0.05,0.11
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,87.25,37.59,153.99
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,83.74,35.32,148.88
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.51,2.27,5.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.09,0.06,0.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,73.17,31.51,129.72
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,69.5,28.99,124.52
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,3.67,2.51,5.2
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,58.01,22.02,106.4
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,55.69,20.46,103.11
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,2.32,1.56,3.29
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,54.28,18.29,99.95
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,54.28,18.29,99.95
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.11,0.07,0.15
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,44.67,15.18,86.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,41.39,13.04,81.97
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,3.28,2.14,4.67
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.12,0.08,0.17
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,38.44,12.98,75.41
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,35.29,10.88,70.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,3.15,2.1,4.45
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.13,0.09,0.18
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,35.87,11.92,70.44
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,32.74,9.83,66.04
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,3.13,2.09,4.4
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.14,0.1,0.2
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,32.82,10.67,64.55
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,29.72,8.59,60.21
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,3.1,2.09,4.34
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,26.8,8.53,54.9
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,26.8,8.53,54.9
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,0.3,0.19,0.43
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,27.66,8.59,55.24
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,25.04,6.9,51.46
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,2.62,1.69,3.78
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.27,0.18,0.39
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,27.94,7.99,55.77
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,24.36,5.61,50.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,3.59,2.38,5.11
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,0.74,0.47,1.08
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,28.6,9.28,55.19
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,23.21,5.85,47.35
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,5.39,3.43,7.84
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,90.92,40.95,160.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,88.84,39.58,157.83
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,2.08,1.37,2.99
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,88.34,39.52,156.59
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,86.16,38.09,153.46
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,2.18,1.44,3.13
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.4,1.24,4.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.4,1.24,4.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,48.27,22.58,86.51
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,47.4,22.07,85.13
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.87,0.52,1.38
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.04,0.03,0.07
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,100.59,49.34,176.04
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,97.46,47.39,171.33
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,3.13,1.95,4.72
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.94,3.58,11.86
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,6.94,3.58,11.86
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.07,0.05,0.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,166.03,81.44,290.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,160.86,78.22,282.8
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,5.17,3.22,7.78
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,187.4,87.33,336.45
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,183.87,85.24,330.9
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,3.53,2.09,5.55
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.11,0.07,0.17
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,249.69,122.39,437.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,241.8,117.47,425.27
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,7.89,4.92,11.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.17,0.11,0.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,312.14,157.53,538.1
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,299.88,149.78,519.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,12.26,7.75,18.22
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,282.17,148.84,475.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,282.17,148.84,475.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.1,0.07,0.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,188.6,94.29,322.49
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,182.97,90.64,314.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,5.63,3.65,8.31
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.26,0.17,0.38
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,231.57,117.8,385.63
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,215.93,107.65,362.48
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,15.64,10.15,23.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,163.72,79.21,286.55
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,163.72,79.21,286.55
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.19,0.12,0.28
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,134.04,60.45,235.89
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,124.45,54.25,221.87
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,9.59,6.19,14.03
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,105.18,50.59,186.68
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,102.56,48.9,182.76
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.62,1.69,3.92
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.12,0.08,0.17
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,89.75,40.67,160.76
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,84.81,37.34,153.68
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,4.94,3.32,7.08
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,74.57,31.68,133.87
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,71.84,29.86,129.92
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,2.72,1.82,3.95
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.08,0.05,0.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,72.97,29.9,128.05
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,70.22,28.09,123.98
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,2.75,1.81,4.07
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,57.84,22.72,107.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,57.84,22.72,107.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,48.15,19.24,92.09
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,48.15,19.24,92.09
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,46.82,18.69,87.94
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,45.1,17.54,85.45
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.72,1.15,2.49
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.18,0.12,0.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,45.11,17.98,82.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,41.16,15.36,76.87
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,3.95,2.63,5.71
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.53,0.36,0.75
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,45.87,20.65,81.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,36.71,14.52,68.31
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,9.16,6.13,12.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,0.59,0.36,0.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,41.88,19.47,72.46
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,34.92,15.06,62.3
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,6.96,4.41,10.16
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,34.26,15.9,58.16
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,34.26,15.9,58.16
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,1.58,0.89,2.48
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,43.05,21.71,71.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,31.5,15.2,53.56
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,11.55,6.5,18.02
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.09,0.05,0.13
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,122.97,60.06,213.25
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,119.0,57.51,207.36
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.98,2.55,5.89
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,122.94,59.95,213.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,118.92,57.36,207.3
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,4.03,2.58,5.96
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.17,0.54,2.12
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.17,0.54,2.12
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.46,10.33,52.3
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,26.46,10.33,52.3
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.27,27.13,111.77
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,62.27,27.13,111.77
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.38,1.55,6.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,3.38,1.55,6.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,102.67,44.73,184.28
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,102.67,44.73,184.28
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,102.84,39.92,203.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,102.84,39.92,203.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,154.33,67.19,276.96
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,154.33,67.19,276.96
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,205.58,94.34,349.75
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,205.58,94.34,349.75
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,218.8,110.32,362.5
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,218.8,110.32,362.5
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,151.08,71.11,257.49
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,150.51,70.75,256.67
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.57,0.36,0.82
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,181.65,85.16,310.69
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,181.65,85.16,310.69
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,142.41,64.02,246.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,142.41,64.02,246.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,110.57,51.62,189.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,107.68,49.79,185.38
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,2.89,1.83,4.2
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,84.72,35.01,150.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,84.72,35.01,150.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,71.04,29.1,129.95
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,68.46,27.36,126.28
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.58,1.74,3.67
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.02,0.03
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,55.97,20.85,106.51
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,55.04,20.23,105.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.93,0.62,1.32
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,53.42,18.59,103.95
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,53.42,18.59,103.95
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,41.19,13.68,81.99
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,41.19,13.68,81.99
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.33,0.21,0.46
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,42.99,17.06,80.33
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,34.47,11.46,68.22
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,8.52,5.6,12.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.31,0.2,0.43
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,39.82,14.91,74.42
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,32.4,10.0,63.93
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,7.43,4.91,10.49
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.28,0.19,0.4
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,36.1,12.39,67.47
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,29.96,8.29,58.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,6.14,4.1,8.59
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.18,0.12,0.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,29.7,9.7,58.81
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,26.53,7.58,54.34
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,3.16,2.13,4.47
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,0.32,0.21,0.47
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,29.02,9.25,58.01
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,24.91,6.56,52.1
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,4.11,2.7,5.91
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.58,0.38,0.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,31.91,10.79,62.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,24.37,5.84,51.33
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,7.55,4.96,10.93
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,0.27,0.17,0.4
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,25.11,7.04,52.56
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,23.11,5.81,49.64
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,2.0,1.23,2.92
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,90.38,40.57,158.51
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,89.53,40.01,157.31
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.85,0.56,1.21
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,88.26,39.37,155.16
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,87.12,38.63,153.54
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,1.14,0.75,1.63
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.33,1.55,10.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.33,1.55,10.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.02,0.02,0.03
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.19,11.61,44.93
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,24.56,10.5,42.61
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.63,1.11,2.32
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.86,19.44,75.23
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,41.12,17.59,71.34
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,2.74,1.85,3.89
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,21.8,6.34,43.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,21.8,6.34,43.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,66.65,29.54,114.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,62.5,26.73,108.42
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,4.16,2.82,5.91
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.12,0.08,0.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.4,52.69,184.82
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,103.09,47.07,173.01
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,8.31,5.62,11.81
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,0.17,0.12,0.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,132.96,75.46,208.74
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,121.9,67.95,192.99
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,11.06,7.5,15.76
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,0.09,0.06,0.13
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,82.81,43.64,134.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,77.3,39.86,126.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,5.5,3.77,7.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,0.13,0.09,0.18
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,105.19,54.49,165.37
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,97.49,49.15,154.58
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,7.7,5.34,10.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,0.05,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,71.11,36.67,115.83
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,68.59,34.94,112.22
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,2.51,1.72,3.6
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,50.0,24.09,87.88
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,47.56,22.42,84.48
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.44,1.67,3.4
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,0.05,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,39.71,18.48,70.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,37.22,16.75,66.75
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.48,1.73,3.52
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,33.38,14.1,60.31
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,30.94,12.36,56.99
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,2.44,1.73,3.32
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.02,0.02,0.03
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.11,9.79,50.14
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,25.23,9.17,48.93
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.89,0.63,1.2
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,25.05,9.56,49.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,25.05,9.56,49.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,18.54,4.87,38.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,18.54,4.87,38.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.09,0.07,0.13
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,17.16,4.91,34.9
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.68,3.1,31.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.48,1.81,3.4
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.05,0.04,0.07
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.6,3.45,30.37
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.2,2.43,28.45
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.4,1.02,1.92
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.27,1.56,24.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,11.27,1.56,24.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.16,0.11,0.21
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,12.18,4.08,25.29
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,9.5,2.18,21.74
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,2.68,1.9,3.55
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.23,0.15,0.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,11.73,5.32,21.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.25,3.68,17.82
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,2.48,1.64,3.44
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.5,5.23,15.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.5,5.23,15.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.76,0.46,1.12
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,13.83,8.44,20.44
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.28,5.07,12.3
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,5.55,3.37,8.14
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,45.05,22.03,75.47
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,42.14,20.03,71.35
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.92,2.0,4.12
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,45.08,22.02,75.61
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,42.16,20.01,71.48
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,2.92,2.0,4.13
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.87,1.65,11.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.87,1.65,11.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.91,12.65,46.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.38,12.29,45.74
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.53,0.36,0.76
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.98,21.14,77.71
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.09,20.54,76.44
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.89,0.6,1.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.92,6.72,47.54
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,23.92,6.72,47.54
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.1,32.01,117.65
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,66.75,31.1,115.73
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.35,0.91,1.92
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.04,0.03,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.9,57.07,187.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,109.21,55.27,183.34
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.69,1.81,3.83
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.12,0.09,0.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,147.37,85.46,233.47
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,139.3,79.86,222.32
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,8.07,5.6,11.16
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.04,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,101.51,53.21,163.19
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,99.38,51.73,160.23
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,2.14,1.48,2.96
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,125.25,64.45,197.19
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,125.25,64.45,197.19
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,96.84,49.22,157.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,96.84,49.22,157.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,69.5,32.72,114.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,69.5,32.72,114.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.05,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,55.5,26.02,94.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,53.42,24.62,91.16
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,2.08,1.4,2.92
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,46.75,22.69,79.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,44.36,20.97,75.95
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.39,1.71,3.29
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,37.23,15.22,65.78
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,35.79,14.21,63.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.44,1.01,1.98
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,35.54,12.93,62.45
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,35.54,12.93,62.45
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,28.16,9.14,53.94
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,26.24,7.84,51.32
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,1.92,1.29,2.62
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,23.92,7.97,47.83
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,22.07,6.7,45.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.84,1.27,2.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,22.02,7.21,43.55
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,20.23,5.97,41.12
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.79,1.24,2.42
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,0.08,0.05,0.11
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,19.78,6.31,38.48
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,18.06,5.12,36.14
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.72,1.2,2.34
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,16.16,5.39,32.38
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,16.16,5.39,32.38
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,0.16,0.11,0.23
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,16.34,5.03,32.26
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,14.87,4.05,30.2
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.47,0.98,2.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,0.16,0.11,0.22
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,16.27,4.39,32.12
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,14.2,2.97,29.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.07,1.42,2.85
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,0.41,0.27,0.58
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,16.68,5.17,32.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,13.71,3.23,28.02
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,2.97,1.94,4.22
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,54.1,26.86,89.71
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,52.78,25.95,87.88
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.32,0.91,1.83
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.04,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,52.93,26.04,88.14
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,51.57,25.1,86.25
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.36,0.94,1.89
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.3,1.99,11.89
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.66,1.59,10.92
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.64,0.39,0.97
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.16,13.65,46.48
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,24.9,12.18,43.22
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,2.26,1.47,3.27
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.05,0.03,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.83,22.53,76.73
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,41.09,20.11,71.34
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,3.73,2.42,5.39
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,25.41,8.01,47.95
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,22.83,6.42,44.04
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.58,1.59,3.91
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.4,34.37,117.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,62.7,30.68,108.85
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,5.7,3.69,8.23
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.13,0.08,0.18
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.5,60.79,186.38
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,102.68,55.0,173.83
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,8.82,5.8,12.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,125.57,68.59,197.91
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,125.57,68.59,197.91
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,84.37,44.25,136.22
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,80.54,41.66,130.78
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.82,2.59,5.45
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.17,0.12,0.25
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,112.6,60.72,176.25
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,102.16,53.62,161.32
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,10.44,7.1,14.93
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,73.45,38.33,121.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,73.45,38.33,121.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.13,0.09,0.19
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,56.7,27.67,95.95
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,50.02,23.17,86.51
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,6.68,4.51,9.44
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,40.22,18.03,70.19
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,38.41,16.81,67.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,1.81,1.22,2.6
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.08,0.06,0.11
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,33.83,12.94,62.2
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,30.67,10.7,57.87
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,3.16,2.24,4.33
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,0.05,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,27.0,9.38,51.23
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,25.25,8.16,48.8
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.75,1.23,2.43
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,26.77,9.32,48.8
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,24.99,8.1,46.27
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,1.78,1.22,2.53
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,18.95,5.12,40.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,18.95,5.12,40.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,14.28,2.84,33.16
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.28,2.84,33.16
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.05,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.0,2.89,31.17
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.0,2.2,29.78
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.01,0.68,1.39
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.11,0.07,0.15
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.65,2.95,28.6
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,11.34,1.38,25.41
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,2.3,1.57,3.19
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,0.3,0.21,0.41
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,14.86,5.95,28.95
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,9.64,2.29,21.95
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,5.22,3.67,7.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,0.34,0.22,0.48
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,13.29,6.35,23.43
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.31,3.68,17.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,3.98,2.66,5.53
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.48,5.27,14.74
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.48,5.27,14.74
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,0.91,0.55,1.35
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,14.9,8.85,22.37
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.26,4.83,12.54
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,6.64,4.01,9.82
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,46.12,23.04,77.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,43.41,21.22,73.21
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.71,1.81,3.86
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,46.34,23.09,77.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,43.6,21.26,73.66
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,2.74,1.83,3.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.01,1.86,12.54
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.01,1.86,12.54
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.7,12.52,44.74
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.7,12.52,44.74
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.02,20.65,73.77
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.02,20.65,73.77
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,24.15,7.49,50.43
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,24.15,7.49,50.43
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,66.93,31.39,112.15
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,66.93,31.39,112.15
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,109.5,55.19,173.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,109.5,55.19,173.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,142.59,81.92,221.58
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,142.59,81.92,221.58
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,101.88,53.13,164.17
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,101.56,52.91,163.71
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.33,0.21,0.46
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,127.95,66.63,207.45
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,127.95,66.63,207.45
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,100.26,50.11,164.61
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,100.26,50.11,164.61
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,72.61,36.05,118.44
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,70.95,34.96,116.09
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.66,1.09,2.35
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,54.18,23.38,90.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,54.18,23.38,90.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,45.74,19.69,79.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,44.07,18.51,77.28
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.67,1.18,2.3
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.97,13.87,66.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,35.37,13.44,66.07
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.6,0.42,0.83
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,34.39,12.98,66.4
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,34.39,12.98,66.4
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.3,8.06,52.69
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,26.3,8.06,52.69
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.19,0.13,0.26
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,26.45,10.86,48.83
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,21.48,7.49,42.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,4.97,3.37,6.77
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.18,0.12,0.24
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,24.32,9.13,44.81
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,20.06,6.23,39.04
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,4.26,2.9,5.78
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.16,0.11,0.21
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,21.81,7.09,40.09
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,18.39,4.74,35.48
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,3.42,2.35,4.61
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.12,0.08,0.16
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,18.14,5.87,35.03
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,16.06,4.42,32.2
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,2.08,1.46,2.84
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,0.19,0.13,0.27
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,17.29,5.36,34.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,14.84,3.69,30.66
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,2.45,1.67,3.41
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.33,0.23,0.46
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,18.62,6.08,35.78
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,14.28,3.13,29.71
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,4.33,2.95,6.07
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,0.15,0.1,0.22
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,14.72,3.89,30.98
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,13.63,3.2,29.41
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,1.09,0.69,1.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,54.1,26.69,89.57
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,53.6,26.35,88.88
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.5,0.34,0.69
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.23,26.03,88.51
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,52.56,25.58,87.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.67,0.46,0.92
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.19,1.21
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.26,0.01,0.75
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.3,0.18,0.46
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.94,0.31,2.03
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.44,0.02,1.25
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.51,0.3,0.78
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.05,0.34
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.16,0.05,0.34
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,0.48,3.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.67,0.03,1.9
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.77,0.45,1.18
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,0.9,5.82
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.17,0.0,3.46
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.54,0.9,2.36
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.85,1.61,9.83
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.84,0.49,6.55
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.01,1.12,3.27
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.66,1.4,9.71
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.71,0.86,8.17
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.95,0.54,1.54
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.02,0.01,0.04
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.26,1.75,10.71
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.9,0.97,8.5
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.37,0.78,2.2
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.3,1.21,8.95
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.87,0.96,8.28
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.42,0.24,0.67
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.41,1.13,9.67
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,4.05,0.92,9.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.36,0.21,0.58
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.38,1.23,9.26
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.04,1.03,8.72
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.33,0.2,0.54
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.47,0.8,7.65
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.15,0.61,7.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.32,0.19,0.5
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.88,0.38,4.2
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.76,0.31,4.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.18
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.34,0.0,3.45
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.34,0.0,3.45
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.31,0.88
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.56,0.31,0.88
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.91,0.55,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.66,0.4,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.25,0.16,0.39
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.53,1.31
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.72,0.44,1.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.14,0.09,0.22
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.8,0.5,1.19
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.5,1.19
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.81,1.14,2.6
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.98,0.61,1.4
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.83,0.52,1.2
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.09,0.05,0.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.85,1.11,2.76
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.94,0.59,1.36
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.9,0.52,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.01,0.63,1.43
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.01,0.63,1.43
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.33,0.18,0.54
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.74,5.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.78,0.48,1.14
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,2.38,1.26,3.91
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.25,0.69,4.69
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.74,0.39,3.87
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.52,0.3,0.82
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.27,0.7,4.72
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.75,0.4,3.89
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.52,0.3,0.83
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.48,0.11,1.06
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.31,0.01,0.81
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.17,0.1,0.25
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.81,0.19,1.77
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.53,0.02,1.35
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.28,0.17,0.42
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.06,0.37
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.06,0.37
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.29,2.68
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.8,0.03,2.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.43,0.26,0.63
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.27,0.52,4.96
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.42,0.0,3.71
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.85,0.52,1.26
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,5.86,1.96,11.49
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.67,0.62,8.06
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,2.19,1.34,3.43
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.84,1.82,12.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.24,1.45,11.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.6,0.37,0.93
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.09,1.38,11.24
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.09,1.38,11.24
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.77,1.77,12.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.77,1.77,12.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.03,1.83,12.56
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.03,1.83,12.56
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.61,2.2,12.93
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.91,1.78,11.9
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.69,0.42,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.61,2.02,11.23
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.87,1.56,10.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.74,0.46,1.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.03,0.97,6.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.55,0.66,5.43
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.48,0.3,0.72
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.85,0.0,4.45
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.85,0.0,4.45
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.02,0.01,0.04
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.35,0.8,2.16
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.64,0.35,1.07
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.71,0.44,1.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.37,0.83,2.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.71,0.42,1.1
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.65,0.41,0.98
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.53,0.95,2.27
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.76,0.46,1.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.77,0.49,1.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,1.09,2.49
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.83,0.51,1.21
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.9,0.58,1.28
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.97,0.62,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.97,0.62,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.75,1.11,2.57
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,1.0,0.64,1.46
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.76,0.48,1.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.14,1.38,3.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,1.05,0.68,1.53
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.1,0.7,1.62
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.21,0.13,0.3
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.48,1.55,3.66
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.99,0.63,1.44
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,1.5,0.93,2.21
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.83,0.91,5.75
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.42,0.65,5.13
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.41,0.25,0.62
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.84,0.94,5.73
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,2.4,0.67,5.06
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.44,0.27,0.67
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.08,0.31
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.13,0.07,0.22
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.69,0.36,1.19
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.26,0.12,0.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.42,0.24,0.69
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.6,1.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.43,0.19,0.82
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.7,0.4,1.14
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.67,0.32,1.24
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.16,0.05,0.35
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.51,0.27,0.89
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.73,0.91,2.99
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.66,0.3,1.25
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.07,0.62,1.75
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.02,0.01,0.04
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.51,4.75
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.16,0.54,2.15
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.63,0.97,2.61
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,2.77,0.43,6.35
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.77,0.43,6.35
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.15,1.19,8.6
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.52,0.83,7.58
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.63,0.36,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.53,1.96,10.72
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.66,0.88,7.68
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.87,1.08,3.05
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.68,1.01,8.04
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.68,1.01,8.04
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.68,1.37,9.6
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.69,0.8,8.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,1.0,0.56,1.58
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.18,1.25,8.43
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.94,1.11,8.03
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.25,0.14,0.4
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.54,0.82,7.31
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.12,0.57,6.66
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.42,0.25,0.65
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,0.44,4.16
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.75,0.31,3.81
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.22,0.13,0.35
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.52,0.13,3.66
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.32,0.0,3.33
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.2,0.13,0.33
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.55,0.32,0.89
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.55,0.32,0.89
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.65,0.4,1.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.65,0.4,1.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.93,0.57,1.4
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.72,0.44,1.09
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.21,0.13,0.32
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,0.8,1.91
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.5,1.18
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.48,0.31,0.72
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,1.61,3.82
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.98,0.62,1.42
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.62,1.0,2.4
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.13,0.07,0.2
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.35,1.39,3.55
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.95,0.6,1.38
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,1.4,0.79,2.17
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.01,0.64,1.46
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.01,0.64,1.46
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.39,0.2,0.65
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.63,1.92,5.87
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.78,0.5,1.15
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,2.85,1.43,4.72
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.15,0.71,4.3
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.66,0.43,3.52
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.49,0.28,0.78
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.19,0.72,4.37
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.7,0.44,3.58
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.49,0.29,0.79
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.01,0.87
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.31,0.01,0.87
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.02,1.43
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.51,0.02,1.43
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.06,0.37
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.06,0.37
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.03,2.17
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.77,0.03,2.17
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.0,3.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.38,0.0,3.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.59,0.57,8.34
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.59,0.57,8.34
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.25,1.58,10.85
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.15,1.52,10.7
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.1,0.06,0.15
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.0,1.48,10.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.0,1.48,10.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.36,1.65,10.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.36,1.65,10.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.53,2.25,13.26
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.02,1.95,12.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.5,0.3,0.76
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.09,2.16,12.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.09,2.16,12.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.16,1.52,10.64
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.64,1.2,9.86
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.52,0.32,0.78
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.7,0.65,5.69
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.51,0.54,5.41
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.19,0.12,0.28
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.96,0.0,4.69
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.96,0.0,4.69
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.63,0.34,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.63,0.34,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.07,0.04,0.1
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.47,1.54,3.75
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.7,0.41,1.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.77,1.12,2.67
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.07,0.05,0.11
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.51,1.58,3.74
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.76,0.46,1.15
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.76,1.12,2.59
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.56,1.63,3.72
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.82,0.51,1.22
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.75,1.12,2.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.04,0.03,0.07
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.73,1.08,2.58
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.96,0.61,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.77,0.47,1.16
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.35,3.2
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.99,0.63,1.45
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.16,0.72,1.75
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.18,0.11,0.27
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.36,2.14,5.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,1.04,0.67,1.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.32,1.46,3.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.96,2.29
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.98,0.62,1.46
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.56,0.34,0.83
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.56,0.78,5.29
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.37,0.66,5.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.19,0.12,0.28
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.64,0.85,5.37
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,2.38,0.68,4.98
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.26,0.17,0.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.32,3.17,10.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,6.05,2.96,10.49
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.27,0.21,0.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.68,15.17,50.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,29.17,14.78,49.68
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.51,0.39,0.63
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,47.67,24.37,80.81
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,46.86,23.74,79.79
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.81,0.63,1.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.75,11.9,40.66
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,22.75,11.12,39.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.0,0.79,1.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,69.57,35.56,117.93
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,68.38,34.65,116.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.19,0.91,1.48
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,113.13,58.06,191.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,111.77,57.02,189.7
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.36,1.04,1.71
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,117.42,62.18,196.43
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,116.01,61.14,194.65
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,1.41,1.04,1.78
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,49.95,25.73,84.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,48.8,24.86,83.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.15,0.87,1.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,61.92,31.66,103.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,60.88,30.88,102.53
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.04,0.78,1.29
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,31.41,15.62,55.17
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,30.24,14.75,53.77
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,1.17,0.87,1.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,18.51,8.8,33.27
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,17.18,7.77,31.69
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,1.33,1.03,1.59
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.61,5.71,20.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,10.86,5.13,19.52
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.75,0.58,0.94
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,8.57,4.36,15.53
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,7.76,3.71,14.56
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.81,0.65,0.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.32,3.6,13.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,6.62,3.05,12.38
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.7,0.55,0.84
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,6.8,3.18,12.76
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,6.28,2.78,12.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.52,0.41,0.63
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,6.29,3.1,10.72
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,5.53,2.5,9.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.77,0.6,0.92
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,5.14,2.41,9.51
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,4.79,2.13,9.09
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.35,0.28,0.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.7,2.12,8.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,4.45,1.93,8.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.25,0.2,0.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.06,1.71,8.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,3.96,1.63,7.88
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.1,0.08,0.12
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,3.32,1.45,6.16
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,3.17,1.33,5.98
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.15,0.12,0.18
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.49,1.55,6.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,3.32,1.42,6.24
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.17,0.13,0.21
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.0,1.24,5.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,2.86,1.13,5.72
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.14,0.11,0.18
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.04,0.03,0.04
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,4.78,2.33,8.14
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,4.51,2.13,7.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.27,0.2,0.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,30.84,15.81,52.48
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,30.13,15.26,51.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.72,0.55,0.88
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,31.74,16.25,54.05
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,30.98,15.67,53.12
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.76,0.58,0.93
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.0,0.05
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.04,0.0,0.05
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.95,1.84,6.72
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.74,1.68,6.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.22,0.15,0.27
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,18.45,9.34,31.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,17.95,8.94,30.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.49,0.4,0.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.11,0.0,0.15
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.11,0.0,0.15
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.53,14.95,50.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,28.74,14.31,49.34
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.79,0.64,0.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.69,6.87,25.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,13.99,6.29,24.15
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.71,0.58,0.87
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,42.91,21.74,73.1
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,41.8,20.81,71.76
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.1,0.93,1.34
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,69.4,35.7,118.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,67.93,34.45,116.48
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.47,1.26,1.78
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,70.69,37.65,110.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,69.54,36.68,109.26
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.15,0.98,1.34
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,28.9,14.69,48.21
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,28.55,14.39,47.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.35,0.3,0.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,35.68,17.99,61.87
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,35.5,17.83,61.67
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.18,0.15,0.21
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,17.73,8.38,31.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,17.54,8.22,31.68
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.13,4.45,18.23
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,10.02,4.37,18.11
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.11,0.09,0.12
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.07,3.34,13.11
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.95,3.24,12.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.12,0.1,0.14
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.47,2.43,10.69
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,5.14,2.14,10.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.33,0.29,0.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.85,2.14,9.14
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,4.56,1.89,8.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.29,0.25,0.34
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.69,2.11,8.89
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,4.37,1.83,8.51
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.33,0.28,0.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.25,1.81,7.47
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,4.06,1.65,7.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.82,1.63,7.26
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,3.54,1.39,6.93
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.28,0.24,0.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.42,1.45,6.49
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,3.26,1.31,6.29
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.16,0.14,0.19
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.88,1.21,5.43
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,2.87,1.21,5.43
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.47,1.35,4.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,2.4,1.29,4.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.59,1.3,4.62
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,2.53,1.25,4.54
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.06,0.05,0.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.16,1.03,3.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,2.15,1.03,3.95
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.42,1.55,6.19
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,3.29,1.46,6.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.13,0.09,0.17
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,18.56,9.37,31.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,18.18,9.06,30.88
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.37,0.31,0.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.52,9.33,31.36
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,18.15,9.02,30.92
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.37,0.31,0.44
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.13,3.04,10.54
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,6.01,2.95,10.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.12,0.09,0.15
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.31,14.87,50.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,28.99,14.63,49.67
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.32,0.24,0.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,47.11,23.89,80.49
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,46.59,23.51,79.83
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.52,0.38,0.66
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.13,11.46,39.75
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,22.69,11.12,39.2
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.44,0.34,0.55
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.74,34.87,117.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,67.98,34.31,116.48
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.76,0.56,0.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.74,56.94,190.71
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,110.68,56.18,189.35
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.06,0.76,1.36
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,116.32,61.51,195.94
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,115.14,60.68,194.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,1.18,0.83,1.52
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.02,0.01,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,49.41,25.92,83.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,48.25,25.1,82.47
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.15,0.82,1.43
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,61.75,33.43,102.63
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,60.68,32.69,101.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.08,0.74,1.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.02,0.01,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,31.39,15.89,55.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,30.22,15.07,53.72
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,1.17,0.82,1.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,18.56,8.9,32.68
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,17.04,7.8,30.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,1.52,1.1,1.86
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.58,5.9,20.73
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,10.8,5.33,19.75
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.78,0.57,0.98
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,8.85,4.29,16.83
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,7.92,3.59,15.7
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.93,0.7,1.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.58,3.66,13.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,6.67,2.97,12.69
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.91,0.68,1.11
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.09,3.33,12.79
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,6.23,2.69,11.74
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.86,0.64,1.05
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,6.53,3.24,11.09
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,5.57,2.52,9.92
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.96,0.72,1.17
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,5.06,2.5,9.2
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,4.71,2.24,8.78
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.34,0.26,0.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.58,2.18,8.38
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,4.33,1.99,8.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.25,0.19,0.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.9,1.73,7.2
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,3.78,1.64,7.06
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.11,0.09,0.14
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,3.41,1.63,6.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,3.09,1.38,6.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.32,0.24,0.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.53,1.62,6.62
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,3.28,1.43,6.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.25,0.19,0.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.9,1.14,5.94
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,2.83,1.08,5.85
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.07,0.05,0.09
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,4.86,2.37,8.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,4.51,2.12,7.81
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.35,0.26,0.44
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,30.61,15.81,52.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,29.93,15.32,51.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.68,0.49,0.84
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,31.33,16.18,53.53
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,30.6,15.65,52.62
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.73,0.53,0.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.0,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.01,0.0,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.94,1.97,6.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.76,1.83,6.59
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.18,0.14,0.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,18.3,9.41,30.27
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,17.99,9.16,29.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.31,0.25,0.38
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.0,0.06
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.04,0.0,0.06
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.33,15.08,48.51
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,28.83,14.68,47.91
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.49,0.4,0.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.76,7.39,25.52
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,14.13,6.87,24.76
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.63,0.52,0.77
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,42.64,21.94,70.54
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,41.94,21.36,69.68
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.7,0.58,0.85
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.62,35.49,112.47
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,67.85,34.85,111.54
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.76,0.63,0.93
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,70.56,37.54,112.46
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,69.56,36.71,111.28
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.99,0.82,1.18
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,28.71,14.65,47.96
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,28.36,14.37,47.55
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.34,0.28,0.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,36.13,18.83,60.98
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,35.93,18.67,60.75
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.19,0.16,0.23
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,17.65,8.22,30.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,17.34,7.97,30.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.31,0.25,0.37
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,9.91,4.39,18.73
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,9.83,4.32,18.63
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.09,0.07,0.1
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.92,3.03,12.74
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.81,2.94,12.62
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.11,0.09,0.12
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.54,2.43,10.64
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,5.11,2.07,10.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.43,0.36,0.51
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.91,2.25,9.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,4.54,1.94,8.96
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.37,0.31,0.44
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.72,2.17,9.36
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,4.38,1.89,8.96
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.34,0.28,0.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.36,2.12,7.94
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,4.02,1.84,7.53
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.34,0.29,0.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.74,1.59,6.95
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,3.49,1.39,6.65
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.25,0.2,0.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.36,1.45,6.46
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,3.22,1.33,6.29
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.14,0.12,0.17
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.85,1.26,5.81
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,2.85,1.26,5.81
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.5,1.37,4.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,2.44,1.31,4.23
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.07,0.05,0.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.62,1.32,4.66
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,2.56,1.28,4.59
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.06,0.04,0.07
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.2,1.09,4.04
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,2.19,1.08,4.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.43,1.55,6.26
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,3.33,1.48,6.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.1,0.07,0.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,18.49,9.43,30.95
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,18.19,9.18,30.58
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.31,0.25,0.37
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.33,9.32,30.78
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,18.02,9.06,30.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.31,0.25,0.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.46,2.45
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.25,0.46,2.45
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.38,6.03,21.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,12.38,6.03,21.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.68,10.6,36.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,20.68,10.6,36.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.66,1.33,7.17
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.66,1.33,7.17
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,33.22,17.02,59.14
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,33.22,17.02,59.14
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,43.08,21.39,75.59
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,43.08,21.39,75.59
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,46.8,24.23,83.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,46.8,24.23,83.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,50.35,26.93,90.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,50.35,26.93,90.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,39.46,21.11,69.62
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,39.46,21.11,69.62
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,24.45,12.75,41.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,24.45,12.75,41.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,28.77,14.84,46.62
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,28.77,14.84,46.62
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,21.15,11.21,34.79
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,21.15,11.21,34.79
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.66,8.28,27.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,16.66,8.28,27.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.71,6.91,24.76
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,13.71,6.91,24.76
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,10.62,5.72,18.54
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,10.62,5.72,18.54
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,8.15,4.42,13.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,8.15,4.42,13.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.8,4.3,12.78
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.8,4.3,12.78
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.32,2.85,8.87
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,5.32,2.85,8.87
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.47,1.82,5.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.47,1.82,5.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.88,1.51,4.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.88,1.51,4.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.01,1.05,3.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.01,1.05,3.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.21,0.61,2.06
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.21,0.61,2.06
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.96,0.49,1.65
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.96,0.49,1.65
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.79,0.42,1.38
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.79,0.42,1.38
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.27,0.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.51,0.27,0.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,18.15,9.41,31.49
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,18.15,9.41,31.49
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.57,9.64,32.15
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,18.57,9.64,32.15
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.54,2.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.13,0.54,2.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.86,5.15,17.11
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,9.86,5.15,17.11
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.13,7.63,25.07
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,14.13,7.63,25.07
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.31,1.57,6.07
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,3.31,1.57,6.07
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.62,12.21,40.13
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,22.62,12.21,40.13
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.81,17.8,58.36
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,33.81,17.8,58.36
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.4,17.04,55.61
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,31.4,17.04,55.61
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.13,16.34,53.03
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,29.13,16.34,53.03
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,17.79,9.65,31.69
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,17.79,9.65,31.69
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.52,5.47,17.84
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,10.52,5.47,17.84
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.86,6.36,19.04
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,11.86,6.36,19.04
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.77,4.34,14.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.77,4.34,14.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.38,3.56,12.21
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,7.38,3.56,12.21
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.17,3.05,10.91
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.17,3.05,10.91
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.6,2.38,8.46
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.6,2.38,8.46
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.57,1.89,6.26
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,3.57,1.89,6.26
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.39,1.85,5.74
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,3.39,1.85,5.74
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.48,1.32,4.1
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,2.48,1.32,4.1
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.69,0.86,2.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.69,0.86,2.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.42,0.71,2.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.42,0.71,2.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.04,0.51,1.74
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.04,0.51,1.74
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.66,0.33,1.2
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.66,0.33,1.2
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.25,0.93
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.51,0.25,0.93
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.22,0.8
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.44,0.22,0.8
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.28,0.13,0.52
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.28,0.13,0.52
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.92,5.27,17.29
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,9.92,5.27,17.29
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.64,5.11,16.77
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,9.64,5.11,16.77
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.46,2.46
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.25,0.46,2.46
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,11.99,5.94,21.33
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,11.99,5.94,21.33
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.4,10.14,35.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,19.4,10.14,35.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.67,1.36,7.2
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.67,1.36,7.2
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.18,16.3,56.29
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,31.18,16.3,56.29
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,41.77,21.14,73.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,41.77,21.14,73.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.81,23.16,78.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,43.81,23.16,78.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,45.73,25.07,83.7
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,45.73,25.07,83.7
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,34.59,18.69,60.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,34.59,18.69,60.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,21.18,11.09,35.69
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,21.18,11.09,35.69
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,24.89,13.06,39.81
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,24.89,13.06,39.81
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,17.98,9.54,28.86
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,17.98,9.54,28.86
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,14.46,7.07,24.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,14.46,7.07,24.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.21,6.11,22.49
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,12.21,6.11,22.49
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,9.68,5.08,17.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,9.68,5.08,17.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.49,3.99,13.05
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,7.49,3.99,13.05
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.19,3.9,12.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.19,3.9,12.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.01,2.68,8.64
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,5.01,2.68,8.64
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.39,1.82,5.7
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.39,1.82,5.7
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.84,1.52,4.75
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.84,1.52,4.75
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.03,1.08,3.39
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.03,1.08,3.39
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.59,2.18
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.25,0.59,2.18
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.48,1.73
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.99,0.48,1.73
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.81,0.43,1.43
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.81,0.43,1.43
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.54,0.28,0.95
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.54,0.28,0.95
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,16.43,8.6,28.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,16.43,8.6,28.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,16.67,8.73,29.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,16.67,8.73,29.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.12,0.53,1.96
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.12,0.53,1.96
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.64,5.04,16.79
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,9.64,5.04,16.79
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,13.65,7.3,23.86
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,13.65,7.3,23.86
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.28,1.55,5.73
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,3.28,1.55,5.73
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,21.88,11.69,38.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,21.88,11.69,38.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.14,17.48,57.72
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,33.14,17.48,57.72
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,30.33,16.31,53.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,30.33,16.31,53.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.71,15.21,48.6
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,27.71,15.21,48.6
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,16.34,8.64,28.03
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,16.34,8.64,28.03
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.53,4.86,16.38
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,9.53,4.86,16.38
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,10.61,5.45,18.56
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,10.61,5.45,18.56
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,7.97,4.14,13.09
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,7.97,4.14,13.09
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.71,3.26,11.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.71,3.26,11.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.61,2.55,10.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.61,2.55,10.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.36,2.4,7.85
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.36,2.4,7.85
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.42,1.89,5.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,3.42,1.89,5.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.27,1.81,5.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,3.27,1.81,5.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.43,1.36,4.05
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,2.43,1.36,4.05
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.69,0.87,2.78
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.69,0.87,2.78
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.41,0.72,2.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.41,0.72,2.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.04,0.52,1.76
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.04,0.52,1.76
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.68,0.34,1.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.68,0.34,1.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.53,0.26,0.95
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.53,0.26,0.95
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.46,0.23,0.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.46,0.23,0.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.28,0.14,0.53
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.28,0.14,0.53
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.38,4.93,16.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,9.38,4.93,16.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.01,4.74,15.63
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,9.01,4.74,15.63
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.96,0.49,1.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.96,0.49,1.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.19,0.16,0.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,42.47,26.89,63.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,28.07,14.58,46.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,14.4,12.31,16.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.4,0.35,0.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,76.25,50.8,110.57
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,47.17,25.66,76.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,29.08,25.14,33.76
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.8,1.44,4.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.8,1.44,4.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.65,0.56,0.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,122.48,81.6,177.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,75.76,41.22,123.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,46.71,40.39,54.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.72,0.61,0.85
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,156.93,99.67,233.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,102.84,53.42,169.53
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,54.09,46.25,63.72
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.95,0.82,1.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,177.45,118.43,257.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,109.28,59.49,177.87
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,68.17,58.94,79.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,1.16,1.01,1.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,196.97,136.26,279.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,115.41,65.25,185.8
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,81.56,71.01,93.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,1.24,1.08,1.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,169.57,121.03,229.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,88.5,50.49,137.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,81.07,70.54,92.03
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,1.23,1.08,1.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,124.29,92.69,163.98
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,55.85,32.46,86.83
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,68.44,60.23,77.15
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,1.15,1.01,1.31
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,135.43,99.74,180.42
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,66.08,38.78,101.51
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,69.34,60.97,78.9
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,1.25,1.11,1.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,119.74,90.3,156.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,50.25,28.69,78.85
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,69.49,61.61,77.57
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,1.31,1.17,1.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,104.7,81.75,134.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,38.54,22.94,60.64
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,66.16,58.81,73.55
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,1.17,1.02,1.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,83.09,64.72,106.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,29.9,18.09,46.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,53.19,46.63,60.35
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.89,0.8,1.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,59.67,46.59,78.51
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,23.42,14.14,38.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,36.25,32.46,40.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.65,0.58,0.73
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,44.47,33.79,60.09
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,20.16,12.15,32.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,24.31,21.64,27.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.54,0.48,0.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,38.83,28.98,53.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,19.41,11.74,31.65
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,19.42,17.24,21.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.47,0.41,0.53
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.23,22.71,43.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,16.76,10.01,27.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,14.47,12.7,16.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.35,0.31,0.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,24.02,16.42,33.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.84,8.29,23.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,9.18,8.13,10.35
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.38,0.34,0.43
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,23.56,16.44,33.06
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,14.3,8.22,22.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,9.26,8.21,10.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.43,0.39,0.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,22.89,16.46,32.05
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,13.51,8.12,21.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,9.38,8.34,10.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,0.37,0.32,0.42
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,18.47,12.87,26.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.15,7.29,19.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,6.31,5.58,7.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,0.52,0.44,0.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,18.15,12.57,26.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,11.61,6.94,18.49
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,6.54,5.62,7.52
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.51,0.43,0.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,18.05,12.41,25.95
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,11.36,6.77,18.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,6.69,5.64,7.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.95,0.79,1.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,17.41,11.97,24.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,10.46,6.25,16.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,6.95,5.72,8.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.72,0.63,0.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,81.83,58.59,112.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,42.27,23.92,67.31
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,39.57,34.67,44.99
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.76,0.67,0.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,84.96,61.09,116.22
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,43.35,24.6,68.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,41.61,36.49,47.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.01,0.0,0.02
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.5,0.14,2.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.33,0.14,0.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,1.18,0.0,1.63
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.06,0.04,0.07
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.93,7.53,22.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,9.52,4.42,17.15
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,4.41,3.11,5.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.15,0.12,0.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.91,17.05,40.03
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,16.23,8.18,27.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,10.67,8.86,12.2
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.04,0.0,0.06
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.4,0.41,6.58
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.96,0.41,1.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,3.44,0.0,4.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.24,0.2,0.27
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.08,27.29,64.09
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,25.99,13.1,44.56
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,17.09,14.19,19.53
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.18,0.15,0.2
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,48.01,27.8,77.69
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,34.74,16.15,62.5
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,13.27,11.66,15.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.33,0.29,0.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,60.65,39.51,90.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,37.36,18.86,63.99
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,23.29,20.64,26.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.47,0.41,0.52
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,72.53,50.5,102.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.83,21.42,65.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,32.71,29.08,36.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.33,0.3,0.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,52.88,35.97,75.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,31.07,16.64,51.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,21.82,19.33,24.52
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.32,0.28,0.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,37.74,26.57,52.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,19.87,10.58,32.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,17.87,15.99,20.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.37,0.33,0.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,45.36,32.33,62.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,23.2,12.43,37.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,22.15,19.9,24.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.27,0.25,0.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,32.93,22.97,46.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,17.77,9.28,30.09
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,15.16,13.69,16.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.35,0.32,0.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,32.08,23.48,43.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,14.18,7.5,23.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,17.9,15.99,20.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.25,0.23,0.28
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,23.28,16.62,32.83
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,11.86,6.38,19.94
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,11.43,10.24,12.89
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.14,0.13,0.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,15.87,10.6,23.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,10.21,5.51,17.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,5.65,5.1,6.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.14,0.13,0.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.8,9.89,21.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,9.63,5.3,15.92
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,5.17,4.59,5.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.16,0.14,0.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,15.11,10.23,21.97
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,9.39,5.23,15.54
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,5.72,5.0,6.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.13,0.11,0.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,13.09,8.58,19.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,9.17,5.11,14.58
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,3.92,3.48,4.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.2,0.18,0.22
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,13.94,9.6,19.9
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,8.75,5.0,14.13
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,5.18,4.61,5.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.17,0.15,0.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.64,8.5,18.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,8.41,4.76,13.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,4.22,3.74,4.71
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.13,0.12,0.15
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.85,6.99,16.34
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,7.94,4.45,13.07
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.91,2.54,3.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.11,0.1,0.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.26,5.61,13.88
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,7.36,3.97,11.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.91,1.65,2.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.27,0.21,0.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,9.88,6.09,14.7
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,7.03,3.81,11.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,2.85,2.28,3.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.2,0.16,0.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.58,5.98,14.55
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,6.94,3.84,11.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.64,2.14,3.08
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.7,0.52,0.85
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,11.58,7.27,16.64
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.46,3.46,10.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,5.12,3.8,6.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.21,0.18,0.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,26.9,18.02,38.83
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,15.41,8.06,25.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,11.49,9.96,12.97
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.22,0.19,0.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,27.37,18.45,39.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,15.63,8.21,26.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,11.74,10.25,13.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.94,0.49,1.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.94,0.49,1.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.08,0.07,0.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.64,19.62,52.05
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,27.46,14.37,44.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,6.18,5.25,7.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.26,0.22,0.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,64.74,40.89,96.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,46.42,25.13,74.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,18.32,15.75,21.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.75,1.42,4.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.75,1.42,4.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.41,0.35,0.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,104.06,65.72,154.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,74.61,40.4,120.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,29.45,25.32,34.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.31,0.26,0.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,124.29,72.67,191.95
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,100.97,52.85,164.09
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,23.32,19.82,27.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.6,0.52,0.7
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,150.58,95.24,223.43
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,107.61,58.29,173.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,42.97,36.94,50.21
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.87,0.76,1.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,175.37,116.52,253.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,113.88,63.43,181.85
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,61.49,53.09,71.27
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,0.99,0.86,1.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,152.26,107.4,209.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,87.45,51.19,135.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,64.81,56.21,74.42
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,1.2,1.05,1.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,121.27,90.47,161.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,55.24,32.44,85.64
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,66.03,58.03,75.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,1.13,1.0,1.31
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,134.19,98.62,181.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,65.77,38.5,102.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,68.42,60.12,78.99
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,1.21,1.08,1.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,117.03,89.33,154.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,49.81,29.38,77.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,67.22,59.95,76.56
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,1.47,1.3,1.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,112.61,87.72,142.51
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,38.46,22.32,58.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,74.15,65.4,84.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,1.18,1.03,1.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,83.57,64.84,108.55
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,29.68,17.92,46.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,53.89,46.91,62.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,1.0,0.88,1.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,63.73,49.67,82.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,23.07,13.79,35.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,40.66,35.89,46.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.83,0.73,0.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,50.62,38.7,66.57
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,19.77,11.55,31.13
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,30.85,27.15,35.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.87,0.77,1.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,50.13,38.37,66.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,18.97,10.88,30.13
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,31.16,27.49,35.88
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.58,0.5,0.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.26,24.91,46.98
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,16.47,9.46,26.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,17.8,15.44,20.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.34,0.29,0.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,23.51,16.4,34.03
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.69,8.73,23.79
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,8.82,7.68,10.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.4,0.35,0.45
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,23.62,16.63,33.5
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,14.11,8.31,22.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,9.51,8.32,10.88
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.49,0.43,0.55
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,23.77,16.97,32.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,13.28,7.72,20.94
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,10.49,9.25,11.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,0.77,0.67,0.88
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,25.36,18.59,33.99
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.18,7.14,18.87
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,13.19,11.44,15.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.7,0.59,0.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,20.99,14.84,28.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,11.56,6.77,17.87
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,9.44,8.07,10.91
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.25,0.2,0.29
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,14.44,9.21,20.87
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,11.21,6.53,17.05
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.23,2.68,3.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,1.22,1.0,1.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,19.27,13.37,26.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,10.36,6.08,16.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,8.91,7.29,10.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.68,0.59,0.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,77.11,54.59,106.63
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,41.76,23.67,65.95
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,35.35,30.92,40.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.73,0.64,0.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,80.44,57.33,110.72
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,42.63,24.24,67.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,37.81,33.09,43.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.79,0.13,1.28
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.32,0.13,0.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.47,0.0,0.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.92,6.98,21.53
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,9.36,4.14,17.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,3.56,2.84,4.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.09,0.08,0.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.68,13.35,36.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,16.05,7.76,28.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,6.62,5.59,7.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.02,0.0,0.02
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.32,0.39,3.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.95,0.39,1.79
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,1.37,0.0,1.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.15,0.12,0.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.34,21.38,58.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,25.73,12.43,46.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,10.61,8.95,12.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.16,0.14,0.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,46.37,25.87,77.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,34.28,15.18,63.7
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,12.09,10.69,13.71
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.21,0.18,0.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,51.81,30.93,83.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,36.99,17.91,66.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,14.82,13.02,16.8
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.25,0.22,0.28
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,56.87,35.64,88.29
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.52,20.45,68.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,17.36,15.19,19.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.29,0.25,0.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,49.83,33.94,72.02
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,30.93,17.35,50.64
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,18.9,16.59,21.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.34,0.3,0.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,38.93,27.9,54.02
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,19.92,10.95,32.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,19.01,16.95,21.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.4,0.36,0.45
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,47.54,34.91,65.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,23.47,13.46,38.76
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,24.07,21.46,27.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.46,0.41,0.51
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,43.27,32.28,56.65
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,17.9,9.4,28.43
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,25.37,22.88,28.21
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.29,0.26,0.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,29.28,20.77,41.07
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,14.44,7.58,24.35
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,14.84,13.19,16.72
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.23,0.2,0.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.18,15.68,31.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,11.85,6.43,19.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,10.33,9.24,11.65
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.18,0.17,0.21
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,17.75,12.36,25.54
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,10.27,5.64,17.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,7.48,6.72,8.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.19,0.17,0.22
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,16.58,11.55,23.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,9.67,5.42,15.8
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,6.91,6.13,7.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.17,0.15,0.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,15.4,10.53,21.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,9.42,5.28,15.03
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,5.98,5.25,6.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.24,0.21,0.27
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,16.51,11.72,23.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,9.23,5.3,15.11
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,7.28,6.42,8.29
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.18,0.16,0.2
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,13.45,9.12,19.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,8.81,5.0,14.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,4.64,4.12,5.15
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.16,0.14,0.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.33,8.3,18.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,8.48,4.89,13.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,3.85,3.41,4.29
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.13,0.11,0.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.83,7.19,16.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,8.03,4.74,13.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.8,2.45,3.13
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.11,0.1,0.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.28,5.55,13.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,7.39,3.91,11.66
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.89,1.64,2.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.27,0.21,0.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,10.12,6.23,14.91
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,7.06,3.79,11.34
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,3.06,2.43,3.56
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.32,0.25,0.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,11.2,7.02,16.5
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,7.03,3.72,11.65
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,4.16,3.3,4.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.55,0.41,0.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,10.42,6.59,15.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.4,3.63,10.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,4.02,2.95,4.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.2,0.17,0.22
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,25.94,17.32,38.11
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,15.39,8.07,26.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,10.55,9.25,11.91
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.21,0.19,0.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,26.57,17.9,38.76
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,15.56,8.21,26.34
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,11.01,9.69,12.42
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.21,0.95,4.07
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.21,0.95,4.07
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.25,0.21,0.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,69.04,41.32,107.06
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,50.27,25.43,84.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,18.77,15.89,22.29
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.52,0.45,0.61
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,151.2,92.47,233.64
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,113.69,60.32,189.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,37.51,32.15,43.86
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,2.77,11.9
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,6.46,2.77,11.9
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.84,0.72,0.98
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,242.86,148.52,375.27
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,182.61,96.88,304.83
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,60.25,51.63,70.44
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.94,0.79,1.11
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,253.34,152.63,391.07
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,182.8,92.94,307.33
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,70.54,59.7,83.74
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,1.22,1.04,1.42
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,351.45,215.47,542.19
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,263.53,140.12,439.39
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,87.93,75.35,102.8
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,1.49,1.28,1.72
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,444.75,275.22,685.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,340.29,184.98,564.97
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,104.46,90.24,120.93
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,1.56,1.35,1.79
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,422.25,268.25,632.59
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,320.16,180.1,515.75
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,102.09,88.15,116.84
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,1.5,1.31,1.71
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,265.1,174.74,386.34
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,181.09,101.4,290.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,84.02,73.34,95.45
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,1.38,1.2,1.57
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,301.55,194.76,441.48
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,218.57,122.53,346.45
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,82.98,72.22,95.02
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,1.53,1.34,1.72
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,234.88,158.14,336.47
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,150.3,83.76,241.32
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,84.58,74.38,95.15
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,1.63,1.44,1.83
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,191.56,133.23,269.59
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,109.43,60.72,177.55
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,82.13,72.51,92.04
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,1.42,1.24,1.63
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,149.19,103.56,212.04
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,84.53,47.25,137.91
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,64.67,56.31,74.13
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,1.31,1.16,1.49
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,120.25,84.62,170.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,66.95,37.56,110.54
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,53.3,47.06,60.34
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.99,0.87,1.12
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,91.73,62.88,132.6
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,55.07,30.7,90.92
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,36.66,32.18,41.68
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.84,0.74,0.96
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,83.19,55.8,121.67
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,53.16,29.51,87.36
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,30.04,26.3,34.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.73,0.64,0.84
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,64.42,42.75,95.28
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,41.7,23.07,69.32
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,22.72,19.67,25.96
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.56,0.49,0.64
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,48.13,30.57,71.64
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,33.43,17.76,54.86
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,14.7,12.81,16.79
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.54,0.47,0.61
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,44.31,28.38,66.28
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,31.2,16.91,51.37
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,13.11,11.47,14.91
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.5,0.44,0.56
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,38.75,25.21,58.5
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,27.95,15.68,46.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,10.8,9.52,12.19
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.49,0.43,0.56
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,31.7,20.59,47.05
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,23.35,13.25,37.5
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,8.35,7.33,9.55
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,0.87,0.73,1.01
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,32.73,21.47,48.23
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,22.2,12.53,36.01
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,10.52,8.94,12.23
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,1.0,0.83,1.18
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,34.14,22.66,50.22
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,21.08,11.76,34.8
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,13.06,10.9,15.42
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,1.73,1.42,2.02
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,33.39,22.07,48.4
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,20.77,11.71,33.7
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,12.62,10.36,14.7
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.92,0.8,1.06
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,169.3,108.98,251.98
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,118.9,65.22,194.21
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,50.39,43.76,57.77
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,0.98,0.85,1.12
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,175.92,113.59,261.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,122.92,67.53,200.61
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,53.0,46.07,60.69
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.02,0.0,0.03
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.38,0.68,5.13
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.46,0.68,2.7
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,1.92,0.0,2.43
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.09,0.06,0.1
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,35.46,18.52,58.12
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,28.83,14.02,50.26
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,6.63,4.5,7.85
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.22,0.18,0.25
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,90.49,51.84,144.91
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,74.64,39.03,126.6
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,15.85,12.81,18.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.07,0.0,0.09
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,9.89,1.98,14.99
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.27,1.98,7.88
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,5.62,0.0,7.1
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.35,0.29,0.41
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,144.86,82.99,232.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,119.49,62.48,202.69
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,25.37,20.51,29.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.26,0.22,0.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,123.43,67.45,203.47
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,103.9,50.62,180.74
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,19.53,16.83,22.74
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.48,0.42,0.55
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,206.2,119.8,330.62
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,171.85,89.97,291.22
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,34.35,29.82,39.4
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.69,0.6,0.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,283.95,168.97,450.04
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,235.67,126.94,394.98
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,48.28,42.03,55.06
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.49,0.43,0.56
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,283.38,171.33,422.25
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,251.09,143.31,385.36
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,32.28,28.02,36.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.46,0.4,0.52
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,184.0,114.26,278.06
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,158.14,91.53,248.77
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,25.87,22.73,29.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.52,0.46,0.58
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,228.93,143.76,345.49
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,197.8,116.29,310.35
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,31.13,27.46,35.15
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.39,0.35,0.44
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,167.73,103.58,259.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,145.89,84.26,235.41
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,21.84,19.32,24.48
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.52,0.46,0.59
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,130.44,84.03,196.61
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,104.13,60.88,166.82
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,26.31,23.14,29.8
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.36,0.32,0.41
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,95.04,59.78,143.87
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,78.52,45.16,125.08
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,16.52,14.62,18.79
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.24,0.21,0.27
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,70.18,42.16,108.32
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,60.44,33.56,97.29
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,9.74,8.6,11.03
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.24,0.21,0.27
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,58.07,34.75,89.76
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,49.31,27.11,79.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,8.76,7.64,9.98
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.27,0.24,0.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,57.26,34.66,88.4
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,47.43,26.2,77.19
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,9.82,8.47,11.2
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.2,0.18,0.23
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,43.79,25.52,68.02
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,37.51,20.07,60.81
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,6.28,5.45,7.21
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.31,0.27,0.35
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,37.63,22.87,59.43
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,29.6,15.88,50.36
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,8.02,6.99,9.07
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.3,0.26,0.33
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,34.15,20.43,54.09
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,26.94,14.16,45.94
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,7.21,6.27,8.15
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.28,0.24,0.32
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.38,17.08,46.76
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,23.29,11.82,39.88
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,6.09,5.27,6.88
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.26,0.22,0.29
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,24.6,14.45,37.38
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,20.19,10.71,32.35
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,4.41,3.74,5.03
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,0.55,0.43,0.65
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,25.27,14.79,38.45
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,19.37,10.1,31.51
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,5.9,4.68,6.94
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.4,0.32,0.47
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,23.56,13.44,36.45
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,18.33,9.26,30.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,5.23,4.18,6.15
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,1.36,1.01,1.65
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,28.99,17.32,43.39
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,19.07,9.97,31.38
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,9.92,7.34,12.01
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.31,0.27,0.36
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,111.37,67.13,171.8
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,94.29,52.63,152.29
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,17.08,14.49,19.5
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.33,0.28,0.38
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,114.08,69.01,175.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,96.59,54.07,155.82
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,17.49,14.94,19.95
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.19,0.95,4.05
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.19,0.95,4.05
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.11,0.09,0.13
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,57.28,31.97,92.29
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,49.21,25.2,82.56
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,8.07,6.77,9.73
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.33,0.28,0.39
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,135.09,79.34,213.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,111.42,59.19,185.72
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,23.67,20.14,27.86
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.41,2.78,11.87
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,6.41,2.78,11.87
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.53,0.45,0.63
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,217.12,127.51,343.27
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,179.08,95.14,298.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,38.04,32.38,44.78
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.4,0.34,0.49
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,210.01,117.97,336.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,179.56,92.44,300.22
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,30.44,25.52,36.71
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.78,0.66,0.91
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,313.88,184.79,495.46
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,258.37,137.55,430.12
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,55.51,47.24,65.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,1.13,0.96,1.31
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,411.82,247.79,644.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,332.67,180.07,552.6
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,79.15,67.72,92.33
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,1.26,1.08,1.46
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,395.77,248.42,600.16
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,313.41,177.67,504.72
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,82.36,70.76,95.44
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,1.47,1.28,1.7
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,258.12,170.97,376.06
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,176.79,100.27,282.23
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,81.33,70.7,93.82
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,1.37,1.18,1.59
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,297.03,194.0,432.18
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,214.58,122.65,336.52
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,82.44,71.34,95.66
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,1.48,1.31,1.7
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,229.15,155.61,328.06
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,147.05,83.27,234.07
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,82.09,72.34,93.99
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,1.83,1.6,2.09
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,199.51,140.59,275.7
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,107.4,59.98,170.39
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,92.11,80.61,105.31
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,1.44,1.24,1.68
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,148.45,103.8,212.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,82.93,47.24,136.57
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,65.52,56.56,76.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,1.47,1.28,1.7
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,125.69,87.6,177.42
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,65.91,35.48,108.42
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,59.78,52.12,69.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,1.27,1.1,1.47
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,100.7,69.69,142.77
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,54.01,29.12,88.69
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,46.69,40.56,54.08
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,1.35,1.17,1.57
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,100.17,70.31,140.62
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,51.98,28.44,84.66
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,48.19,41.88,55.96
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.9,0.78,1.05
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,69.01,45.76,100.53
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,41.03,21.72,68.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,27.97,24.04,32.53
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.54,0.46,0.63
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,47.44,30.51,71.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,33.32,18.36,55.42
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,14.13,12.15,16.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.55,0.47,0.63
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,44.25,28.61,66.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,30.96,17.11,51.13
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,13.29,11.49,15.37
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.56,0.49,0.64
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,39.67,25.88,58.72
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,27.59,15.33,44.96
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,12.08,10.55,13.76
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,1.01,0.88,1.17
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,40.79,28.19,57.47
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,23.35,13.13,37.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,17.44,15.06,20.12
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,1.08,0.9,1.26
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,36.03,24.13,51.8
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,22.14,12.36,35.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,13.89,11.77,16.22
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.48,0.4,0.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,27.22,16.71,41.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,20.93,11.53,33.94
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,6.29,5.17,7.56
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,2.22,1.8,2.64
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,36.85,24.65,52.48
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,20.69,11.52,33.28
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,16.16,13.12,19.2
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.88,0.76,1.02
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,161.88,103.5,242.13
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,116.55,64.3,189.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,45.33,39.21,52.55
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.95,0.82,1.1
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,168.47,108.28,251.11
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,119.95,66.28,194.9
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,48.52,42.0,56.22
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.21,0.66,3.55
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.45,0.66,2.57
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.76,0.0,0.98
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.07,0.05,0.08
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.85,18.03,56.87
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,28.59,13.94,50.71
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,5.27,4.09,6.16
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.13,0.11,0.16
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,84.22,46.95,136.6
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,74.46,38.9,125.24
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,9.76,8.04,11.36
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.03,0.0,0.04
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,1.95,10.4
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.23,1.95,7.52
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,2.22,0.0,2.88
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.22,0.18,0.25
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,134.96,75.22,218.89
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,119.32,62.33,200.68
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,15.63,12.89,18.21
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.24,0.2,0.27
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,121.19,65.94,203.99
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,103.48,50.57,183.55
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,17.7,15.38,20.44
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.3,0.26,0.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,193.37,108.54,313.68
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,171.64,89.79,288.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,21.73,18.75,25.18
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.36,0.31,0.42
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,260.62,148.22,415.86
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,235.14,126.33,386.27
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,25.49,21.89,29.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.43,0.37,0.49
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,279.36,172.12,417.81
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,251.38,148.05,385.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,27.98,24.07,32.23
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.49,0.42,0.56
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,185.11,116.5,277.12
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,157.78,92.6,245.86
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,27.33,23.89,31.26
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.56,0.49,0.64
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,232.81,146.26,348.13
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,199.03,116.6,309.53
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,33.78,29.66,38.61
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.66,0.58,0.75
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,182.52,119.03,269.73
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,146.2,87.02,228.44
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,36.31,32.01,41.29
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.43,0.37,0.49
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,125.75,79.95,188.67
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,104.15,61.13,163.9
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,21.6,18.82,24.76
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.32,0.28,0.37
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,92.43,56.76,143.09
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,77.65,43.79,126.16
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,14.78,12.97,16.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.31,0.28,0.36
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,72.53,44.64,110.89
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,59.82,33.46,96.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,12.71,11.18,14.54
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.32,0.28,0.37
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,60.32,37.17,92.45
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,48.84,27.19,79.24
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,11.47,9.98,13.2
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.28,0.24,0.33
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,57.03,35.23,87.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,46.9,26.5,75.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,10.13,8.73,11.66
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.37,0.32,0.43
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,49.09,30.21,75.38
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,37.57,20.27,62.03
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,11.52,9.94,13.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.27,0.23,0.31
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,36.78,21.78,57.62
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,29.69,15.62,49.56
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,7.09,6.15,8.06
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.27,0.23,0.31
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,33.41,19.91,52.63
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,26.9,14.27,45.21
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,6.52,5.64,7.41
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.27,0.23,0.3
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,28.88,17.4,45.9
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,23.14,12.45,39.36
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,5.74,4.94,6.54
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.25,0.21,0.29
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,24.41,14.29,37.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,20.12,10.69,32.41
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,4.29,3.6,4.93
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,0.54,0.42,0.64
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,25.56,15.11,38.95
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,19.35,10.21,31.62
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,6.21,4.9,7.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.62,0.49,0.73
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,26.59,15.89,40.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,18.46,9.48,30.89
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,8.13,6.41,9.61
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,1.06,0.77,1.28
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,26.6,15.83,40.26
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,18.91,10.22,30.91
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,7.69,5.61,9.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.3,0.25,0.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,109.82,66.52,168.94
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,94.24,53.13,151.02
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,15.58,13.38,17.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.32,0.28,0.37
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,112.41,68.4,172.49
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,96.1,54.34,153.75
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,16.31,14.05,18.74
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.22,2.24,6.58
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.72,1.84,5.97
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.5,0.4,0.61
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,17.36,9.91,27.18
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,16.43,9.16,26.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.93,0.74,1.12
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.88,15.92,43.65
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,26.39,14.72,41.85
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.49,1.2,1.79
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,15.86,8.43,24.73
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,13.97,6.93,22.45
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.88,1.5,2.28
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.69,23.23,63.7
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,38.52,21.48,61.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.17,1.75,2.62
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,64.31,37.3,100.76
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,61.86,35.32,97.81
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.45,1.98,2.94
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,0.04,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,76.73,48.55,113.67
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,74.32,46.53,110.8
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.41,2.02,2.87
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,0.05,0.05,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,52.01,32.4,77.69
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,49.01,29.86,74.17
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.01,2.54,3.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,63.27,39.38,94.8
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,60.15,36.76,91.13
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,3.12,2.62,3.67
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,48.45,30.24,71.91
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,45.17,27.44,68.15
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.28,2.8,3.77
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,36.85,22.87,55.58
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,33.29,19.83,51.46
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.57,3.04,4.12
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.49,17.52,44.75
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,26.87,15.33,41.6
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.62,2.19,3.14
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.14,0.12,0.17
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,28.68,17.71,42.26
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,22.95,12.93,35.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,5.73,4.78,6.74
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.12,0.11,0.14
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,23.46,14.29,35.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,18.89,10.45,29.81
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,4.57,3.84,5.3
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.11,0.1,0.13
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,22.79,13.64,33.94
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,18.7,10.14,29.23
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,4.09,3.5,4.71
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.12,0.1,0.13
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,17.37,10.57,27.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,13.78,7.55,22.96
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,3.6,3.02,4.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.1,0.08,0.12
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,12.65,7.56,19.1
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,10.05,5.36,16.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.6,2.21,3.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.02,6.56,16.87
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.3,5.1,14.85
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.73,1.46,2.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.67,5.11,13.63
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,8.21,4.72,13.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.46,0.39,0.56
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,6.96,4.2,10.29
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,6.56,3.86,9.83
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.4,0.34,0.46
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,6.57,3.93,9.83
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.05,3.51,9.21
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.52,0.43,0.62
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.69,3.99,10.23
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,5.8,3.27,9.16
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.88,0.72,1.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.26,3.09,7.88
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,4.97,2.87,7.54
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.28,0.22,0.35
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,29.18,17.77,44.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,27.03,15.97,41.56
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.15,1.8,2.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,30.9,18.84,46.66
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,28.57,16.89,43.93
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,2.33,1.95,2.73
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.0,0.3
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.25,0.0,0.3
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.09,2.96,9.97
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.67,2.76,9.47
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.42,0.2,0.51
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.91,14.72,43.47
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.12,14.19,42.51
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.79,0.53,0.95
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.72,0.0,0.87
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.72,0.0,0.87
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.08,23.57,69.59
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,41.82,22.72,68.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.27,0.85,1.53
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.12,11.08,36.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,21.22,10.34,35.44
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.89,0.74,1.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.34,34.28,100.81
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,60.82,33.04,98.99
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.52,1.24,1.82
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,100.12,56.08,161.2
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,98.02,54.36,158.68
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.1,1.72,2.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,132.52,80.97,191.8
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,131.04,79.71,190.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.49,1.26,1.77
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,98.03,61.16,147.25
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,96.55,59.89,145.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.48,1.27,1.72
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,126.7,80.19,189.68
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,124.79,78.53,187.48
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.91,1.66,2.2
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,100.07,62.08,155.48
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,98.78,60.96,154.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,1.28,1.12,1.48
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,70.81,45.36,109.22
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,69.28,44.06,107.44
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.53,1.3,1.79
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,51.8,32.03,77.47
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,50.66,31.06,76.16
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,1.13,0.98,1.31
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.75,23.75,58.74
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,38.4,22.59,57.17
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.35,1.16,1.57
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.04,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.62,18.54,48.1
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,30.35,17.46,46.61
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.27,1.08,1.48
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.04,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,30.78,18.01,47.51
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,29.31,16.76,45.79
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,1.48,1.25,1.72
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,22.39,12.61,35.41
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,21.45,11.83,34.32
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.93,0.78,1.09
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,16.5,9.47,27.36
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,15.31,8.46,25.99
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.19,1.01,1.37
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.07,0.06,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,15.1,8.54,24.89
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,13.56,7.21,23.13
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.55,1.32,1.76
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,0.09,0.08,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.19,7.25,21.49
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.15,5.49,19.2
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.03,1.76,2.29
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.09,0.08,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,11.08,6.29,16.6
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,9.5,4.97,14.79
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.58,1.32,1.81
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,0.1,0.07,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,10.24,5.59,15.65
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.02,4.61,14.22
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.22,0.98,1.44
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,0.06,0.04,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.26,4.58,14.53
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.52,4.0,13.63
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.74,0.58,0.89
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,0.16,0.11,0.19
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,9.8,5.51,15.19
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,8.67,4.69,13.8
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,1.13,0.82,1.38
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,50.71,30.6,77.43
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,49.58,29.7,76.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.13,0.9,1.32
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.07,32.1,81.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,51.87,31.12,79.64
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.2,0.97,1.4
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.92,2.1,6.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.7,1.93,6.08
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.22,0.17,0.26
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.96,9.63,26.54
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,16.38,9.17,25.84
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.58,0.46,0.7
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.26,15.48,42.66
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,26.33,14.74,41.54
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.93,0.74,1.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.77,7.92,23.92
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,13.96,7.27,22.92
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.81,0.65,1.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,39.78,22.59,62.25
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,38.42,21.51,60.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.36,1.09,1.64
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,63.35,36.43,98.39
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,61.48,34.94,96.15
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.87,1.49,2.24
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,76.31,47.88,113.53
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,74.35,46.26,111.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,1.97,1.62,2.35
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,0.06,0.05,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,52.1,32.63,76.82
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,49.1,30.13,73.31
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.99,2.5,3.51
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,63.72,39.66,92.09
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,60.55,37.1,88.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,3.16,2.56,3.75
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,48.72,30.11,71.58
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,45.52,27.42,67.9
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.2,2.69,3.68
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.08,0.07,0.09
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,37.6,24.29,55.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,33.62,20.89,50.44
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.98,3.39,4.62
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.67,18.45,45.58
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,27.02,16.23,42.42
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.64,2.22,3.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.16,0.13,0.19
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,29.48,17.43,43.33
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,23.04,11.99,35.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,6.43,5.45,7.55
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,0.16,0.14,0.19
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,24.74,15.01,36.57
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,18.84,9.98,29.72
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,5.9,5.03,6.85
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,0.18,0.16,0.21
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,25.16,16.03,36.66
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,18.6,10.41,29.1
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,6.56,5.62,7.56
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,0.14,0.12,0.16
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,18.1,10.66,27.72
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,13.68,6.88,22.62
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,4.42,3.78,5.1
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.1,0.08,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,12.72,7.55,19.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,10.23,5.41,16.69
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.49,2.13,2.92
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.08,6.56,17.21
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.4,5.13,15.24
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.68,1.43,1.97
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.73,5.15,13.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,8.22,4.72,13.16
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.52,0.43,0.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.39,4.56,10.81
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,6.57,3.85,9.85
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.83,0.71,0.96
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,0.04,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,6.66,4.03,9.99
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.04,3.51,9.26
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.62,0.52,0.73
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.23,3.67,9.72
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,5.8,3.33,9.21
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.42,0.35,0.51
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.31,3.12,8.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,4.95,2.84,7.68
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.36,0.27,0.44
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,29.28,17.86,43.82
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,27.09,16.04,41.26
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.18,1.83,2.56
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.06,0.05,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,31.01,18.95,46.36
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,28.59,16.92,43.53
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,2.42,2.03,2.83
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.09,0.0,0.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.09,0.0,0.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.08,3.09,10.21
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.8,2.92,9.86
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.28,0.17,0.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.02,14.9,42.92
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.57,14.59,42.36
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.46,0.32,0.57
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.28,0.0,0.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.28,0.0,0.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.3,23.88,68.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,42.57,23.38,67.87
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.73,0.51,0.91
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.59,11.63,38.04
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,21.8,10.99,37.08
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.79,0.64,0.96
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.86,34.74,99.89
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,61.92,34.0,98.72
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.94,0.73,1.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,100.37,56.27,157.51
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,99.3,55.44,156.15
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.07,0.82,1.36
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,134.14,85.66,194.09
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,132.88,84.68,192.49
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.26,0.98,1.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,98.84,62.45,146.56
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,97.31,61.21,144.68
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.53,1.24,1.88
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,128.63,79.6,189.81
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,126.6,77.93,187.31
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,2.03,1.67,2.49
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,102.03,65.78,153.8
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,99.96,64.08,151.28
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,2.07,1.7,2.52
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,71.14,45.49,105.51
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,69.93,44.51,104.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.21,0.97,1.48
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,51.45,31.25,79.77
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,50.48,30.44,78.6
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.98,0.81,1.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.04,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.7,23.85,59.37
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,38.0,22.43,57.32
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.7,1.42,2.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.63,18.71,48.35
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,30.02,17.37,46.4
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.61,1.34,1.94
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,30.33,18.2,46.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,28.85,16.98,44.84
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,1.48,1.22,1.77
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.05,0.04,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,23.2,12.97,36.79
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,21.55,11.61,34.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,1.66,1.37,2.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,16.41,9.03,26.62
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,15.4,8.19,25.41
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.02,0.83,1.22
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.88,8.32,23.98
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,13.49,7.16,22.36
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.38,1.16,1.62
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.09,0.07,0.1
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.81,7.36,20.42
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,10.93,5.77,18.26
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.88,1.59,2.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.09,0.07,0.1
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,10.86,6.19,16.65
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,9.35,4.97,14.89
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.5,1.22,1.76
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,0.09,0.07,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,10.15,5.68,15.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,8.91,4.71,14.29
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.24,0.98,1.49
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.09,0.07,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.62,5.14,15.37
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.5,4.27,13.99
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.12,0.87,1.38
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,0.12,0.08,0.15
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,9.39,5.34,14.5
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,8.53,4.74,13.43
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.85,0.6,1.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,51.14,31.23,77.18
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,50.09,30.4,75.89
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.05,0.83,1.28
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.37,32.65,80.52
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,52.22,31.73,79.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,1.15,0.92,1.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.65,2.99,4.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,3.61,2.97,4.39
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.1,0.08,0.12
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.22,5.98,8.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.23,0.11,0.42
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,6.99,5.87,8.34
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.16,0.13,0.19
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.6,9.61,14.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.37,0.18,0.67
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,11.23,9.42,13.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.18,0.15,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.73,11.24,16.83
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.07,0.34
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,13.56,11.16,16.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.23,0.19,0.27
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.93,14.02,20.53
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.54,0.27,0.97
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,16.39,13.75,19.56
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.27,0.23,0.32
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.98,16.67,24.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.9,0.45,1.57
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,19.09,16.22,22.47
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.26,0.22,0.31
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,19.08,15.37,23.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.87,0.82,3.33
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,17.2,14.55,20.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.2,0.17,0.24
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,14.39,11.17,18.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,2.98,1.48,5.03
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,11.41,9.7,13.37
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.16,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.16,9.12,15.82
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.69,1.27,4.66
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.48,7.85,11.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,14.14,10.78,18.19
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.49,1.68,5.77
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,10.65,9.09,12.42
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.22,0.19,0.25
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,14.83,11.54,18.88
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.76,1.9,6.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,11.07,9.63,12.79
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.18,0.15,0.21
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.29,8.7,15.13
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.19,1.78,5.43
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,8.1,6.91,9.7
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.26,0.23,0.3
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,12.72,10.24,16.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.21,1.06,3.89
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,10.51,9.17,12.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,8.34,6.78,10.36
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.25,0.63,2.14
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,7.09,6.14,8.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.17,0.14,0.2
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,6.98,5.7,8.58
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,0.98,0.55,1.57
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,6.0,5.15,7.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.13,0.11,0.14
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.2,3.51,5.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.31,0.17,0.52
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,3.88,3.34,4.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.1,0.08,0.11
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.86,2.36,3.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.28,0.16,0.46
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.57,2.2,2.99
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.76,2.64
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.28,0.16,0.44
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.87,1.6,2.2
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.88,1.47
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.86,0.72,1.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.09,0.08,0.1
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.74,1.45,2.12
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.39
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.49,1.3,1.73
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.29,0.25,0.35
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.56,2.92,4.29
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,3.29,2.76,3.88
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.41,0.34,0.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,5.61,4.6,6.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,5.34,4.43,6.36
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.7,0.58,0.83
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.44,4.41,6.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.31,0.19,0.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,5.13,4.21,6.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.15,0.13,0.17
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.29,7.41,11.63
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.33,0.66,2.25
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,7.96,6.75,9.38
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.16,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.75,7.76,12.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.45,0.72,2.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,8.3,7.04,9.77
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.46,0.0,0.66
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.46,0.0,0.66
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.02,0.01,0.03
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.62,1.04,2.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,1.59,1.03,1.98
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.09,3.1,5.04
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.2,0.09,0.37
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,3.89,3.01,4.67
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.02,0.0,0.02
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.36,0.0,1.93
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,1.36,0.0,1.92
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.09,0.07,0.1
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.55,4.97,8.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.32,0.15,0.59
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,6.23,4.82,7.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.8,3.91,5.88
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.14,0.05,0.29
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,4.66,3.86,5.59
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.12,0.1,0.14
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.91,7.23,10.87
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.46,0.22,0.86
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,8.44,7.01,10.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.17,0.14,0.2
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.77,10.35,15.55
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.77,0.37,1.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,12.0,9.97,14.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.12,0.1,0.14
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,9.49,7.09,12.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,1.66,0.63,3.23
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,7.83,6.46,9.26
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.11,0.09,0.13
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.82,6.37,11.94
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.65,1.2,4.78
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,6.17,5.17,7.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.11,0.1,0.13
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,9.34,6.89,12.51
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,2.45,1.13,4.55
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,6.89,5.76,7.96
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.09,0.08,0.11
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.24,5.8,11.3
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.03,1.45,5.28
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,5.21,4.35,6.03
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.13,0.11,0.15
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.04,7.16,13.61
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.27,1.39,5.82
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,6.78,5.77,7.79
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.08,0.07,0.1
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.72,4.73,9.54
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.88,1.43,5.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.85,3.3,4.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.49,3.0,6.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.08,0.94,4.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.41,2.06,2.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.06,0.05,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.23,2.29,4.53
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.2,0.58,2.19
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,2.03,1.72,2.34
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.28,2.46,4.29
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,0.98,0.53,1.63
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,2.3,1.93,2.66
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.58,1.2,2.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.34,0.17,0.56
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,1.24,1.03,1.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.67,1.31,2.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.31,0.17,0.5
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.37,1.14,1.6
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.57,1.23,1.95
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.3,0.17,0.47
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.27,1.06,1.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,1.12,1.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.29,0.16,0.44
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.14,0.96,1.32
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.12,0.88,1.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.86,0.72,1.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.18,0.13,0.21
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.06,1.55,2.54
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.29,0.18,0.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.76,1.37,2.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.14,0.11,0.17
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.13,1.63,2.6
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.28,0.17,0.43
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.85,1.47,2.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.49,0.36,0.59
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.91,2.86,4.86
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.38,0.23,0.57
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,3.54,2.63,4.29
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.08,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,5.28,3.87,6.97
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,1.19,0.55,2.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,4.09,3.32,4.82
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.08,0.07,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,5.48,4.02,7.26
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,1.3,0.6,2.34
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,4.18,3.42,4.91
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.6,1.27,2.03
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,1.56,1.25,1.94
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.68,3.81,5.75
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.23,0.11,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,4.45,3.69,5.34
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.1,0.08,0.12
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.52,6.12,9.25
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.37,0.18,0.66
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,7.15,5.93,8.59
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.08,0.06,0.1
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.04,4.78,7.65
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.07,0.34
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,5.87,4.71,7.3
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.15,0.12,0.17
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,10.98,8.93,13.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.55,0.27,0.97
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,10.43,8.66,12.53
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.21,0.18,0.25
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.63,12.83,19.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.9,0.45,1.55
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,14.73,12.38,17.46
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.22,0.19,0.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,16.28,12.95,20.54
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.87,0.85,3.4
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,14.4,12.1,17.14
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.2,0.17,0.24
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,14.16,10.86,18.38
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.01,1.5,5.12
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,11.15,9.36,13.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.16,0.13,0.19
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.48,9.23,16.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.7,1.31,4.59
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.78,7.92,11.59
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,14.03,10.74,18.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.52,1.86,5.74
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,10.51,8.88,12.35
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.25,0.21,0.29
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.29,12.61,21.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.83,1.9,6.43
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,12.46,10.72,14.79
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.18,0.15,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.41,8.5,15.58
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.21,1.64,5.55
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,8.21,6.86,10.03
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.29,0.25,0.34
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,13.96,11.13,17.66
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.2,1.03,3.8
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,11.76,10.09,13.86
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.24,0.21,0.29
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,10.27,8.32,12.78
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.24,0.62,2.11
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,9.03,7.7,10.67
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.27,0.23,0.32
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,10.6,8.68,13.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,0.98,0.55,1.6
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,9.62,8.13,11.48
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.15,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.1,4.27,6.11
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.32,0.17,0.52
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,4.79,4.1,5.59
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.09,0.08,0.11
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.76,2.25,3.38
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.29,0.16,0.46
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.47,2.08,2.93
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.13,1.71,2.66
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.28,0.16,0.44
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.85,1.55,2.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.04,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.23,0.95,1.61
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.96,0.79,1.2
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.18,0.16,0.21
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,3.37,2.83,4.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.39
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,3.1,2.67,3.66
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.32,0.26,0.38
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.86,3.15,4.69
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.27,0.17,0.42
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,3.58,2.99,4.28
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.2,0.16,0.24
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.84,2.26,3.55
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,2.57,2.1,3.14
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.9,0.73,1.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,6.86,5.5,8.32
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.32,0.2,0.48
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,6.54,5.3,7.84
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.14,0.12,0.17
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.45,6.64,10.75
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.34,0.67,2.28
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,7.11,5.97,8.48
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.15,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.03,7.08,11.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.46,0.73,2.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,7.56,6.35,9.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.18,0.0,0.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.18,0.0,0.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,0.95,1.6
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,1.25,0.94,1.53
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.56,1.99,3.24
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.2,0.09,0.36
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,2.37,1.9,2.88
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.53,0.0,0.77
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.53,0.0,0.77
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.11,3.19,5.19
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.32,0.15,0.58
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,3.79,3.04,4.61
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.32,3.58,5.29
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.13,0.05,0.28
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,4.19,3.53,5.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.74,4.63,7.2
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.46,0.21,0.85
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,5.28,4.42,6.35
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.09,0.07,0.11
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.05,5.62,8.98
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.76,0.37,1.38
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,6.29,5.25,7.61
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.1,0.09,0.12
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,8.49,6.35,11.2
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,1.67,0.67,3.14
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,6.82,5.67,8.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.11,0.1,0.14
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.1,6.63,12.21
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.65,1.21,4.57
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,6.44,5.42,7.63
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.12,0.11,0.15
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,9.91,7.47,13.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,2.42,1.09,4.13
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,7.48,6.38,8.87
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.15,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,11.61,8.61,15.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.04,1.43,5.05
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,8.57,7.18,10.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.11,0.09,0.13
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.72,6.05,12.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.26,1.46,5.61
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,5.46,4.59,6.46
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.27,4.25,8.97
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.9,1.43,4.99
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.37,2.83,3.98
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.08,0.07,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.18,3.6,7.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.08,0.93,3.95
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,3.1,2.67,3.54
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.78,2.77,5.16
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.19,0.57,2.16
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,2.58,2.2,3.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.32,2.51,4.35
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,0.98,0.54,1.62
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,2.34,1.97,2.73
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.58,2.04,3.21
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.34,0.17,0.57
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,2.24,1.87,2.64
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.49,1.17,1.89
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.31,0.17,0.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.19,1.0,1.39
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,1.12,1.79
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.3,0.17,0.47
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.14,0.96,1.33
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.35,1.06,1.67
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.28,0.16,0.43
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.07,0.9,1.24
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.84,1.37
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.39
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.83,0.68,0.97
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.17,0.13,0.2
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.62,2.65
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.29,0.17,0.44
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.86,1.44,2.21
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.22,0.17,0.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.11,2.4,3.76
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.27,0.17,0.42
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.84,2.23,3.34
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.37,0.27,0.45
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.08,2.21,3.86
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.36,0.22,0.56
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,2.71,1.99,3.3
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.86,3.6,6.45
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,1.19,0.55,2.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,3.67,3.05,4.37
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.08,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,5.14,3.8,6.82
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,1.3,0.6,2.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,3.84,3.19,4.56
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.39,0.8,7.08
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.99,0.6,6.38
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.4,0.2,0.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.2,6.5,27.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,14.4,6.03,26.74
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.8,0.47,1.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.33,10.41,44.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,23.06,9.66,42.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.28,0.75,2.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.05,3.09,27.23
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,11.5,2.32,24.53
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.54,0.77,2.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.2,15.05,64.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,33.35,13.97,61.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.85,1.08,2.89
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.27,25.35,97.2
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,52.16,24.0,94.14
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.11,1.35,3.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.03,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.59,22.86,96.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,51.32,21.62,92.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.27,1.25,3.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.05,0.03,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,26.76,9.56,51.21
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,23.84,7.91,46.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.92,1.65,4.76
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.07,0.04,0.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,31.91,11.55,58.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,27.52,9.01,51.56
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,4.4,2.54,7.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,18.78,5.77,38.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,16.7,4.62,35.15
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,2.08,1.16,3.35
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,13.53,2.65,29.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.19,0.76,24.55
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.34,1.89,5.44
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.05,0.03,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.31,1.8,21.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.91,0.42,16.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.4,1.38,4.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,6.96,3.65,12.31
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.48,2.78,10.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,1.47,0.87,2.27
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.7,2.98,10.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.27,2.14,7.8
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.43,0.84,2.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,6.11,3.2,10.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.05,2.01,7.65
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,2.07,1.18,3.27
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.62,1.86,6.15
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.97,1.47,5.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.65,0.39,1.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.07,0.05,0.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,4.16,2.35,7.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.21,1.1,4.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,1.95,1.25,2.97
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.04,0.03,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.09,1.71,5.29
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.97,1.0,3.58
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.12,0.72,1.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.65,0.86,2.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.65,0.86,2.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.05,1.13,3.42
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.21,0.6,2.14
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.85,0.52,1.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.19,1.12,3.75
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.6,0.76,2.83
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.59,0.35,0.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.03,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.61,0.76,2.95
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.15,0.51,2.18
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.47,0.26,0.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.02,1.48,5.16
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.72,1.31,4.68
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.31,0.18,0.49
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,16.05,6.26,30.19
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,14.44,5.34,27.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.61,0.92,2.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,16.53,6.48,31.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,14.8,5.49,28.29
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,1.73,0.99,2.78
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.45,1.16,7.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,2.37,0.48,5.53
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,1.08,0.68,1.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.44,4.73,22.89
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,11.05,3.84,20.83
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.39,0.88,2.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.9,7.56,36.62
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,17.68,6.15,33.32
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.22,1.41,3.3
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.06,0.03,0.08
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.22,4.45,27.32
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,9.08,1.85,21.21
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,4.14,2.6,6.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,28.7,10.9,52.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,25.49,8.87,48.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,3.21,2.04,4.76
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,41.94,16.42,74.61
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.52,14.87,71.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.41,1.56,3.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,39.4,15.21,69.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,38.14,14.43,67.8
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.26,0.78,1.98
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,17.13,5.77,32.98
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,16.38,5.29,31.85
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.75,0.47,1.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,18.63,6.04,35.24
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,17.66,5.42,33.8
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.98,0.63,1.44
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,10.63,2.41,24.79
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,10.15,2.09,24.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.49,0.32,0.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.13,0.68,18.14
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.66,0.38,17.44
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.48,0.3,0.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.36,2.74,9.23
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.93,2.47,8.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.43,0.26,0.64
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.84,1.87,6.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.18,1.43,5.95
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.67,0.44,0.98
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.34,1.7,6.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.53,1.18,4.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.81,0.52,1.22
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.03,2.17,7.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,2.36,1.12,4.74
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,1.67,1.05,2.54
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,0.96,3.54
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.95,0.96,3.54
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.45,1.34,4.15
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.58,0.78,2.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.87,0.56,1.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.02,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.03,1.11,3.47
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.42,0.72,2.58
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.61,0.4,0.89
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.48,0.82,2.58
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.22,0.63,2.19
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.27,0.19,0.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.04,0.55,1.85
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.88,0.44,1.62
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.15,0.1,0.23
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.52,1.94
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,1.0,0.48,1.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.07,0.04,0.1
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.72,0.32,1.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.72,0.32,1.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.66,2.46
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,1.36,0.65,2.43
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,11.26,4.08,21.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,10.3,3.47,19.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.96,0.61,1.43
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,11.09,4.05,20.91
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,10.18,3.47,19.55
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.91,0.58,1.36
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.0,0.41,6.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.0,0.41,6.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.62,6.15,30.41
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,15.02,5.77,29.54
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.6,0.38,0.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.9,9.8,48.46
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,23.94,9.19,47.08
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.96,0.61,1.38
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,11.62,1.58,26.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,11.62,1.58,26.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.4,14.33,70.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,35.0,13.44,68.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.4,0.89,2.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.04,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,57.81,25.35,109.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,55.19,23.69,105.48
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.61,1.66,3.76
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.07,0.04,0.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,58.54,25.46,100.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,54.03,23.05,92.78
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,4.52,2.4,7.67
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.08,0.05,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.37,11.46,56.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,24.9,8.97,48.74
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,4.47,2.49,7.37
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.08,0.05,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,34.24,14.13,66.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,29.3,11.29,58.8
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,4.95,2.85,8.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,19.9,6.73,43.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,16.78,5.0,38.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.12,1.74,4.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.08,0.04,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,14.65,4.09,30.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.61,1.85,23.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,4.03,2.23,6.63
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.13,0.07,0.21
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.15,3.79,28.49
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,7.36,0.5,18.79
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,5.79,3.28,9.69
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.16,0.09,0.26
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,12.18,6.56,20.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.55,2.73,10.63
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,6.63,3.82,10.37
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.2,0.11,0.32
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,11.46,6.23,19.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.29,2.13,8.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,7.17,4.1,11.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.28,0.16,0.44
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,13.92,7.58,23.37
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.07,2.03,7.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,9.85,5.55,15.66
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.15,0.09,0.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.73,4.27,13.16
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.95,1.48,5.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,4.78,2.79,7.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.08,0.05,0.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,4.3,2.39,7.3
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.19,1.05,4.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.11,1.34,3.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.07,0.05,0.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.76,2.16,6.26
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.95,0.98,3.56
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.81,1.18,2.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.07,0.05,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.05,1.86,4.88
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.63,0.88,2.95
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,1.41,0.98,1.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.19,0.12,0.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,4.44,2.58,7.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.2,0.6,2.18
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,3.24,1.99,4.85
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.14,0.08,0.22
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.59,1.96,5.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.59,0.77,2.86
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,2.0,1.19,3.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.08,0.04,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.14,1.03,3.79
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.14,0.51,2.15
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.99,0.52,1.65
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.14,0.08,0.22
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.74,1.91,6.36
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.74,1.33,4.75
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,1.0,0.57,1.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,18.04,7.32,34.3
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,15.11,5.64,29.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.93,1.67,4.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.08,0.05,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.75,7.72,35.48
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,15.38,5.78,30.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,3.38,1.93,5.42
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.72,0.43,5.94
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,2.47,0.28,5.57
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.25,0.16,0.38
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.53,4.76,24.51
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,11.84,4.31,23.48
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.7,0.45,1.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.95,7.58,39.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,18.84,6.87,37.38
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.11,0.71,1.65
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.52,1.68,22.98
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,9.55,1.08,21.53
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.96,0.6,1.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.09,11.06,56.91
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,27.48,10.02,54.51
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.62,1.04,2.4
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.99,19.08,85.94
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,42.81,17.67,82.73
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.18,1.41,3.22
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,41.0,16.7,76.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,41.0,16.7,76.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.12,5.95,35.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,17.43,5.52,34.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.69,0.43,1.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,20.16,5.68,41.69
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,19.19,5.07,40.24
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.96,0.61,1.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,11.21,1.61,24.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,10.73,1.29,24.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.48,0.32,0.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.76,0.92,17.46
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.82,0.33,16.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.95,0.59,1.4
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.2,3.27,10.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.03,2.56,8.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,1.17,0.71,1.76
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.57,1.69,6.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.26,1.5,6.35
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.31,0.2,0.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.94,1.46,5.56
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.58,1.23,5.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.36,0.23,0.55
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.73,1.36,5.3
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,2.41,1.15,4.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.33,0.21,0.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.42,1.31,4.34
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.96,1.01,3.63
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.47,0.3,0.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.57,0.79,2.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.57,0.79,2.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.53,0.8,2.72
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.41,0.72,2.55
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.12,0.08,0.17
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.47,0.81,2.53
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.21,0.63,2.14
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.26,0.18,0.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.16,0.63,2.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.88,0.45,1.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.28,0.18,0.42
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.17,0.59,2.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.99,0.47,1.79
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.18,0.11,0.26
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.34,1.47
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.72,0.3,1.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.05,0.04,0.08
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.52,0.74,2.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,1.37,0.65,2.37
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.15,0.09,0.23
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,11.58,4.1,22.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,11.02,3.74,21.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.56,0.36,0.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,11.34,4.05,22.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,10.78,3.7,21.42
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.56,0.35,0.83
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.06,1.28,5.58
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,3.06,1.28,5.58
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.66,16.15,40.25
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,26.66,16.15,40.25
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.98,25.1,63.29
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,40.98,25.1,63.29
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,9.03,3.79,16.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,9.03,3.79,16.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.62,40.2,101.36
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,65.62,40.2,101.36
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,93.8,58.44,138.87
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,93.8,58.44,138.87
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,90.88,56.45,139.26
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,90.88,56.45,139.26
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,88.37,54.73,139.6
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,88.37,54.73,139.6
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.44,30.39,82.17
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,53.44,30.39,82.17
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.43,15.47,47.02
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,29.43,15.47,47.02
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,34.49,19.26,55.19
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,34.49,19.26,55.19
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,23.49,11.32,38.98
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,23.49,11.32,38.98
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.85,7.16,27.49
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,16.85,7.16,27.49
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.72,5.32,22.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,12.72,5.32,22.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,9.94,4.99,18.42
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,9.94,4.99,18.42
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.51,3.43,13.72
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,7.51,3.43,13.72
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.29,2.56,13.54
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.29,2.56,13.54
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.65,2.46,7.94
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,4.65,2.46,7.94
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.98,1.35,5.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.98,1.35,5.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.56,1.15,4.64
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.56,1.15,4.64
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.0,0.88,3.55
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.0,0.88,3.55
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.37,0.51,2.54
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.37,0.51,2.54
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.07,0.41,2.03
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.07,0.41,2.03
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.34,2.04
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.99,0.34,2.04
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.65,0.31,1.2
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.65,0.31,1.2
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,27.6,15.8,43.48
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,27.6,15.8,43.48
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,26.33,14.92,41.7
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,26.33,14.92,41.7
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,0.6,3.49
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.72,0.6,3.49
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.41,8.81,22.05
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,14.41,8.81,22.05
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.31,12.01,31.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,20.31,12.01,31.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,5.1,1.76,10.31
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,5.1,1.76,10.31
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.48,19.21,50.28
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,32.48,19.21,50.28
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,50.4,32.11,74.68
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,50.4,32.11,74.68
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.59,26.93,67.96
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,44.59,26.93,67.96
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,39.63,22.5,62.22
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.63,22.5,62.22
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,21.25,10.73,35.33
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,21.25,10.73,35.33
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.21,5.14,19.8
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,11.21,5.14,19.8
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.76,5.97,22.72
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,12.76,5.97,22.72
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.51,3.25,16.05
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.51,3.25,16.05
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.45,2.03,12.9
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.45,2.03,12.9
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.87,2.54,8.39
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.87,2.54,8.39
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.66,1.9,6.25
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.66,1.9,6.25
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,1.34,4.7
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.71,1.34,4.7
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,1.27,4.43
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,2.6,1.27,4.43
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.67,0.75,3.1
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.67,0.75,3.1
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.36,2.24
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.09,0.36,2.24
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.91,0.34,1.81
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.91,0.34,1.81
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.68,0.32,1.26
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.68,0.32,1.26
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.19,0.88
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.44,0.19,0.88
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.32,0.13,0.63
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.32,0.13,0.63
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.3,0.12,0.58
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.3,0.12,0.58
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.07,0.37
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.19,0.07,0.37
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,12.38,6.75,20.12
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,12.38,6.75,20.12
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,11.15,5.98,18.3
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,11.15,5.98,18.3
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.14,1.22,5.96
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,3.14,1.22,5.96
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.98,16.1,42.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,26.98,16.1,42.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.87,24.32,63.62
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,40.87,24.32,63.62
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,9.03,3.52,17.15
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,9.03,3.52,17.15
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.14,38.77,101.39
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,65.14,38.77,101.39
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,95.38,58.79,146.46
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,95.38,58.79,146.46
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,91.04,55.04,140.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,91.04,55.04,140.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,87.29,51.81,134.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,87.29,51.81,134.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.87,31.69,85.91
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,53.87,31.69,85.91
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.15,16.41,47.5
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,29.15,16.41,47.5
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,34.03,19.91,56.12
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,34.03,19.91,56.12
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,23.09,12.65,37.26
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,23.09,12.65,37.26
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.57,8.22,27.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,16.57,8.22,27.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.34,5.86,21.08
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,12.34,5.86,21.08
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,10.11,4.11,19.07
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,10.11,4.11,19.07
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.53,3.12,13.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,7.53,3.12,13.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.21,2.53,13.55
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.21,2.53,13.55
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.65,2.54,7.93
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,4.65,2.54,7.93
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.01,1.31,5.32
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.01,1.31,5.32
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.56,1.08,4.59
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.56,1.08,4.59
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,0.77,3.63
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.97,0.77,3.63
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.35,0.5,2.52
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.35,0.5,2.52
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.4,2.01
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.06,0.4,2.01
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.34,1.92
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.99,0.34,1.92
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.65,0.31,1.26
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.65,0.31,1.26
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,27.58,15.86,44.06
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,27.58,15.86,44.06
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,25.99,14.83,41.71
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,25.99,14.83,41.71
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,0.5,3.35
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.72,0.5,3.35
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.28,7.94,22.48
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,14.28,7.94,22.48
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.09,11.49,31.53
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,20.09,11.49,31.53
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.95,1.45,9.65
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.95,1.45,9.65
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.98,18.3,50.2
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,31.98,18.3,50.2
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,50.29,29.26,77.33
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,50.29,29.26,77.33
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.36,26.02,68.79
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,44.36,26.02,68.79
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,39.28,23.25,61.48
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.28,23.25,61.48
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,21.18,10.89,34.55
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,21.18,10.89,34.55
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.09,5.26,19.34
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,11.09,5.26,19.34
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.67,6.22,21.67
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,12.67,6.22,21.67
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.51,3.37,16.52
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.51,3.37,16.52
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.14,2.22,11.99
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.14,2.22,11.99
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.86,2.48,8.71
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.86,2.48,8.71
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.7,1.86,6.25
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.7,1.86,6.25
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,1.3,4.7
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.71,1.3,4.7
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.59,1.27,4.46
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,2.59,1.27,4.46
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.65,0.66,3.11
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.65,0.66,3.11
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.39,2.1
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.06,0.39,2.1
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.9,0.36,1.74
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.9,0.36,1.74
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.69,0.32,1.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.69,0.32,1.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.19,0.86
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.44,0.19,0.86
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.32,0.14,0.63
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.32,0.14,0.63
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.13,0.61
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.31,0.13,0.61
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.07,0.37
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.19,0.07,0.37
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,12.3,6.59,20.08
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,12.3,6.59,20.08
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,10.92,5.79,17.98
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,10.92,5.79,17.98
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.95,0.5,1.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.95,0.5,1.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,27.19,13.38,47.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,26.78,13.18,46.32
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.4,0.21,0.69
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,46.15,23.61,78.48
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,45.11,22.97,76.88
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.04,0.64,1.6
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.81,1.46,4.86
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.81,1.46,4.86
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,73.9,37.81,125.68
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,72.23,36.78,123.12
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.67,1.03,2.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,101.8,50.04,176.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,100.26,49.24,173.38
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.54,0.8,2.63
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,105.63,54.04,179.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,103.22,52.55,175.91
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.42,1.49,3.71
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,108.93,57.49,182.72
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,105.77,55.4,178.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,3.17,2.08,4.63
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,0.05,0.03,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,82.22,43.85,137.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,79.06,42.11,132.62
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,3.16,1.74,5.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,0.09,0.05,0.14
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,60.1,29.97,103.73
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,55.19,27.05,96.12
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,4.91,2.92,7.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,0.14,0.09,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,70.9,35.72,121.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,62.46,30.54,108.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,8.44,5.18,12.96
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,53.5,26.08,95.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,50.34,24.19,90.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.16,1.89,4.91
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,0.1,0.06,0.16
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,46.9,22.11,84.18
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,41.64,18.99,76.17
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,5.26,3.11,8.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,0.1,0.06,0.15
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,40.04,17.96,68.46
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,35.7,15.38,61.59
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,4.34,2.58,6.87
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,32.29,14.3,59.14
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,29.78,12.71,55.46
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,2.51,1.59,3.68
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,27.52,12.18,50.48
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,24.98,10.59,46.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,2.54,1.58,3.83
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.11,0.06,0.16
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,28.04,12.76,50.14
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,24.28,10.44,44.32
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,3.76,2.31,5.82
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,20.83,8.81,39.82
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,19.67,8.08,38.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,1.16,0.73,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.14,0.09,0.21
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,20.41,8.44,38.06
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,16.69,6.03,32.5
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,3.71,2.42,5.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.08,0.05,0.12
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,17.88,7.03,33.16
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,15.74,5.64,29.96
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,2.14,1.39,3.2
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.44,5.12,26.52
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,14.44,5.12,26.52
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,0.12,0.07,0.17
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.11,5.58,29.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,13.14,4.3,26.15
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.96,1.28,2.94
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,0.13,0.08,0.2
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,14.02,4.9,27.06
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,12.32,3.82,24.48
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,1.7,1.07,2.58
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.14,0.08,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,14.08,4.8,27.23
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,12.28,3.72,24.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,1.81,1.08,2.81
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.16,0.1,0.23
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,12.16,3.88,23.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,11.0,3.16,21.81
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,1.16,0.72,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.05,0.03,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,44.2,21.88,76.49
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,41.57,20.29,72.44
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.63,1.59,4.05
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.06,0.04,0.1
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,44.83,22.06,77.79
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,41.95,20.32,73.36
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,2.88,1.74,4.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.5,0.24,0.89
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.5,0.24,0.89
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.44,6.23,28.26
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.77,5.74,27.37
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.67,0.49,0.88
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,23.75,10.24,44.45
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,22.77,9.56,43.07
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.98,0.67,1.38
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.49,0.7,2.63
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.49,0.7,2.63
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,37.98,16.38,71.1
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,36.41,15.3,68.89
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.57,1.08,2.21
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,53.96,23.22,105.86
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,51.4,21.35,102.47
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,2.56,1.86,3.39
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.12,23.31,101.38
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,51.86,21.76,98.19
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,2.26,1.55,3.19
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.26,23.39,97.55
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,52.25,22.1,94.54
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.01,1.29,3.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,39.43,18.34,72.92
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,38.32,17.67,71.22
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.11,0.68,1.7
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,27.26,11.26,50.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,26.16,10.55,48.99
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.1,0.71,1.62
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,31.33,12.73,55.62
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,29.62,11.63,53.06
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.71,1.1,2.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,24.43,9.74,46.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,23.5,9.07,45.31
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.93,0.67,1.25
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,20.68,7.54,39.76
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,19.78,6.98,38.45
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.9,0.56,1.32
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,17.25,6.24,32.7
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,16.52,5.79,31.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.73,0.46,1.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,14.77,4.51,28.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,13.93,3.96,27.34
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.85,0.56,1.26
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,12.99,3.99,25.7
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,11.99,3.35,24.18
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.0,0.64,1.52
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,13.71,4.57,27.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,11.65,3.28,23.87
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,2.05,1.29,3.13
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,9.99,2.68,20.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,9.99,2.68,20.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.08,0.05,0.11
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,11.01,3.44,24.24
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,9.01,2.11,21.25
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,2.01,1.33,2.99
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.07,0.05,0.1
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.28,3.12,22.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,8.62,2.01,19.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.66,1.11,2.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.06,0.04,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.33,2.72,19.19
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,8.11,1.89,17.48
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.22,0.82,1.7
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.6,1.27,16.16
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,7.22,1.03,15.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.38,0.25,0.55
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,7.05,1.22,15.17
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,6.77,1.05,14.75
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.28,0.18,0.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.79,1.18,14.58
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,6.79,1.18,14.58
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,6.63,1.2,14.52
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.21,0.95,13.88
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.41,0.25,0.64
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,21.35,8.69,40.28
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,20.35,8.02,38.83
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.0,0.66,1.46
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.02,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,21.11,8.43,39.95
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,20.08,7.74,38.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.04,0.68,1.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.97,0.48,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.97,0.48,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.66,12.07,48.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,26.66,12.07,48.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,45.73,22.5,79.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,44.86,21.93,78.11
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.87,0.57,1.27
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.38,4.97
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.79,1.38,4.97
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,72.89,35.86,126.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,71.49,34.96,124.49
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.39,0.91,2.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,100.36,45.33,183.67
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,100.36,45.33,183.67
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,105.25,51.79,182.65
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,103.22,50.46,179.68
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.03,1.33,2.96
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.05,0.03,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,109.48,57.37,181.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,105.69,54.9,176.24
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,3.79,2.47,5.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,0.09,0.05,0.15
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,85.25,42.38,144.11
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,79.16,39.04,134.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,6.09,3.34,10.08
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,0.13,0.08,0.21
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,62.08,29.79,105.71
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,54.89,25.57,94.32
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,7.19,4.21,11.4
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,0.15,0.09,0.24
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,71.13,33.83,123.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,61.91,28.25,108.45
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.22,5.58,14.55
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,0.08,0.05,0.13
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,54.6,26.24,90.06
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,50.02,23.45,82.93
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,4.58,2.79,7.13
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,0.12,0.07,0.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,48.12,22.98,80.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,41.99,19.36,70.89
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,6.13,3.62,9.5
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,0.22,0.13,0.35
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,45.1,20.23,80.63
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,35.0,14.4,64.72
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,10.1,5.83,15.91
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,0.27,0.17,0.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.59,18.74,67.17
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,28.78,11.92,51.16
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,10.82,6.83,16.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.34,0.21,0.51
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,36.55,17.55,63.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,24.36,9.97,44.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,12.19,7.57,18.43
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.48,0.3,0.74
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,40.19,19.74,69.68
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,22.94,9.15,43.06
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,17.25,10.59,26.62
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.26,0.16,0.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,28.52,13.52,50.21
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,20.43,8.47,38.14
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,8.1,5.05,12.06
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.15,0.1,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,20.7,7.93,37.92
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,16.83,5.42,32.12
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,3.87,2.51,5.8
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.16,0.1,0.23
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,19.86,7.91,35.99
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,16.11,5.46,30.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,3.76,2.44,5.6
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.17,0.11,0.25
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,18.76,7.88,33.43
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,15.15,5.52,28.1
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,3.61,2.36,5.33
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,0.41,0.27,0.63
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,20.14,8.49,37.38
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.97,3.87,26.58
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,7.17,4.62,10.8
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.4,0.25,0.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,17.5,6.99,33.16
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,12.29,3.71,25.23
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,5.21,3.27,7.92
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.28,0.17,0.44
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,16.01,5.64,31.68
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,12.35,3.47,25.93
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.67,2.16,5.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,0.49,0.3,0.75
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,14.68,5.92,27.66
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,11.09,3.7,22.22
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,3.6,2.22,5.44
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.12,0.07,0.18
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,46.28,22.25,79.83
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,41.42,19.3,72.32
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,4.86,2.95,7.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.14,0.09,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,47.23,22.66,81.36
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,41.56,19.22,72.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,5.67,3.44,8.75
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.49,0.21,0.95
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.49,0.21,0.95
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.25,4.93,25.79
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.1,4.82,25.58
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.15,0.11,0.21
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.28,9.44,42.46
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,21.75,9.09,41.67
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.54,0.35,0.79
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.41,0.61,2.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.41,0.61,2.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.48,15.03,67.59
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,34.62,14.47,66.33
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.86,0.56,1.26
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,49.83,18.45,96.97
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,49.23,18.02,96.18
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.59,0.43,0.79
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,51.09,21.64,97.31
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,49.84,20.82,95.48
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.25,0.81,1.84
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,52.16,24.36,97.6
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,50.35,23.22,94.87
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.81,1.14,2.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,37.0,14.43,63.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,37.0,14.43,63.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.02,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,26.76,10.32,49.16
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,25.52,9.52,47.32
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.24,0.79,1.84
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,30.2,12.09,56.05
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,28.51,10.99,53.51
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.69,1.09,2.54
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,24.0,10.0,45.65
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,23.08,9.32,44.4
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.92,0.68,1.24
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.04,0.02,0.05
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,21.6,7.36,39.89
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,19.81,6.26,37.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.79,1.1,2.69
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.5,6.55,37.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,16.51,5.34,34.17
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,1.99,1.21,3.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,14.46,3.97,28.51
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,14.07,3.72,27.94
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.39,0.25,0.57
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,12.56,3.37,25.97
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,11.97,2.99,25.1
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.59,0.38,0.88
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,12.05,3.61,25.8
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,11.65,3.36,25.18
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.4,0.25,0.62
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,10.85,2.38,23.1
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,9.81,1.7,21.56
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,1.04,0.68,1.53
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,9.09,2.23,19.31
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,9.09,2.23,19.31
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.02,0.02,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.97,1.93,18.96
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,8.43,1.58,18.2
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.53,0.36,0.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.06,0.04,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.81,1.56,18.51
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,7.6,0.75,16.78
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.21,0.81,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.04,0.03,0.06
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.74,1.48,16.62
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,7.05,1.04,15.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.69,0.44,1.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.14,0.09,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,7.9,1.69,16.67
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,6.61,0.89,14.68
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.29,0.79,1.98
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.04,0.02,0.07
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,7.21,1.25,15.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,6.64,0.91,14.63
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.56,0.34,0.89
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.36,0.22,0.56
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.7,2.32,17.71
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.05,0.71,13.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,2.64,1.61,4.1
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,20.54,7.89,38.92
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,19.77,7.39,37.79
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.77,0.5,1.14
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,20.28,7.62,38.58
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,19.43,7.07,37.31
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.85,0.55,1.27
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.02,1.78,7.23
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,4.02,1.78,7.23
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.07,0.05,0.12
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,67.68,35.26,112.83
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,62.07,31.8,104.15
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,5.61,3.46,8.68
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.16,0.1,0.23
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,139.2,74.77,230.93
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,127.86,67.47,214.02
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,11.33,7.29,16.91
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,11.84,5.25,21.31
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,11.84,5.25,21.31
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.25,0.16,0.37
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,222.91,119.73,369.81
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,204.76,108.05,342.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,18.15,11.68,27.08
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.29,0.18,0.44
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,248.76,130.5,413.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,227.2,117.18,379.83
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,21.57,13.32,33.38
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.36,0.23,0.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,317.12,170.84,525.37
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,290.87,153.94,486.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,26.25,16.9,39.17
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.43,0.28,0.63
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,375.99,205.58,621.98
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,345.71,185.6,577.83
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,30.28,19.98,44.15
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.5,0.32,0.74
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,335.39,179.84,544.92
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,302.95,159.1,496.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,32.44,20.74,48.19
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.64,0.42,0.94
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,220.21,112.26,366.04
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,184.45,88.89,313.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,35.76,23.38,52.31
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.88,0.57,1.28
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,267.66,140.39,438.38
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,214.84,106.15,361.27
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,52.83,34.24,77.1
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.44,0.3,0.63
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,182.28,92.47,310.6
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,158.02,76.02,275.8
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,24.25,16.45,34.8
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.76,0.5,1.11
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,156.69,72.67,269.85
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,118.51,47.46,213.99
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,38.18,25.22,55.87
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.64,0.42,0.94
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,125.27,55.86,213.76
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,96.03,36.74,171.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,29.24,19.12,42.76
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.34,0.23,0.48
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,92.91,42.01,166.82
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,79.26,32.59,147.34
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,13.66,9.42,19.48
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.37,0.25,0.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,77.64,34.3,140.35
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,63.96,25.03,120.7
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,13.68,9.26,19.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.55,0.37,0.8
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,81.63,36.73,143.74
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,61.82,23.52,115.08
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,19.82,13.21,28.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.21,0.15,0.31
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,53.53,21.64,102.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,46.9,17.14,93.18
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,6.63,4.5,9.48
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.79,0.56,1.09
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,57.41,26.34,101.99
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,36.65,11.69,73.46
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,20.76,14.65,28.53
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.46,0.32,0.63
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,45.65,18.92,83.6
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,33.7,10.48,67.18
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,11.95,8.43,16.42
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.69,8.86,58.65
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,29.69,8.86,58.65
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.56,0.39,0.79
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,35.6,14.33,65.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,25.93,7.66,51.96
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,9.67,6.67,13.58
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,0.78,0.53,1.11
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,34.09,14.0,62.82
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,24.44,7.47,49.18
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,9.65,6.53,13.64
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.87,0.58,1.26
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,35.05,14.25,65.98
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,23.59,6.68,49.49
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,11.46,7.57,16.5
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,1.05,0.71,1.46
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,30.56,13.2,54.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,22.9,8.04,44.28
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,7.67,5.16,10.67
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.38,0.25,0.56
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,144.94,74.24,242.93
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,125.23,61.32,214.07
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,19.71,12.92,28.86
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,0.43,0.28,0.62
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,148.17,75.43,248.9
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,127.16,61.63,218.22
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,21.01,13.8,30.68
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.23,0.83,4.38
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,2.23,0.83,4.38
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.18,0.13,0.25
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,50.88,26.96,85.89
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,36.99,17.03,67.23
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,13.88,9.94,18.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.25,0.18,0.34
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,103.17,53.89,171.15
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,85.01,40.98,146.42
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,18.16,12.91,24.72
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.58,2.46,12.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,6.58,2.46,12.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.4,0.28,0.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,165.02,86.2,273.74
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,135.98,65.55,234.2
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,29.05,20.65,39.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.71,0.51,0.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,188.84,101.07,317.03
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,135.58,62.94,245.47
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,53.26,38.12,71.57
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.57,0.41,0.78
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,235.1,123.25,389.1
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,193.21,93.46,332.07
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,41.9,29.79,57.03
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.46,0.32,0.63
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,274.66,142.21,450.71
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,242.48,119.54,406.11
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,32.18,22.67,44.61
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.26,0.18,0.37
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,256.53,131.72,426.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,239.53,119.7,402.59
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,17.0,12.02,24.15
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.2,0.14,0.28
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,165.14,80.2,281.7
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,153.59,71.99,265.7
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,11.55,8.21,16.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.26,0.18,0.36
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,196.17,99.67,326.87
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,180.43,88.5,305.32
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,15.74,11.17,21.56
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.15,0.11,0.2
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,144.97,66.3,256.58
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,136.7,60.21,245.5
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,8.27,6.09,11.08
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.16,0.11,0.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,112.66,47.54,201.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,104.85,42.04,190.99
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,7.81,5.5,10.74
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.16,0.11,0.22
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,91.43,42.2,158.65
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,84.17,37.15,148.53
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,7.26,5.06,10.12
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.33,0.24,0.45
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,82.0,36.86,140.77
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,68.63,27.04,122.43
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,13.37,9.82,18.34
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.42,0.3,0.58
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,71.02,31.96,122.87
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,55.45,20.91,101.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,15.57,11.04,21.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.89,0.62,1.24
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,85.27,41.51,142.68
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,53.62,19.42,98.35
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,31.65,22.09,44.33
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,41.38,15.11,78.43
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,41.38,15.11,78.43
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.72,0.53,0.96
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,53.03,24.7,94.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,34.03,10.71,68.96
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,19.0,13.99,25.25
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.68,0.51,0.9
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,49.02,22.31,87.71
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,32.34,9.95,65.75
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,16.68,12.36,21.96
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.63,0.47,0.82
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,43.82,19.21,79.28
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,30.13,8.95,61.59
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,13.68,10.26,17.69
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.45,0.33,0.58
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,34.47,12.8,63.62
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,26.74,7.12,53.68
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,7.73,5.68,9.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,0.36,0.25,0.48
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,30.64,10.27,58.12
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,26.29,7.16,52.4
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,4.35,3.11,5.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,24.57,6.92,49.86
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,24.57,6.92,49.86
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,0.56,0.37,0.77
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,31.32,10.16,58.7
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,27.23,7.43,53.06
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,4.09,2.73,5.64
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.27,0.19,0.37
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,110.99,54.8,188.19
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,96.58,44.53,168.47
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,14.41,10.27,19.72
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.3,0.22,0.41
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,111.92,54.72,190.35
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,97.61,44.51,170.75
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,14.32,10.21,19.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.11,1.7,7.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,4.11,1.7,7.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,62.27,30.22,109.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,62.27,30.22,109.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.12,0.08,0.17
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,136.87,71.03,230.96
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,128.44,65.48,218.74
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,8.43,5.55,12.22
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,11.83,4.89,22.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,11.83,4.89,22.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.19,0.13,0.28
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,218.13,113.21,368.08
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,204.7,104.36,348.61
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,13.43,8.85,19.47
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,229.11,112.02,400.12
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,229.11,112.02,400.12
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.28,0.18,0.4
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,313.39,163.23,527.83
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,293.75,150.29,499.36
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,19.64,12.94,28.46
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.52,0.34,0.75
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,386.21,207.46,638.17
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,349.6,183.35,585.11
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,36.6,24.12,53.06
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.96,0.61,1.45
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,369.2,197.6,594.42
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,306.55,157.83,500.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,62.65,39.77,94.42
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.98,0.63,1.45
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,239.56,124.54,394.86
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,185.69,89.73,314.99
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,53.87,34.81,79.87
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.96,0.62,1.42
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,275.79,146.64,454.52
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,218.08,109.5,369.14
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,57.7,37.15,85.38
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.64,0.43,0.93
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,192.93,97.86,324.05
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,157.49,73.97,272.32
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,35.43,23.89,51.74
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.89,0.58,1.3
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,165.05,81.87,276.34
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,120.27,52.52,210.68
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,44.78,29.35,65.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,1.51,0.96,2.23
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,164.05,81.02,276.67
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,95.47,37.22,174.98
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,68.58,43.8,101.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,1.47,1.0,2.11
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,137.84,69.72,231.22
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,78.25,29.22,145.43
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,59.58,40.5,85.78
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,1.86,1.24,2.68
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,129.91,68.37,215.32
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,63.07,23.84,118.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,66.84,44.53,96.63
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,2.57,1.68,3.74
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,152.13,82.34,248.23
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,60.1,22.41,114.38
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,92.03,59.93,133.84
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,1.52,1.03,2.18
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,94.37,50.63,157.47
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,47.33,18.7,89.93
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,47.03,31.93,67.54
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.84,0.59,1.15
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,58.98,26.94,103.26
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,37.06,11.41,73.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,21.91,15.53,30.14
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.79,0.56,1.09
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,53.4,23.83,93.99
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,34.14,10.22,67.44
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,19.27,13.62,26.55
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.73,0.51,1.01
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,46.01,19.72,81.7
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,30.25,8.63,59.91
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,15.75,11.09,21.79
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,2.09,1.43,2.95
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,61.82,32.01,104.16
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,25.86,7.45,53.47
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,35.96,24.56,50.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,2.33,1.56,3.31
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,53.69,27.18,92.01
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,24.44,7.52,50.47
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,29.25,19.65,41.54
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,1.8,1.17,2.62
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,47.2,21.87,85.84
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,23.63,6.58,51.58
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,23.56,15.28,34.26
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,3.31,2.21,4.67
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,47.06,24.79,78.24
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,22.92,8.66,44.22
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,24.14,16.13,34.03
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.75,0.49,1.09
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,159.22,82.5,265.27
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,126.19,60.85,216.89
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,33.03,21.65,48.38
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.9,0.59,1.31
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,165.11,85.62,274.7
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,127.4,60.87,219.53
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,37.71,24.76,55.17
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.21,0.71,4.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,2.21,0.71,4.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.04,0.03,0.06
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,39.7,17.55,70.2
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,36.48,15.25,65.79
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,3.22,2.31,4.41
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.13,0.09,0.18
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,94.53,47.32,161.35
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,85.3,40.81,148.59
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,9.23,6.51,12.76
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.37,2.06,12.39
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,6.37,2.06,12.39
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.21,0.14,0.28
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,150.5,75.33,256.87
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,135.8,64.97,236.56
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,14.7,10.36,20.32
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.17,0.12,0.23
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,147.15,65.82,259.09
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,134.71,56.89,242.04
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,12.44,8.92,17.05
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.3,0.21,0.41
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,216.54,108.9,368.91
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,195.11,93.79,339.28
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,21.43,15.11,29.63
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.41,0.29,0.58
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,275.91,145.76,462.87
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,246.79,125.36,422.48
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,29.12,20.4,40.39
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,243.58,120.13,401.16
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,243.58,120.13,401.16
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.22,0.16,0.31
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,167.62,80.27,284.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,156.11,72.15,268.71
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,11.51,8.12,15.89
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.26,0.18,0.36
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,201.41,98.66,339.86
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,185.77,87.58,318.23
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,15.65,11.08,21.63
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.15,0.11,0.2
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,147.52,69.83,255.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,139.27,63.79,244.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,8.24,6.04,10.99
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.31,0.22,0.43
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,120.82,50.44,209.93
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,105.24,39.53,188.31
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,15.58,10.91,21.62
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.44,0.3,0.61
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,104.71,51.8,184.8
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,84.82,37.96,157.03
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,19.89,13.84,27.76
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.15,0.11,0.21
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,74.51,32.31,131.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,68.35,27.82,123.19
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,6.15,4.49,8.41
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.22,0.16,0.3
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,62.67,26.11,113.95
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,55.16,20.74,103.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,7.51,5.37,10.26
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.17,0.12,0.24
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,59.52,24.48,112.22
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,53.31,20.17,103.55
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,6.21,4.31,8.67
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.34,0.25,0.46
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,51.92,20.47,94.59
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,41.32,12.84,80.3
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,10.6,7.63,14.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,34.12,10.72,67.81
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,34.12,10.72,67.81
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.28,0.21,0.36
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,38.05,13.64,72.46
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,32.08,9.21,64.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,5.97,4.44,7.8
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.63,0.47,0.82
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,43.06,17.36,78.37
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,29.49,7.28,60.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,13.57,10.08,17.71
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.82,0.6,1.06
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,40.71,17.25,72.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,26.53,6.82,54.38
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,14.19,10.42,18.28
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,1.67,1.15,2.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,42.53,18.79,73.73
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,26.1,7.33,51.53
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,16.44,11.46,22.2
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.63,0.46,0.86
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,32.58,12.7,58.89
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,24.35,6.76,47.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,8.23,5.94,11.2
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,3.6,2.4,5.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,53.29,25.9,87.76
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,27.07,8.44,51.35
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,26.22,17.47,36.41
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.21,0.15,0.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,106.99,51.05,183.57
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,97.77,44.52,170.89
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,9.22,6.53,12.67
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.28,0.2,0.39
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,108.37,51.38,186.32
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,98.42,44.33,172.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,9.95,7.04,13.66
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.96,4.69,17.59
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.58,1.85,11.1
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,4.38,2.84,6.5
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.12,0.08,0.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.72,19.09,58.76
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,27.07,13.36,46.19
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,8.65,5.74,12.57
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.19,0.13,0.28
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,57.2,30.58,94.1
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,43.35,21.39,73.97
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,13.85,9.18,20.14
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.22,0.15,0.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,38.29,18.03,67.64
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,21.47,7.12,42.66
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,16.83,10.91,24.98
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.28,0.18,0.4
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,82.73,44.23,136.11
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,62.7,30.94,106.98
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,20.03,13.28,29.12
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.32,0.22,0.46
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,121.0,66.79,195.08
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,98.21,51.46,162.38
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,22.79,15.33,32.7
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,0.38,0.25,0.55
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,140.96,80.9,218.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,116.21,64.45,182.47
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,24.75,16.45,35.7
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,0.46,0.32,0.66
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,98.14,55.22,152.76
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,72.32,37.66,116.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,25.82,17.56,36.59
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,0.61,0.41,0.86
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,123.21,71.1,189.44
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,86.52,46.5,137.52
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,36.7,24.6,51.93
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,0.32,0.23,0.44
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,81.13,47.4,127.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,63.55,34.87,102.92
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,17.58,12.54,24.29
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,0.55,0.38,0.78
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,73.46,38.86,116.68
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,45.89,19.83,77.38
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,27.57,19.02,39.3
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,0.46,0.32,0.65
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,58.02,29.1,91.3
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,36.89,14.75,61.6
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,21.13,14.35,29.7
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.22,0.16,0.31
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,40.21,18.22,69.25
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,31.1,11.62,56.58
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,9.11,6.6,12.67
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.25,0.18,0.35
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.69,15.1,61.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,25.51,8.6,48.53
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,9.19,6.5,12.8
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.37,0.26,0.52
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,38.14,17.73,64.54
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,24.87,8.5,46.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,13.26,9.23,18.54
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.15,0.1,0.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,23.67,8.09,47.51
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,19.1,4.87,41.18
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,4.57,3.22,6.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.55,0.4,0.72
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,28.78,13.5,49.77
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.4,2.99,30.83
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,14.38,10.5,18.93
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.32,0.23,0.42
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,21.37,8.55,39.34
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.09,2.5,28.45
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,8.28,6.05,10.9
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.31,1.83,25.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,11.31,1.83,25.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.34,0.25,0.47
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.94,6.36,28.83
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,9.99,2.11,20.82
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,5.94,4.25,8.01
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.52,0.36,0.7
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,15.5,6.75,28.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.24,2.35,19.5
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,6.26,4.41,8.5
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,0.59,0.41,0.81
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,16.7,7.32,31.2
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,8.99,2.0,20.55
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,7.7,5.33,10.65
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.72,0.5,0.95
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,13.51,6.77,23.2
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.29,3.11,16.23
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,5.22,3.66,6.97
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.27,0.19,0.39
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,54.23,29.27,87.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,39.95,19.56,66.79
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,14.28,9.72,20.28
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.3,0.21,0.43
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,57.4,30.87,92.25
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,42.25,20.54,70.8
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,15.15,10.33,21.46
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.15,0.11,0.19
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,17.42,10.07,26.68
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.39,1.98,12.18
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,11.03,8.09,14.51
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.2,0.14,0.26
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.85,26.01,69.24
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,30.51,15.55,50.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,14.34,10.45,19.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.31,0.23,0.42
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,71.74,41.6,110.75
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,48.81,24.87,80.25
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,22.93,16.72,30.5
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.56,0.41,0.74
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,66.82,38.61,102.35
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,24.51,7.58,46.71
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,42.3,31.03,55.64
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.45,0.33,0.6
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,103.47,60.0,159.74
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,70.4,35.88,115.74
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,33.08,24.12,44.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.36,0.26,0.48
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,134.81,78.28,208.8
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,109.63,60.07,174.76
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,25.19,18.21,34.04
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.2,0.15,0.28
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,151.53,86.01,238.51
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,138.16,76.2,219.97
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,13.38,9.81,18.54
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.15,0.11,0.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,103.35,55.98,165.93
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,94.49,49.48,153.96
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,8.86,6.5,11.97
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.2,0.14,0.26
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,126.99,72.62,200.34
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,115.07,63.88,184.45
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,11.92,8.74,15.88
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.11,0.08,0.15
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,94.97,48.63,156.56
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,88.74,43.93,148.35
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,6.23,4.7,8.2
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.12,0.09,0.16
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,71.63,35.4,117.06
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,65.73,31.11,109.15
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,5.9,4.29,7.9
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.12,0.09,0.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,57.41,28.25,95.72
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,51.87,24.26,88.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,5.54,3.99,7.51
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,0.27,0.2,0.36
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,54.28,26.72,88.03
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,43.44,18.53,73.47
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,10.84,8.19,14.56
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.34,0.25,0.46
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,48.36,23.55,79.27
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,35.77,14.38,62.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,12.58,9.17,17.1
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.71,0.51,0.98
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,60.62,31.67,95.52
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,35.08,13.36,60.61
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,25.55,18.31,34.91
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,27.17,10.44,50.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,27.17,10.44,50.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.55,0.42,0.71
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,36.5,18.34,60.53
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,21.93,7.23,41.86
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,14.57,11.11,18.67
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.53,0.41,0.67
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,33.83,16.49,57.44
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,21.0,6.66,41.11
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,12.83,9.84,16.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,0.49,0.38,0.62
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,30.37,14.09,53.42
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,19.79,5.91,40.13
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,10.58,8.18,13.3
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.38,0.28,0.48
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,24.41,10.12,43.39
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,17.93,5.3,35.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,6.48,4.82,8.23
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,0.29,0.21,0.38
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,21.47,7.91,39.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,17.91,5.33,34.73
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,3.56,2.59,4.59
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,16.49,5.13,32.87
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,16.49,5.13,32.87
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,0.43,0.3,0.58
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,22.25,7.68,40.04
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,19.1,5.52,35.82
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,3.14,2.16,4.22
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.21,0.16,0.29
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,62.48,33.92,99.77
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,51.16,25.63,84.65
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,11.31,8.29,15.11
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.24,0.17,0.31
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,64.86,34.85,104.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,53.62,26.6,89.06
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,11.24,8.25,15.02
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.58,1.62,11.17
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.58,1.62,11.17
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.09,0.06,0.13
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,33.72,17.71,55.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,27.38,13.44,46.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,6.33,4.27,9.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.14,0.1,0.2
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,53.73,28.22,88.61
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,43.64,21.42,74.26
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,10.09,6.8,14.35
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,21.59,6.26,43.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,21.59,6.26,43.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.21,0.14,0.3
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,78.54,41.26,129.53
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,63.8,31.31,108.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,14.75,9.95,20.98
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.39,0.26,0.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,127.75,71.5,204.11
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,100.26,52.96,165.01
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,27.49,18.54,39.1
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,0.73,0.48,1.06
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,164.27,95.06,250.12
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,116.64,63.51,180.8
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,47.62,31.55,69.31
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,0.71,0.48,1.01
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,112.15,64.23,172.66
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,73.15,37.98,116.73
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,39.0,26.25,55.93
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.66,0.44,0.95
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,128.94,75.83,194.88
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,89.05,49.2,137.85
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,39.9,26.62,57.03
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,0.46,0.33,0.65
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,89.32,50.11,141.39
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,63.71,32.05,105.1
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,25.6,18.07,36.29
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.64,0.44,0.91
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,79.43,44.27,125.62
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,47.2,22.17,79.82
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,32.23,22.1,45.79
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,1.09,0.72,1.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,86.57,48.35,133.34
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,37.12,15.52,62.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,49.45,32.83,70.79
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.98,0.7,1.37
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,70.63,38.26,113.81
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,30.97,9.95,58.15
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,39.66,28.3,55.66
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,1.25,0.87,1.75
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,70.14,39.54,111.27
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,25.24,8.36,48.26
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,44.9,31.18,63.01
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,1.72,1.16,2.42
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,86.09,50.21,133.35
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,24.55,8.71,46.68
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,61.54,41.5,86.68
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,1.05,0.74,1.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,51.17,28.89,82.69
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,18.79,5.94,37.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,32.38,22.95,45.09
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.58,0.43,0.76
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,29.82,14.58,51.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.66,3.42,31.08
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,15.16,11.16,19.93
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.52,0.38,0.69
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,26.0,11.93,45.34
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.18,2.5,28.38
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,12.82,9.43,16.96
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.45,0.33,0.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,20.93,8.42,37.83
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,11.22,1.28,24.8
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,9.71,7.14,13.03
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,1.28,0.91,1.74
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,32.2,18.02,51.84
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.12,2.34,21.86
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,22.08,15.68,29.98
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,1.52,1.06,2.07
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,28.04,15.62,45.67
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.28,2.5,20.04
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,18.77,13.12,25.64
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,1.21,0.82,1.69
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,24.75,12.83,43.34
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,8.96,2.14,21.28
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,15.8,10.69,22.06
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,2.26,1.58,3.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,24.62,14.61,37.83
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.2,3.16,15.62
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,16.41,11.45,22.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.52,0.36,0.74
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,63.83,35.64,100.53
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,40.44,19.7,67.32
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,23.39,15.94,33.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.62,0.43,0.88
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,69.26,38.8,108.9
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,42.68,20.66,71.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,26.58,18.14,37.69
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.13,4.07,15.47
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.58,2.19,12.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,2.55,1.88,3.42
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.1,0.07,0.14
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,38.52,21.15,60.76
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,31.27,15.9,50.99
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,7.25,5.25,9.77
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.16,0.12,0.22
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,61.32,33.67,96.73
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,49.78,25.31,81.17
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,11.54,8.37,15.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.13,0.1,0.18
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,35.32,15.75,59.82
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,25.44,8.48,46.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,9.88,7.27,13.22
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.23,0.17,0.32
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,89.42,49.1,141.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,72.58,36.9,118.37
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,16.83,12.2,22.68
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.32,0.23,0.44
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,135.71,77.64,210.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,112.92,61.22,179.78
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,22.79,16.42,30.77
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,140.67,77.3,218.77
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,140.67,77.3,218.77
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.17,0.12,0.23
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,105.41,56.6,167.7
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,96.69,50.23,156.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,8.72,6.37,11.7
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.2,0.14,0.26
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,131.88,72.33,207.5
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,120.02,63.64,191.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,11.85,8.69,15.94
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.11,0.08,0.15
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,97.17,52.65,155.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,90.96,48.0,147.37
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,6.22,4.65,8.09
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.23,0.17,0.32
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,77.84,37.38,125.52
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,66.09,28.85,109.64
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,11.75,8.53,15.88
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.33,0.24,0.45
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,67.83,36.5,114.19
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,52.67,25.54,93.73
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,15.16,10.96,20.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.12,0.09,0.16
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,47.77,23.32,79.84
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,42.79,19.56,73.18
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,4.98,3.75,6.66
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.17,0.13,0.23
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,41.39,19.09,71.42
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,35.45,14.7,63.53
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,5.94,4.39,7.9
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.14,0.1,0.19
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,39.82,17.97,71.16
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,34.81,14.39,64.35
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,5.02,3.58,6.82
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.26,0.2,0.34
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.45,15.25,61.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,27.31,9.17,50.94
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,8.14,6.09,10.61
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,21.97,7.07,42.85
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,21.97,7.07,42.85
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.21,0.16,0.27
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,25.57,9.88,47.4
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,20.95,6.33,41.57
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,4.62,3.55,5.83
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.48,0.37,0.61
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,30.16,13.45,53.19
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,19.67,5.38,39.95
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,10.49,8.06,13.24
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.69,0.52,0.88
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,29.78,13.86,50.98
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,17.89,4.98,35.93
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,11.89,8.88,15.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,1.31,0.92,1.75
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,30.97,15.0,51.24
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,17.88,5.65,33.99
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,13.09,9.35,17.25
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.5,0.37,0.67
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,22.96,10.07,39.4
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,16.44,5.28,30.68
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,6.52,4.79,8.72
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,2.77,1.9,3.74
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,39.28,20.61,61.71
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,19.1,6.78,34.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,20.18,13.83,27.25
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.16,0.12,0.22
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,59.41,31.35,95.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,52.27,26.13,85.99
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,7.14,5.22,9.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.22,0.16,0.29
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,62.4,32.69,100.76
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,54.69,27.06,90.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,7.71,5.63,10.3
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.47,0.23,0.9
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.43,0.22,0.8
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.16,0.46,2.4
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.31,0.01,0.92
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.84,0.45,1.49
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.85,0.74,3.85
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.5,0.02,1.47
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.35,0.72,2.38
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.82,0.9,3.46
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.06,0.39
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.65,0.85,3.07
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.01,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.68,1.07,5.57
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.73,0.03,2.13
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.96,1.05,3.44
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.42,1.22,7.38
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.2,0.0,3.62
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.22,1.22,3.76
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.03,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,5.18,1.83,10.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.91,0.53,6.48
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.26,1.3,3.64
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.79,2.03,11.33
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.67,0.79,7.98
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.12,1.24,3.35
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,7.15,2.76,13.54
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.86,0.83,8.36
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,3.29,1.93,5.18
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.37,1.91,10.35
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.93,1.03,8.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,1.44,0.88,2.24
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.95,1.89,11.51
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.94,0.71,8.4
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.01,1.19,3.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.17,1.68,11.01
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.81,0.87,8.82
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,1.36,0.81,2.19
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.52,0.86,7.7
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.96,0.5,6.84
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.56,0.36,0.86
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.22,0.61,4.77
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.7,0.26,4.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.52,0.34,0.77
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.05,0.49,4.6
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.33,0.0,3.56
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.72,0.49,1.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.76,0.42,1.24
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.51,0.27,0.87
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.25,0.16,0.37
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.7,1.68
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.38,0.21,0.62
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.72,0.48,1.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.75,0.47,1.16
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.34,0.2,0.55
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.41,0.28,0.61
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.29,0.17,0.45
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.29,0.17,0.45
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.05,0.04,0.08
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.75,1.67
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.22,0.13,0.32
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.92,0.61,1.34
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.09,0.06,0.14
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.31,0.83,1.97
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.21,0.13,0.32
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,1.1,0.7,1.65
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.11,0.07,0.18
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.68,1.03,2.56
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.19,0.11,0.29
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,1.48,0.91,2.27
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.14,0.09,0.2
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.21,0.75,1.83
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.23,0.15,0.35
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.98,0.61,1.48
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.87,1.03,5.68
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.67,0.33,3.75
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.2,0.69,1.94
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.08,1.1,6.1
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.83,0.37,4.08
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,1.26,0.73,2.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.16,0.7,1.78
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,1.11,0.69,1.67
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.83,0.91,3.12
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.37,0.01,0.92
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.45,0.9,2.21
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.92,1.46,5.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.6,0.02,1.47
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.32,1.44,3.53
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.44,2.69,6.82
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.18,0.06,0.4
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,4.26,2.63,6.42
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.21,2.11,7.21
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.86,0.03,2.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,3.35,2.08,5.09
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.02,1.62,7.54
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.44,0.0,3.57
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.57,1.62,3.96
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.91,1.43,10.2
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.67,0.68,8.26
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.25,0.75,1.94
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.18,2.05,12.39
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.34,1.52,11.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.85,0.53,1.28
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,2.3,12.96
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.33,1.59,11.29
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.13,0.71,1.67
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.42,2.27,12.62
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.8,1.87,11.7
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.62,0.4,0.92
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.77,1.89,13.86
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.23,1.55,13.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.54,0.34,0.82
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.55,2.43,12.62
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.98,2.08,11.74
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.57,0.35,0.88
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.45,1.87,10.96
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.43,1.23,9.43
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.02,0.64,1.53
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.62,1.38,7.17
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.45,0.67,5.34
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.17,0.72,1.83
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.31,1.83,8.45
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.94,0.4,4.7
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,2.38,1.44,3.75
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.59,0.28,1.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.59,0.28,1.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.99,1.22,3.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.43,0.23,0.73
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.56,0.99,2.32
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.07,0.04,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,1.24,2.95
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.22,0.64
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.58,1.02,2.31
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.07,0.05,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,1.26,2.83
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.34,0.2,0.53
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.62,1.06,2.3
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.04,0.03,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.67,1.34
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.4
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.72,0.51,0.94
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.04,0.03,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.75,0.48,1.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.3,0.18,0.45
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.45,0.3,0.61
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.15,0.39
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.26,0.15,0.39
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.07,0.04,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.88,0.54,1.3
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.37,0.23,0.56
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.5,0.31,0.74
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.52,1.36,6.76
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.39,0.65,5.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.13,0.7,1.71
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.7,1.42,7.13
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,2.57,0.71,5.42
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.13,0.7,1.71
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.92,0.34,1.94
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.3,0.01,0.87
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.62,0.33,1.08
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.47,0.55,3.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.48,0.02,1.39
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.99,0.53,1.71
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.06,0.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.06,0.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,0.8,4.53
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.7,0.03,2.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.45,0.78,2.5
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.04,0.02,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.87,1.45,8.12
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.16,0.0,3.45
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.71,1.45,4.67
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.26,3.02,13.83
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.84,0.54,6.48
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,4.42,2.48,7.35
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.8,2.65,12.88
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.6,0.8,7.7
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.2,1.85,5.18
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.06,0.03,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,7.44,2.94,13.68
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.8,0.84,7.92
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,3.64,2.1,5.76
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.02,2.13,11.63
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.89,0.83,8.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,2.12,1.3,3.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.28,2.31,11.89
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.89,0.92,8.16
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.39,1.39,3.74
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.07,0.04,0.12
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.89,2.79,13.13
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.65,0.94,7.83
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.23,1.86,5.3
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.32,2.05,10.18
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.83,0.51,6.44
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,2.48,1.54,3.75
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.07,0.05,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.23,1.94,7.57
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.64,0.27,3.78
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,2.58,1.67,3.8
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.1,0.06,0.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.71,2.29,8.27
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.33,0.0,3.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,3.38,2.29,4.88
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.29,1.4,3.49
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.51,0.27,0.87
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,1.78,1.14,2.61
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.15,0.73,1.72
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.38,0.21,0.59
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.77,0.52,1.13
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.04,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.76,1.81
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.34,0.2,0.52
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.87,0.56,1.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.31,0.79,1.93
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.29,0.17,0.43
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,1.02,0.62,1.5
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.2,0.13,0.3
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,3.68,2.42,5.39
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.22,0.14,0.33
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,3.46,2.28,5.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.27,0.17,0.41
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.49,2.2,5.24
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.22,0.13,0.33
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,3.27,2.07,4.91
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.24,0.14,0.37
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.3,2.02,5.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.2,0.12,0.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.1,1.91,4.79
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.43,0.26,0.65
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.37,2.05,5.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.24,0.15,0.36
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,3.12,1.89,4.78
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.49,1.43,6.55
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.64,0.34,3.6
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.85,1.09,2.95
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.05,0.03,0.08
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.89,1.62,7.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.8,0.38,3.94
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,2.09,1.24,3.31
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.01
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.18,0.51
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.26,0.16,0.41
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.47,2.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.37,0.01,0.92
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.75,0.46,1.16
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.77,0.75,3.32
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.59,0.02,1.47
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.19,0.73,1.85
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.19,0.69,1.98
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.18,0.06,0.41
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.01,0.62,1.58
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.59,1.09,4.84
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.85,0.03,2.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.73,1.06,2.7
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.78,1.43,7.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.43,0.0,3.62
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.35,1.43,3.67
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.72,0.81,8.15
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.72,0.81,8.15
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.25,2.14,12.57
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.39,1.61,11.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.86,0.53,1.32
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,6.5,2.35,12.95
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.36,1.66,11.24
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.14,0.69,1.7
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.63,2.21,13.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.0,1.81,12.31
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.63,0.39,0.94
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.48,2.56,15.08
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.38,1.88,13.43
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.09,0.68,1.65
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.03,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.32,3.01,14.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.75,2.04,11.59
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,1.57,0.96,2.52
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.01,1.48,10.2
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.54,1.19,9.47
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.47,0.29,0.73
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.06,0.89,6.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.45,0.52,5.35
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.61,0.37,0.94
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.32,0.27,5.49
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.85,0.0,4.76
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.47,0.27,0.73
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.87,2.49
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.59,0.3,1.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.95,0.57,1.44
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.43,0.24,0.68
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.43,0.24,0.68
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.67,1.64
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.22,0.61
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.71,0.45,1.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.08,0.05,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.94,1.22,2.86
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.33,0.2,0.51
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.61,1.02,2.35
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.08,0.05,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.59,1.08,2.18
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.33,0.92,1.8
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.2,0.13,0.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.17,1.39,3.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.29,0.17,0.43
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.88,1.21,2.71
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.08,0.06,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.33,0.92,1.89
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.25,0.14,0.37
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.09,0.77,1.52
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.45,0.27,0.66
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.61,2.16,5.37
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.36,0.22,0.54
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,3.24,1.94,4.84
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.12,6.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.41,0.66,5.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.75,0.46,1.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.43,1.24,6.76
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,2.6,0.72,5.49
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.83,0.51,1.27
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.09,1.7,10.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,4.7,1.57,9.25
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.39,0.13,0.87
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,23.21,10.26,42.45
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,22.42,9.98,40.69
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.79,0.28,1.76
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.42,17.87,73.94
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,39.05,17.39,70.88
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.37,0.48,3.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,21.84,7.3,43.45
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,20.18,6.73,39.72
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.66,0.57,3.73
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,60.74,26.86,111.11
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,58.68,26.13,106.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.06,0.73,4.6
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.04,0.01,0.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,98.28,45.74,176.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,95.84,44.86,170.96
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.44,0.88,5.45
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.04,0.02,0.09
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,90.64,42.83,155.13
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,87.87,41.81,149.22
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.78,1.03,5.91
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,38.99,15.8,72.25
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,37.61,15.26,69.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.38,0.54,2.83
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,37.37,13.75,71.36
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,37.37,13.75,71.36
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,17.01,3.89,37.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,17.01,3.89,37.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,12.59,3.42,29.03
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.21,2.41,24.35
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.38,1.01,4.69
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.04,0.02,0.09
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.42,1.29,22.34
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,7.39,0.48,18.34
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.03,0.8,4.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.54,0.38,14.83
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.54,0.38,14.83
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.02,1.59,11.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,5.02,1.59,11.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.94,2.53,9.24
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.94,2.53,9.24
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.31,2.21,7.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,4.31,2.21,7.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.61,1.85,6.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.61,1.85,6.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.3,1.72,6.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,3.3,1.72,6.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.87,1.55,5.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.87,1.55,5.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.33,0.15,0.63
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.73,3.64,14.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,2.2,1.11,3.91
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,5.53,2.53,11.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.18,0.08,0.35
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,5.35,2.52,10.2
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,2.32,1.14,4.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,3.03,1.38,6.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.93,0.91,3.52
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.93,0.91,3.52
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.43,1.61,6.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,3.43,1.61,6.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,23.58,9.78,43.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,22.65,9.42,42.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.92,0.36,1.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,25.67,10.78,47.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,24.75,10.43,45.55
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.92,0.35,1.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.34,0.93,7.13
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,2.88,0.73,6.23
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.46,0.2,0.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.2,5.58,27.25
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,13.83,5.42,26.53
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.37,0.16,0.72
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.67,9.7,47.35
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,24.03,9.42,46.09
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.64,0.27,1.26
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.28,3.99,30.53
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,12.32,3.14,26.67
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.96,0.84,3.86
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.01,0.01,0.03
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.99,14.54,71.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,36.03,14.13,69.11
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.96,0.41,1.89
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,58.76,24.66,109.8
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,58.76,24.66,109.8
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.5,23.43,95.99
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,53.5,23.43,95.99
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.67,8.67,43.14
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,22.63,8.65,43.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.04,0.02,0.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,22.71,8.28,42.39
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,22.71,8.28,42.39
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,9.83,1.46,23.43
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,9.83,1.46,23.43
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.84,0.49,16.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,5.84,0.49,16.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.83,2.48,8.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.52,2.34,8.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.31,0.14,0.59
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.47,1.62,6.92
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.47,1.62,6.92
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.14,1.52,5.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,3.14,1.52,5.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.03,1.49,5.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,3.03,1.49,5.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.42,5.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,2.79,1.42,5.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.42,1.25,4.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,2.42,1.25,4.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.22,1.16,3.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,2.22,1.16,3.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.96,1.05,3.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.96,1.05,3.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.52,0.81,2.66
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,1.52,0.81,2.66
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.74,0.87,3.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,1.74,0.87,3.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.63,2.54
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,1.38,0.63,2.54
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.71,1.33,4.68
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,2.71,1.33,4.68
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,13.98,5.43,26.8
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,13.8,5.35,26.44
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.18,0.08,0.36
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,15.01,5.87,28.65
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,14.82,5.79,28.29
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.19,0.08,0.37
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.36,1.54,11.27
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,4.76,1.33,9.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.59,0.21,1.34
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.71,9.38,41.69
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,22.02,9.14,40.14
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.69,0.24,1.55
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,39.72,16.4,72.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,38.51,15.98,70.21
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.21,0.42,2.72
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.03,0.01,0.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.26,6.68,48.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,20.67,5.79,43.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.58,0.9,5.82
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.01,0.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,59.99,24.77,110.14
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,58.16,24.14,106.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.83,0.63,4.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,95.5,42.26,169.34
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,94.41,41.88,166.91
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.1,0.38,2.44
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.15,0.05,0.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,98.25,42.02,174.18
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,88.69,38.65,153.23
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,9.57,3.37,20.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.05,0.02,0.11
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,40.79,15.43,76.09
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,37.48,14.23,68.92
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.31,1.2,7.17
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,39.25,14.27,74.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,37.83,13.72,71.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.42,0.54,3.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,19.55,5.0,40.96
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,16.9,3.95,35.46
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,2.65,1.05,5.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,9.96,1.86,23.17
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,9.96,1.86,23.17
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.74,0.51,15.58
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.74,0.51,15.58
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.19,0.36,13.85
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.19,0.36,13.85
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.83,1.54,10.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.83,1.54,10.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.88,2.46,9.2
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.88,2.46,9.2
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.23,2.11,7.58
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,4.23,2.11,7.58
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.52,1.75,6.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.52,1.75,6.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.22,1.65,5.87
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,3.22,1.65,5.87
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.8,1.51,4.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.8,1.51,4.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.3,0.12,0.66
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.52,3.39,14.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,2.13,1.11,3.84
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,5.36,2.28,11.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.16,0.07,0.36
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,5.23,2.38,10.23
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,2.27,1.13,4.13
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,2.94,1.25,6.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.92,0.9,3.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.92,0.9,3.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.39,1.64,6.16
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,3.39,1.64,6.16
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,24.03,9.33,44.94
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,22.58,8.81,41.79
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.45,0.52,3.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,26.08,10.23,48.52
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,24.52,9.67,45.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,1.56,0.56,3.4
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.0,0.63,6.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.0,0.63,6.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.13,5.78,26.45
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,13.94,5.7,26.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.19,0.08,0.37
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.66,10.09,46.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,24.32,9.95,45.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.34,0.14,0.65
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.99,2.72,28.16
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,12.99,2.72,28.16
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,37.16,15.2,69.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,36.66,14.99,68.57
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.51,0.21,0.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.01,0.01,0.03
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,60.39,27.19,109.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,59.4,26.77,107.39
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.99,0.42,1.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.74,25.31,98.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,53.74,25.31,98.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.58,8.75,44.63
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,22.52,8.72,44.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.06,0.03,0.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,22.81,7.43,46.74
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,22.55,7.31,46.24
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.26,0.12,0.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,9.99,1.18,24.38
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,9.99,1.18,24.38
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.0,0.4,15.38
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.0,0.4,15.38
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.5,2.3,8.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.5,2.3,8.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.5,1.64,6.86
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.5,1.64,6.86
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.15,1.56,5.96
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,3.15,1.56,5.96
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.05,1.56,5.81
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,3.05,1.56,5.81
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.44,4.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,2.79,1.44,4.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.06,0.02,0.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,4.18,1.99,7.54
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,2.41,1.19,4.31
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.77,0.8,3.23
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.23,1.6,5.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,2.22,1.14,3.92
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.01,0.46,1.85
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,1.07,3.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.97,1.07,3.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.53,0.74,2.67
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,1.53,0.74,2.67
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.75,0.83,3.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,1.75,0.83,3.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.61,2.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,1.39,0.61,2.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.73,1.34,4.71
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,2.73,1.34,4.71
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,14.09,5.61,27.22
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,13.94,5.54,26.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.15,0.07,0.29
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,15.0,6.01,28.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,14.85,5.95,28.6
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.15,0.07,0.29
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.52,0.09,1.14
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.52,0.09,1.14
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.1,1.71,10.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.1,1.71,10.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.95,3.59,17.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,8.95,3.59,17.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.66,0.29,3.66
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,1.66,0.29,3.66
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.59,6.25,30.64
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,15.59,6.25,30.64
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,20.19,7.06,41.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,20.19,7.06,41.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.59,9.24,44.2
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,22.59,9.24,44.2
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.9,11.34,47.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,24.9,11.34,47.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,18.32,7.59,36.87
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,18.32,7.59,36.87
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.28,4.69,24.87
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,12.28,4.69,24.87
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,13.58,5.16,27.28
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,13.58,5.16,27.28
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,10.06,3.8,20.62
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,10.06,3.8,20.62
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.3,2.69,17.05
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.3,2.69,17.05
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.8,2.19,13.99
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.8,2.19,13.99
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.29,1.73,10.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.29,1.73,10.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.05,1.6,7.92
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.05,1.6,7.92
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.8,1.83,6.83
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.8,1.83,6.83
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.45,1.1,4.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.45,1.1,4.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.5,0.56,3.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.5,0.56,3.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.49,2.48
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.22,0.49,2.48
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.83,0.39,1.57
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.83,0.39,1.57
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.48,0.21,1.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.48,0.21,1.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.16,0.82
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.39,0.16,0.82
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.34,0.11,0.68
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.34,0.11,0.68
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.1,0.4
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.2,0.1,0.4
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.68,3.38,17.34
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,8.68,3.38,17.34
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.13,3.58,18.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,9.13,3.58,18.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.38,0.1,0.83
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.38,0.1,0.83
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.29,1.11,6.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.29,1.11,6.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.08,1.84,10.43
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,5.08,1.84,10.43
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.31,2.67
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.22,0.31,2.67
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.83,3.19,18.12
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,8.83,3.19,18.12
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.84,4.42,26.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,12.84,4.42,26.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.64,4.63,25.84
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,12.64,4.63,25.84
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.44,4.82,25.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,12.44,4.82,25.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.98,2.69,16.09
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,7.98,2.69,16.09
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.31,1.92,10.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.31,1.92,10.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.6,1.58,11.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.6,1.58,11.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.45,1.98,7.81
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,4.45,1.98,7.81
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.73,1.59,6.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.73,1.59,6.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.07,1.4,6.55
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.07,1.4,6.55
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,0.83,4.06
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.15,0.83,4.06
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.65,0.63,3.19
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.65,0.63,3.19
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.63,2.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.54,0.63,2.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.35,2.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.06,0.35,2.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.34,1.28
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.71,0.34,1.28
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.58,0.27,1.07
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.58,0.27,1.07
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.4,0.17,0.78
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.4,0.17,0.78
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.24,0.09,0.52
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.24,0.09,0.52
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.07,0.41
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.19,0.07,0.41
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.04,0.38
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.17,0.04,0.38
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.28,1.56,8.62
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,4.28,1.56,8.62
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.44,1.61,8.94
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,4.44,1.61,8.94
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.38,0.02,1.1
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.38,0.02,1.1
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.16,1.01,9.54
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,4.16,1.01,9.54
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.91,2.77,17.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,7.91,2.77,17.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.06,3.54
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,1.22,0.06,3.54
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,13.83,4.85,30.1
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,13.83,4.85,30.1
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,16.81,4.33,37.71
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,16.81,4.33,37.71
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.27,7.29,43.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,20.27,7.29,43.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,23.62,10.15,49.38
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,23.62,10.15,49.38
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,18.32,7.89,36.08
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,18.32,7.89,36.08
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.29,4.72,24.13
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,12.29,4.72,24.13
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,13.55,5.29,24.35
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,13.55,5.29,24.35
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,10.32,3.56,21.94
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,10.32,3.56,21.94
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.27,2.91,16.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.27,2.91,16.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.87,1.82,13.92
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.87,1.82,13.92
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.08,1.37,11.43
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.08,1.37,11.43
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.98,1.46,8.06
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.98,1.46,8.06
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.87,1.85,6.88
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.87,1.85,6.88
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.45,1.05,4.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.45,1.05,4.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.53,0.58,2.89
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.53,0.58,2.89
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.24,0.5,2.34
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.24,0.5,2.34
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.84,0.38,1.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.84,0.38,1.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.48,0.21,0.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.48,0.21,0.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.16,0.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.39,0.16,0.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.34,0.11,0.68
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.34,0.11,0.68
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.1,0.41
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.21,0.1,0.41
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.26,3.02,17.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,8.26,3.02,17.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.64,3.18,17.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,8.64,3.18,17.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.35,0.05,0.91
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.35,0.05,0.91
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.04,0.86,6.82
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.04,0.86,6.82
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.78,1.61,10.08
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,4.78,1.61,10.08
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.12,0.16,2.93
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.12,0.16,2.93
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.34,2.81,17.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,8.34,2.81,17.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.0,3.56,26.49
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,12.0,3.56,26.49
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.01,4.15,25.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,12.01,4.15,25.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.01,4.73,23.61
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,12.01,4.73,23.61
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.9,2.71,15.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,7.9,2.71,15.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.26,1.92,10.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.26,1.92,10.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.61,1.68,12.49
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.61,1.68,12.49
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.38,1.97,7.88
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,4.38,1.97,7.88
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.67,1.59,6.89
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.67,1.59,6.89
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.09,1.24,5.75
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.09,1.24,5.75
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.24,1.0,4.36
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.24,1.0,4.36
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.67,0.72,3.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.67,0.72,3.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.52,0.68,2.86
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.52,0.68,2.86
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.07,0.38,2.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.07,0.38,2.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.32,1.33
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.71,0.32,1.33
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.58,0.25,1.12
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.58,0.25,1.12
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.17,0.84
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.41,0.17,0.84
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.09,0.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.09,0.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.07,0.39
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.2,0.07,0.39
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.04,0.33
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.16,0.04,0.33
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.16,1.48,8.5
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,4.16,1.48,8.5
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.28,1.52,8.76
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,4.28,1.52,8.76
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.06,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.14,0.06,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.04,0.02,0.07
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.74,2.5,13.85
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.84,1.09,8.61
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,2.89,1.4,5.24
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.08,0.04,0.15
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.37,4.76,24.39
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,6.33,1.81,13.81
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,6.04,2.95,10.58
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.18,0.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.44,0.18,0.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.15,0.07,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,21.55,8.3,42.49
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,11.03,3.16,24.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,10.52,5.14,18.43
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.16,0.08,0.3
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,28.47,10.53,58.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,16.05,4.5,36.12
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,12.42,6.02,22.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.22,0.11,0.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.16,12.37,63.42
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,16.35,4.66,35.73
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,15.81,7.72,27.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,0.27,0.13,0.47
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.72,14.16,68.05
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,16.63,4.81,35.36
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,19.09,9.35,32.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,0.32,0.15,0.54
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,33.05,13.44,63.94
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,12.29,3.35,28.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,20.76,10.09,35.07
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,0.18,0.09,0.31
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.2,7.31,35.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,8.09,2.15,17.99
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,10.12,5.16,17.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,8.79,1.42,20.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,8.79,1.42,20.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.5,0.89,16.07
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,6.5,0.89,16.07
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,0.28,0.15,0.49
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,19.76,10.5,33.67
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.55,2.86,9.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,14.2,7.64,24.4
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,0.39,0.21,0.64
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.22,11.72,36.43
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.41,2.2,7.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,17.81,9.51,29.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.56,1.83,5.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.56,1.83,5.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.24,1.77,5.32
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.24,1.77,5.32
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.12,1.74,5.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.12,1.74,5.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.92,1.71,4.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.92,1.71,4.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,1.55,4.37
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.71,1.55,4.37
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,1.49,4.18
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.6,1.49,4.18
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.44,1.41,3.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.44,1.41,3.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,1.89,1.02,3.13
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,34.91,19.03,57.25
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,2.2,1.26,3.55
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,32.72,17.77,53.71
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,1.04,0.56,1.71
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,19.96,10.91,32.72
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,2.06,1.18,3.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,17.9,9.72,29.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.99,1.14,3.24
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.99,1.14,3.24
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.71,1.01,2.82
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,1.71,1.01,2.82
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.13,0.07,0.22
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,12.91,5.33,24.65
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,6.14,1.91,13.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,6.77,3.43,11.55
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.12,0.06,0.21
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,13.18,5.32,25.4
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,6.39,1.9,13.78
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,6.79,3.41,11.62
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.01,0.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.05,0.01,0.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.4,2.14,7.64
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.43,0.53,2.92
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,2.97,1.61,4.72
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.79,2.31,8.48
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,2.4,1.02,4.68
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,2.39,1.29,3.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.05,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.16,0.05,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.05,0.03,0.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.32,4.02,14.73
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,4.17,1.77,8.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,4.15,2.25,6.6
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.17,0.09,0.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,18.66,9.11,32.36
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,5.95,2.22,12.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,12.71,6.88,20.22
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.08,0.04,0.13
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.4,6.0,21.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,6.17,2.63,12.03
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,6.22,3.37,9.9
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.39,3.02,11.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,6.39,3.02,11.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.64,2.35,8.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,4.64,2.35,8.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.46,2.36,7.57
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.84,1.43,5.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.62,0.93,2.55
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,3.08,1.57,5.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,3.08,1.57,5.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,2.2,1.07,3.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,2.2,1.07,3.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,0.86,3.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.72,0.86,3.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.25,0.15,0.39
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.84,7.29,20.56
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,1.41,0.7,2.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,11.43,6.6,18.05
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.2,0.61,2.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.2,0.61,2.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.15,0.6,2.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.15,0.6,2.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.12,0.57,1.97
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.12,0.57,1.97
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.61,1.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.11,0.61,1.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.07,0.58,1.88
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.07,0.58,1.88
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.03,0.56,1.81
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.03,0.56,1.81
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.98,0.52,1.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.98,0.52,1.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.9,0.47,1.59
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.9,0.47,1.59
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.46,1.52
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.86,0.46,1.52
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.88,0.46,1.5
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.88,0.46,1.5
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.43,1.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.74,0.43,1.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.0,2.03,6.95
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.24,1.04,4.15
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.77,0.98,2.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.03,0.02,0.04
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.98,2.0,6.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,2.31,1.08,4.28
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.67,0.93,2.65
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.13,0.05,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.13,0.05,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.06,0.03,0.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,7.88,2.81,15.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.54,0.79,7.6
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,4.34,2.02,8.24
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.07,0.03,0.13
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.18,4.05,22.45
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,6.05,1.65,12.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,5.14,2.4,9.65
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.42,0.17,0.85
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.42,0.17,0.85
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.12,0.06,0.23
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.56,7.08,39.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,10.57,2.89,22.4
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,8.98,4.19,16.88
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.25,0.12,0.47
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.76,12.01,67.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,14.91,3.25,32.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,18.84,8.75,35.75
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.18,0.09,0.35
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.32,10.6,58.88
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,15.75,4.27,33.39
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,13.56,6.33,25.49
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.12,0.06,0.22
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,25.03,9.24,50.23
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,16.57,5.26,34.65
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,8.47,3.98,15.58
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,1.07,0.5,1.86
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,82.32,35.66,146.25
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,12.13,3.1,24.9
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,70.2,32.56,121.35
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,0.38,0.19,0.66
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,32.05,13.55,58.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,7.92,1.96,16.76
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,24.13,11.6,41.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,0.19,0.1,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,20.17,7.09,39.18
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,8.66,1.06,19.61
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,11.51,6.03,19.57
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,0.32,0.17,0.53
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,23.92,10.14,45.13
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,6.34,0.82,15.96
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,17.58,9.32,29.17
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.4,2.69,9.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.4,2.69,9.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.31,2.23,7.25
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.31,2.23,7.25
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.5,1.87,5.99
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.5,1.87,5.99
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.17,1.77,5.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.17,1.77,5.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.06,1.72,5.12
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.06,1.72,5.12
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.83,1.68,4.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.83,1.68,4.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.61,1.52,4.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.61,1.52,4.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.5,1.45,4.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.5,1.45,4.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.36,1.36,3.89
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.36,1.36,3.89
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,1.8,0.99,3.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,33.23,18.16,54.72
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,2.13,1.2,3.45
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,31.13,16.96,51.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.99,0.54,1.64
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,19.06,10.43,31.39
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.99,1.12,3.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,17.09,9.31,28.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.92,1.07,3.16
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.92,1.07,3.16
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.64,0.92,2.77
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,1.64,0.92,2.77
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.18,0.09,0.31
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,16.43,6.8,30.6
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,5.97,1.77,12.32
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,10.46,5.03,18.28
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.19,0.09,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,17.52,7.19,32.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,6.18,1.76,12.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,11.34,5.44,19.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.4,0.53,2.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.4,0.53,2.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.73,1.67,7.18
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,2.37,0.96,4.67
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.36,0.71,2.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.05,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.16,0.05,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.03,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.52,2.91,12.52
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,4.14,1.68,8.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.37,1.23,4.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.87,2.24,11.79
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,5.87,2.24,11.79
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.05,0.03,0.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,9.74,4.35,18.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,6.16,2.5,12.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,3.58,1.85,6.6
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.1,0.05,0.19
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,13.46,6.38,25.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,6.44,2.74,12.41
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,7.01,3.64,12.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.69,2.49,8.41
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,4.69,2.49,8.41
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.04,0.02,0.08
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.53,2.91,9.77
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.85,1.45,5.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,2.68,1.46,4.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.19,0.1,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,14.44,7.75,25.28
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,3.11,1.57,5.67
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,11.33,6.18,19.61
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,2.22,1.04,3.98
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,2.22,1.04,3.98
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,0.84,3.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.72,0.84,3.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,1.4,0.72,2.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,1.4,0.72,2.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.17,0.62,2.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.17,0.62,2.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.6,1.98
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.13,0.6,1.98
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.1,0.57,1.89
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.1,0.57,1.89
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.1,0.6,1.92
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.1,0.6,1.92
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.49,0.26,0.82
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,14.11,7.38,23.36
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.08,0.58,1.9
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,13.03,6.8,21.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.28,0.15,0.47
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.52,4.45,14.15
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.04,0.55,1.84
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,7.48,3.9,12.31
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.51,1.75
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.99,0.51,1.75
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.93,0.46,1.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.93,0.46,1.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.44,1.53
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.87,0.44,1.53
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.45,1.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.86,0.45,1.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.75,0.37,1.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.75,0.37,1.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.06,2.0,7.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.24,1.03,4.2
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.82,0.97,3.19
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.18,2.06,7.61
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,2.3,1.06,4.31
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,1.88,1.0,3.31
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.65,0.15,1.4
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.65,0.15,1.4
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.06,0.03,0.12
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.1,7.25,45.39
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,17.58,5.24,36.7
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,4.52,2.02,8.69
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.13,0.06,0.24
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.19,27.65,121.94
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,55.82,23.42,104.29
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,9.37,4.23,17.66
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.09,0.47,4.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.09,0.47,4.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.23,0.1,0.43
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,113.56,48.16,212.41
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,97.23,40.79,181.65
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,16.33,7.36,30.76
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.26,0.11,0.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,92.74,30.66,190.26
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,73.32,22.0,152.95
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,19.43,8.67,37.31
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.34,0.15,0.64
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,169.59,72.12,316.91
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,145.05,61.06,270.7
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,24.53,11.06,46.22
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.42,0.19,0.78
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,243.75,112.14,439.16
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,214.29,98.77,384.34
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,29.46,13.37,54.82
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.49,0.22,0.89
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,241.18,114.32,418.67
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,209.17,99.71,360.39
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,32.01,14.61,58.27
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.28,0.13,0.51
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,136.17,60.02,247.09
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,120.44,52.56,218.78
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,15.73,7.46,28.31
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,132.87,57.8,242.45
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,132.87,57.8,242.45
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,87.11,33.97,167.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,87.11,33.97,167.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.45,0.22,0.83
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,86.62,35.47,167.48
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,63.61,24.16,125.76
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,23.01,11.3,41.72
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.59,0.29,1.03
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,77.64,30.35,147.73
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,50.52,16.93,100.56
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,27.12,13.42,47.17
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,42.74,13.94,85.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,42.74,13.94,85.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.67,11.53,68.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,34.67,11.53,68.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,32.88,11.58,62.9
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,32.88,11.58,62.9
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,24.58,7.75,49.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,24.58,7.75,49.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,18.22,5.6,37.18
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,18.22,5.6,37.18
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,17.02,6.91,32.2
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,17.02,6.91,32.2
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,15.37,8.72,25.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,15.37,8.72,25.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,3.25,1.68,5.68
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,68.29,35.75,117.1
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.27,7.01,19.55
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,55.99,28.75,97.55
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,1.78,0.92,3.11
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,42.26,22.14,72.15
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,11.61,6.42,18.79
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,30.63,15.73,53.37
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,10.73,5.62,17.77
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,10.73,5.62,17.77
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,10.99,5.85,18.04
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,10.99,5.85,18.04
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.21,0.1,0.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,80.7,34.46,149.13
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,70.09,29.48,129.77
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,10.61,4.98,19.36
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,0.19,0.09,0.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,84.6,36.38,155.83
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,73.99,31.44,136.4
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,10.61,4.95,19.43
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.43,0.11,0.94
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.43,0.11,0.94
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.09,0.05,0.14
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,19.82,7.47,38.23
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.32,4.04,27.44
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,6.5,3.43,10.8
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.07,0.04,0.12
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,52.85,23.3,95.67
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,47.62,20.54,86.99
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,5.22,2.76,8.68
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.36,3.01
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.38,0.36,3.01
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.12,0.06,0.2
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,91.81,40.47,166.22
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,82.74,35.68,151.14
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,9.08,4.79,15.08
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.37,0.2,0.61
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,83.42,31.59,160.53
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,55.61,16.92,114.33
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,27.81,14.67,46.2
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.18,0.1,0.3
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,136.99,60.51,247.74
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,123.38,53.33,225.13
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,13.61,7.18,22.61
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,188.35,88.24,331.37
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,188.35,88.24,331.37
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,212.23,113.15,339.87
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,212.23,113.15,339.87
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.08,0.04,0.13
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,146.07,73.54,243.28
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,142.56,71.55,237.57
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,3.51,1.99,5.7
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,169.31,86.57,281.45
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,169.31,86.57,281.45
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,123.31,60.07,212.24
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,123.31,60.07,212.24
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,86.63,37.73,152.99
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,86.63,37.73,152.99
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.54,0.31,0.89
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,88.9,40.79,153.59
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,64.09,26.74,113.29
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,24.81,14.05,40.3
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,48.44,20.23,89.26
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,48.44,20.23,89.26
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,38.56,15.11,71.62
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,38.56,15.11,71.62
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,36.62,13.9,66.78
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,36.62,13.9,66.78
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.78,9.26,52.36
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,26.78,9.26,52.36
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,20.4,5.48,42.79
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,20.4,5.48,42.79
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,18.07,4.82,38.32
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,18.07,4.82,38.32
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.96,3.95,32.39
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,14.96,3.95,32.39
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,12.41,3.77,25.3
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,12.41,3.77,25.3
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,12.08,3.85,24.81
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,12.08,3.85,24.81
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,11.39,3.13,25.03
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,11.39,3.13,25.03
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,12.23,4.95,23.46
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,12.23,4.95,23.46
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.06,0.04,0.11
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,78.82,37.18,136.47
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,74.96,35.09,130.13
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,3.85,2.09,6.34
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.06,0.03,0.1
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,81.14,38.56,140.04
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,77.49,36.59,134.02
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,3.65,1.97,6.02
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.07,1.37
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.51,0.07,1.37
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.09,0.04,0.18
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.48,6.92,49.15
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,16.68,3.98,35.72
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,6.8,2.94,13.43
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.36,25.03,117.33
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,54.35,21.56,101.6
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,8.0,3.47,15.73
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.64,0.23,4.4
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,1.64,0.23,4.4
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.19,0.08,0.37
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,109.07,43.78,205.22
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,95.07,37.71,177.7
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,14.0,6.08,27.52
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.39,0.17,0.77
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,100.2,29.78,208.74
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,70.7,17.02,150.44
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,29.5,12.76,58.3
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.29,0.12,0.56
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,163.89,66.01,307.7
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,142.74,56.83,266.13
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,21.14,9.18,41.57
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.19,0.08,0.36
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,225.45,101.03,403.36
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,212.39,95.31,377.98
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,13.06,5.71,25.39
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,1.65,0.72,3.08
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,319.15,141.24,566.35
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,211.06,94.12,365.16
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,108.1,47.13,201.19
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.59,0.26,1.08
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,157.97,66.65,286.22
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,120.99,50.07,217.93
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,36.99,16.58,68.3
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.28,0.13,0.52
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,151.3,65.46,270.04
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,134.4,57.34,239.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,16.9,8.12,31.04
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.49,0.24,0.88
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,115.37,44.62,217.54
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,88.17,31.43,169.1
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,27.2,13.19,48.44
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,64.33,23.39,124.45
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,64.33,23.39,124.45
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,49.81,16.71,96.89
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,49.81,16.71,96.89
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,41.23,11.56,82.91
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,41.23,11.56,82.91
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,33.9,11.03,66.32
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,33.9,11.03,66.32
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,32.49,12.54,60.93
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,32.49,12.54,60.93
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,24.66,8.24,48.31
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,24.66,8.24,48.31
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,18.37,5.1,38.14
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,18.37,5.1,38.14
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,17.06,6.56,32.81
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,17.06,6.56,32.81
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,15.24,8.6,25.43
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,15.24,8.6,25.43
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,3.09,1.56,5.48
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,65.36,33.65,113.84
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.2,6.86,19.63
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,53.16,26.79,94.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,1.69,0.86,3.01
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,40.73,21.08,70.53
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,11.56,6.38,18.83
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,29.17,14.7,51.7
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,10.68,5.76,17.74
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,10.68,5.76,17.74
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,10.98,5.85,18.07
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,10.98,5.85,18.07
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.28,0.13,0.52
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,86.1,35.2,158.95
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,69.92,27.94,128.72
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,16.18,7.25,30.23
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.29,0.13,0.54
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,91.09,37.5,167.68
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,73.59,29.68,134.95
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,17.5,7.82,32.73
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.4,0.07,1.01
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.4,0.07,1.01
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.95,3.66,26.49
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,12.95,3.66,26.49
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.05,0.02,0.08
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,50.02,22.33,90.92
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,46.83,20.73,85.14
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,3.19,1.61,5.78
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,0.21,3.26
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.28,0.21,3.26
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.08,0.04,0.14
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,87.26,38.96,158.63
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,81.7,36.16,148.54
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,5.56,2.8,10.09
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,54.68,15.61,111.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,54.68,15.61,111.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.12,0.06,0.22
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,130.86,58.61,237.42
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,122.47,54.4,222.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,8.39,4.22,15.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.23,0.12,0.42
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,204.05,99.93,358.67
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,187.61,91.66,328.85
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,16.44,8.27,29.82
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,213.49,112.41,355.75
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,213.49,112.41,355.75
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.1,0.05,0.17
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,149.03,76.04,251.53
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,143.24,73.0,241.53
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,5.79,3.04,10.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.41,0.21,0.7
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,195.25,101.32,328.04
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,170.73,88.45,285.68
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,24.52,12.87,42.36
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,125.88,62.93,212.62
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,125.88,62.93,212.62
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,86.53,40.69,150.49
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,86.53,40.69,150.49
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,63.71,29.41,112.78
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,63.71,29.41,112.78
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,48.25,17.78,88.13
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,48.25,17.78,88.13
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,38.24,14.31,71.72
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,38.24,14.31,71.72
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,35.9,14.44,69.02
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,35.9,14.44,69.02
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,27.24,9.31,52.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,27.24,9.31,52.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,1.28,0.71,2.06
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,53.99,24.72,95.39
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,20.56,6.02,41.44
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,33.43,18.71,53.97
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.73,0.41,1.18
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,37.45,15.94,68.88
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,18.27,5.21,37.93
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,19.18,10.73,30.96
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,15.19,4.12,33.2
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,15.19,4.12,33.2
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,12.65,3.92,26.03
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,12.65,3.92,26.03
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,12.06,3.74,24.6
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,12.06,3.74,24.6
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,11.1,3.31,22.16
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,11.1,3.31,22.16
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,11.93,3.91,24.51
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,11.93,3.91,24.51
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.09,0.05,0.15
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,79.37,38.02,138.37
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,75.16,35.81,131.1
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,4.21,2.21,7.27
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.09,0.05,0.15
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,81.9,39.5,142.44
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,77.58,37.24,134.95
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,4.32,2.26,7.5
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.28,0.99,9.08
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.91,0.85,8.31
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.37,0.14,0.77
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,18.69,8.23,33.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,17.96,7.96,31.88
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.73,0.27,1.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.55,14.34,58.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,31.28,13.87,55.54
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.27,0.47,2.74
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,18.37,4.26,38.99
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,16.77,3.65,35.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.6,0.61,3.31
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,48.91,21.54,87.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,47.0,20.83,83.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.91,0.71,4.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,78.39,38.22,134.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,76.18,37.42,129.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.2,0.8,4.9
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,0.04,0.02,0.08
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,91.54,47.95,146.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,89.08,46.96,141.25
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.47,0.99,5.36
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,61.86,30.92,104.71
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,60.16,30.22,101.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.69,0.7,3.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,70.86,37.47,118.59
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,70.86,37.47,118.59
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,51.0,24.93,87.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,51.0,24.93,87.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,0.06,0.03,0.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,40.02,17.19,75.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,36.72,15.78,68.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.3,1.41,6.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,0.08,0.04,0.16
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,33.05,13.07,62.84
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,29.29,11.52,55.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.76,1.56,7.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,26.4,10.01,49.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,26.4,10.01,49.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,21.23,6.39,41.54
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,21.23,6.39,41.54
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,20.17,5.01,40.32
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,20.17,5.01,40.32
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.63,2.6,31.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,14.63,2.6,31.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,10.2,1.54,22.53
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,10.2,1.54,22.53
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.71,3.11,19.1
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.71,3.11,19.1
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.03,5.27,14.4
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,9.03,5.27,14.4
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.48,0.24,0.9
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.61,8.36,26.37
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,7.25,4.33,10.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,8.36,4.03,15.52
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.26,0.13,0.49
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,11.25,6.05,18.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.68,3.85,10.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,4.57,2.2,8.49
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.3,3.41,10.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,6.3,3.41,10.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.44,3.02,8.37
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,5.44,3.02,8.37
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,32.63,15.06,57.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,31.55,14.61,54.98
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.08,0.44,2.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,33.73,15.79,58.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,32.7,15.38,56.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,1.03,0.42,2.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.43,2.02,12.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.69,1.65,11.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.74,0.36,1.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.7,12.46,46.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.11,12.17,44.98
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.59,0.29,1.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.01,0.01,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,46.39,21.65,79.93
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,45.36,21.15,78.14
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.03,0.51,1.79
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.04,0.02,0.07
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,27.51,8.63,54.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,24.35,7.07,48.96
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,3.16,1.56,5.48
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,69.57,32.47,119.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,68.02,31.71,117.17
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.55,0.76,2.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,109.89,55.33,182.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,109.89,55.33,182.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,144.19,84.69,214.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,144.19,84.69,214.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,109.64,59.46,173.76
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,109.09,59.17,172.81
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.55,0.29,0.95
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,135.2,74.74,215.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,135.2,74.74,215.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,103.79,54.98,170.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,103.79,54.98,170.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,72.23,34.27,119.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,72.23,34.27,119.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.09,0.04,0.15
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,55.92,23.79,96.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,52.02,21.72,89.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.9,2.07,6.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.43,16.76,71.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,39.43,16.76,71.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.35,11.97,57.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,31.35,11.97,57.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,29.92,10.67,54.53
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,29.92,10.67,54.53
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,21.51,6.72,42.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,21.51,6.72,42.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,15.94,3.18,34.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,15.94,3.18,34.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.98,2.7,31.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,13.98,2.7,31.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.39,2.07,26.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.39,2.07,26.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.54,2.28,20.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,9.54,2.28,20.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,9.07,2.32,19.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.07,2.32,19.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,8.76,1.88,20.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.76,1.88,20.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.4,2.98,16.75
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,8.4,2.98,16.75
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.91,27.15,89.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,53.4,26.89,88.15
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.5,0.26,0.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,55.19,28.12,90.64
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,54.72,27.88,89.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.47,0.24,0.81
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.74,1.04,9.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,4.19,0.83,8.59
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.56,0.2,1.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,18.85,8.15,32.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,18.22,7.92,31.14
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.63,0.23,1.33
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.02,0.0,0.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.97,14.26,56.79
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,31.86,13.86,54.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.11,0.4,2.33
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,20.59,4.5,42.18
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,18.18,3.61,37.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.41,0.89,4.9
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,49.8,21.54,85.78
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,48.12,20.93,82.25
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.67,0.61,3.52
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.01,0.0,0.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,78.03,38.01,127.92
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,77.07,37.67,125.73
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.96,0.34,2.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,0.12,0.05,0.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,98.45,47.54,164.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,90.38,44.47,147.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,8.07,3.07,17.78
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,0.05,0.02,0.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,64.19,30.08,109.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,60.94,28.81,102.75
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.25,1.27,6.93
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,74.14,37.74,122.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,72.09,36.92,118.36
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,2.05,0.83,4.33
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,0.06,0.02,0.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,55.25,23.97,96.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,51.79,22.53,89.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.47,1.43,6.8
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,37.79,15.37,69.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,37.79,15.37,69.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.3,11.65,54.62
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,29.3,11.65,54.62
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,25.59,7.94,47.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,25.59,7.94,47.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,20.81,6.07,39.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,20.81,6.07,39.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,19.81,6.04,38.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,19.81,6.04,38.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.89,3.27,31.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,14.89,3.27,31.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,10.5,1.12,24.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,10.5,1.12,24.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.89,2.84,20.17
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.89,2.84,20.17
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.06,5.23,14.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,9.06,5.23,14.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,0.45,0.21,0.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.04,7.79,26.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,7.28,4.26,11.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,7.76,3.54,14.92
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,0.25,0.12,0.48
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,10.97,5.8,18.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.71,3.86,10.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,4.26,1.94,8.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.33,3.56,10.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,6.33,3.56,10.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.44,3.08,8.42
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,5.44,3.08,8.42
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,33.47,14.72,58.23
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,32.02,14.15,55.18
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.45,0.57,3.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,34.73,15.48,60.08
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,33.2,14.88,56.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,1.53,0.6,3.25
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.47,1.63,10.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.47,1.63,10.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,25.87,12.53,44.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,25.53,12.36,43.94
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.34,0.16,0.64
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,45.13,21.85,77.77
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.54,21.57,76.66
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.59,0.28,1.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.66,7.03,44.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,23.66,7.03,44.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.01,0.01,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.02,32.94,117.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,67.13,32.51,115.54
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.89,0.42,1.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,110.64,57.82,187.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,108.89,56.99,183.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.75,0.83,3.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,145.25,81.89,227.88
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,145.25,81.89,227.88
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,110.73,60.88,176.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,109.94,60.5,175.26
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.79,0.38,1.41
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.05,0.03,0.1
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,140.15,78.96,221.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,136.81,77.37,215.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,3.34,1.59,5.97
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,106.27,58.19,169.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,106.27,58.19,169.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,71.9,37.33,117.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,71.9,37.33,117.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,51.87,24.59,90.09
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,51.87,24.59,90.09
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.19,14.51,69.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,39.19,14.51,69.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.04,11.21,57.79
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,31.04,11.21,57.79
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,29.22,11.1,56.71
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,29.22,11.1,56.71
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,21.96,6.74,42.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,21.96,6.74,42.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.41,0.23,0.63
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,26.66,10.07,49.93
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,16.09,3.81,33.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,10.56,6.26,16.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.23,0.13,0.36
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,20.24,6.73,40.08
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,14.17,3.14,30.63
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,6.06,3.59,9.45
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.59,2.23,26.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.59,2.23,26.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.77,2.51,20.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,9.77,2.51,20.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,9.03,2.26,19.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.03,2.26,19.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,8.49,2.08,17.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.49,2.08,17.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.03,1.93,17.82
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,8.03,1.93,17.82
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,54.31,27.9,89.9
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,53.59,27.52,88.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.71,0.37,1.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.02,0.01,0.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,55.66,28.86,91.77
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,54.97,28.5,90.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.69,0.36,1.19
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.9,0.35,1.87
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.87,0.34,1.81
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.03,0.01,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.98,0.8,4.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.17,0.08,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.82,0.73,3.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.04,0.02,0.09
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.45,1.4,7.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.29,0.13,0.54
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,3.16,1.27,6.52
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.86,1.51,8.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.13,0.05,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,3.74,1.47,7.76
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.07,0.03,0.14
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.19,2.11,10.61
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.44,0.2,0.81
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,4.75,1.91,9.8
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.08,0.03,0.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,2.68,13.09
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.73,0.35,1.32
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,5.73,2.33,11.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.09,0.04,0.18
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.62,2.51,16.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.61,0.0,4.18
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,6.01,2.51,11.93
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.05,0.02,0.09
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.84,1.3,10.24
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,2.29,0.24,5.22
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.54,1.06,5.01
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.26,0.0,5.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.26,0.0,5.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,2.53,0.46,5.67
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,2.53,0.46,5.67
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.06,0.03,0.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.96,1.66,12.55
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.83,0.42,6.38
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.13,1.24,6.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.08,0.04,0.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.15,2.09,12.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,2.63,0.53,5.32
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.52,1.56,6.8
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,0.0,4.69
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,1.95,0.0,4.69
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.14,0.19,2.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.14,0.19,2.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.46,1.48
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,0.86,0.46,1.48
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.12,0.46
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.26,0.12,0.46
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.23,0.11,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.23,0.11,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.11,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.21,0.11,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.12,0.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.19,0.12,0.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.54,0.27,0.99
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.56,4.51,17.47
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.18,0.09,0.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,9.41,4.39,17.23
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.3,0.15,0.54
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,5.31,2.52,9.69
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.18,0.1,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,5.15,2.4,9.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.17,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.1,0.3
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.2,0.1,0.3
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.04,0.02,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.89,0.92,6.01
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.07,0.16,2.36
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.83,0.76,3.65
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.89,0.92,6.03
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.03,0.15,2.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,1.86,0.77,3.74
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.37,1.27,3.97
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,2.33,1.26,3.89
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.07,1.1,3.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.2,0.09,0.38
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.87,1.01,3.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.04,0.02,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.6,1.92,6.09
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.35,0.16,0.65
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,3.26,1.76,5.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.13,0.07,0.22
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.12,5.45,16.97
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.15,0.05,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,9.97,5.39,16.65
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.06,0.04,0.11
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.4,2.88,9.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.52,0.24,0.98
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,4.88,2.64,8.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.88,0.41,1.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.88,0.41,1.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,1.94,0.0,5.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,1.94,0.0,5.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.99,1.12,8.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.69,0.38,6.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.3,0.74,2.11
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,0.4,5.99
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,2.71,0.4,5.99
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.03,0.58,6.62
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.03,0.58,6.62
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.09,0.52,7.21
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.09,0.52,7.21
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.2,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.24,5.83,21.49
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.07,0.57,6.55
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,9.17,5.25,14.93
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.18,0.41,5.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.18,0.41,5.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,0.38,2.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.28,0.38,2.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.01,0.53,1.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.01,0.53,1.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.15,0.56
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.31,0.15,0.56
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.27,0.14,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.27,0.14,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.14,0.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.25,0.14,0.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.24,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.24,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.19,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.22,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.22,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.13,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.21,0.13,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.32,0.16,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.32,0.16,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.64,1.02,5.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,1.24,0.24,2.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.4,0.77,2.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.52,0.96,4.87
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,1.2,0.23,2.68
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.32,0.73,2.19
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.34,0.52,2.79
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,1.31,0.51,2.73
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.71,0.68,3.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.16,0.08,0.3
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.54,0.61,3.2
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.04,0.01,0.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.99,1.2,6.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.29,0.13,0.53
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,2.7,1.06,5.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.07,0.03,0.16
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.8,2.27,12.1
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.13,0.04,0.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,5.67,2.22,11.83
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.05,0.02,0.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.51,1.81,9.25
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.43,0.2,0.8
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,4.08,1.61,8.45
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.27,1.36,6.49
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.73,0.35,1.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.54,1.01,5.19
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.31,0.13,0.63
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,21.81,8.13,45.01
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.54,0.0,3.9
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,20.26,8.13,41.11
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.1,0.04,0.2
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.66,2.88,18.19
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,2.35,0.36,5.37
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,6.3,2.52,12.82
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,4.19,1.07,9.7
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.28,0.35,5.62
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.91,0.72,4.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.06,0.02,0.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.32,1.96,13.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,2.82,0.57,6.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.5,1.39,6.98
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.91,0.56,6.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.91,0.56,6.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.58,0.49,5.53
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,2.58,0.49,5.53
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.87,0.0,4.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,1.87,0.0,4.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.19,2.46
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.11,0.19,2.46
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.46,1.51
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,0.87,0.46,1.51
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.12,0.47
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.26,0.12,0.47
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.22,0.11,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.22,0.11,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.11,0.32
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.21,0.11,0.32
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.11,0.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.19,0.11,0.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.51,0.24,0.99
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.08,4.11,17.14
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.18,0.09,0.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,8.9,3.99,16.9
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.28,0.13,0.54
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,5.06,2.3,9.54
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.18,0.1,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,4.88,2.19,9.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.17,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.1,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.21,0.1,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.91,1.33,8.16
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.08,0.2,2.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.83,1.13,5.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.12,1.42,8.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.05,0.19,2.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,3.07,1.22,6.25
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.02,0.01,0.03
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.49,0.75,2.63
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.2,0.09,0.37
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.3,0.66,2.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.03,0.02,0.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.61,1.31,4.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.34,0.16,0.64
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.26,1.15,3.95
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.15,0.05,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.15,0.05,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.05,0.02,0.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.93,1.97,6.92
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.52,0.24,0.97
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,3.41,1.73,5.96
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.09,0.05,0.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.56,3.81,13.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.87,0.42,1.59
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,6.68,3.39,11.68
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,1.91,0.0,4.82
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,1.91,0.0,4.82
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.93,1.57,10.01
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.67,0.4,6.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,2.26,1.18,3.84
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.16,0.08,0.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.24,5.49,22.34
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,2.65,0.5,6.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,9.59,4.99,16.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.03,0.54,6.71
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.03,0.54,6.71
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.24,0.53,7.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.24,0.53,7.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.85,0.55,6.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.85,0.55,6.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,0.0,5.23
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.15,0.0,5.23
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.26,0.23,2.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.26,0.23,2.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.02,0.53,1.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.02,0.53,1.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.15,0.55
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.31,0.15,0.55
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.31,0.18,0.49
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,8.33,4.95,13.24
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.26,0.14,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,8.07,4.81,12.81
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.18,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.88,2.9,7.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.25,0.13,0.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,4.63,2.76,7.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.23,0.13,0.36
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.23,0.13,0.36
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.21,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.22,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.22,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.2,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.27,0.16,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.75,1.02,5.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,1.23,0.22,2.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.52,0.8,2.58
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.05,5.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,1.2,0.22,2.7
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,1.59,0.83,2.71
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.78,0.46,5.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.78,0.46,5.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.69,4.79,24.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,12.69,4.79,24.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.36,7.69,38.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,20.36,7.69,38.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.52,1.75,22.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,10.52,1.75,22.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,30.01,11.33,57.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,30.01,11.33,57.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,48.69,20.51,90.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,48.69,20.51,90.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.22,0.12,0.34
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,60.77,25.87,103.14
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,46.59,18.25,80.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,14.18,7.62,22.73
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.18,0.1,0.28
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,30.66,12.07,55.99
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,20.73,6.5,39.97
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,9.94,5.57,16.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.16,0.09,0.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,34.14,13.15,62.68
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,24.35,7.61,46.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.8,5.54,16.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.18,0.1,0.28
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,23.26,9.09,45.46
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,13.7,3.54,30.15
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,9.57,5.55,15.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.17,0.1,0.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,17.03,5.46,34.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.58,0.56,20.97
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,8.44,4.9,13.48
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.15,0.08,0.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.54,4.3,25.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.59,0.45,14.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,6.94,3.85,11.24
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.38,2.09,8.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,4.38,2.09,8.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.04,0.02,0.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.69,2.38,8.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.39,1.63,6.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.3,0.76,2.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.11,0.06,0.16
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,6.99,3.71,12.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.22,1.51,6.31
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,3.78,2.2,5.87
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.39,1.21,4.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.39,1.21,4.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.8,0.89,3.26
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.8,0.89,3.26
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.61,0.81,2.9
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.61,0.81,2.9
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.36,0.7,2.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.36,0.7,2.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.01,0.49,1.88
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.01,0.49,1.88
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.05,0.02,0.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.92,0.94,3.35
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.31,0.64,2.4
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.59,0.31,0.95
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.15,0.07,0.22
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.89,1.41,4.89
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.96,0.44,1.85
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,1.89,1.0,3.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.38,1.19,4.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.38,1.19,4.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.07,0.04,0.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,16.63,6.55,30.76
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,12.91,4.46,24.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.72,2.09,5.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.07,0.04,0.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,16.27,6.44,30.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,12.57,4.36,24.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,3.71,2.08,5.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.08,0.12,5.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,2.08,0.12,5.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.98,2.72,18.62
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,8.98,2.72,18.62
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.37,4.35,29.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,14.37,4.35,29.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,7.84,0.44,19.56
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,7.84,0.44,19.56
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,21.15,6.41,43.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,21.15,6.41,43.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,33.83,12.09,66.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,33.83,12.09,66.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,31.44,11.58,57.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,31.44,11.58,57.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.43,3.96,27.59
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,13.43,3.96,27.59
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,15.41,4.23,33.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,15.41,4.23,33.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.78,0.57,20.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.78,0.57,20.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.33,0.43,15.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,5.33,0.43,15.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.98,2.1,7.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.98,2.1,7.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.1,0.06,0.15
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,6.61,3.75,11.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.6,1.18,5.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,4.01,2.58,5.94
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.46,1.85,6.08
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.08,0.96,4.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.38,0.89,2.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.96,0.91,3.85
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.96,0.91,3.85
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.63,0.77,3.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.63,0.77,3.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.32,0.61,2.44
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.32,0.61,2.44
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.46,0.76,2.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.17,0.56,2.14
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.29,0.2,0.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.03,0.01,0.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.62,0.94,2.68
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.0,0.51,1.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.62,0.44,0.88
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.35,1.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.71,0.35,1.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.92,0.44,1.65
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.84,0.39,1.54
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.08,0.05,0.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.02,0.0,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.37,1.39
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.58,0.25,1.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.19,0.12,0.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.02,0.0,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.24,0.58,2.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,1.17,0.53,2.08
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.08,0.05,0.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.93,2.79,18.24
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,8.7,2.64,17.89
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.23,0.15,0.34
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.01,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.08,2.59,16.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,7.82,2.42,16.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.26,0.17,0.39
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.15,0.54,6.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.74,0.32,6.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.41,0.21,0.72
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.94,4.8,25.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,12.0,4.31,23.69
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.94,0.49,1.64
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.64,7.66,40.38
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,19.14,6.87,37.77
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.5,0.79,2.61
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,11.84,2.01,25.68
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,10.29,1.21,22.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.55,0.8,2.72
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,30.43,11.29,59.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,28.22,10.13,55.7
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.21,1.16,3.85
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.04,0.02,0.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,48.32,20.22,92.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,45.46,18.71,87.19
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.85,1.5,4.94
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.24,0.13,0.4
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,62.21,27.22,107.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,46.3,18.76,81.74
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,15.91,8.46,26.22
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.15,0.08,0.24
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,28.88,11.33,53.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,20.42,6.68,40.15
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,8.46,4.66,13.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.12,0.07,0.21
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,31.1,12.28,59.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,23.79,8.18,46.99
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,7.31,4.1,12.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.13,0.07,0.21
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,20.79,7.11,42.08
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,13.55,2.98,30.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,7.24,4.12,11.52
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.12,0.06,0.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,13.98,4.13,29.31
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.1,0.75,19.94
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,5.87,3.38,9.37
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.11,0.06,0.17
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.34,3.09,21.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.51,0.45,13.57
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,4.84,2.63,7.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.27,2.0,8.09
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,4.27,2.0,8.09
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.74,1.82,6.93
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.29,1.56,6.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.45,0.25,0.7
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.42,2.21,8.16
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.13,1.47,6.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,1.3,0.74,2.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.32,1.15,4.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.32,1.15,4.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.76,0.84,3.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.76,0.84,3.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.58,0.76,2.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.58,0.76,2.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.33,0.66,2.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.33,0.66,2.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.08,0.05,0.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.27,3.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.98,0.47,1.76
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.19,0.8,1.6
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.07,0.05,0.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.22,1.2,3.64
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.29,0.63,2.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.92,0.57,1.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.04,0.04,0.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.57,0.75,2.76
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.93,0.45,1.75
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.6,0.3,1.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.1,0.05,0.19
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.19,1.64,5.32
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.32,1.16,3.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.82,0.48,1.35
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.06,0.03,0.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,15.97,6.22,30.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,12.5,4.31,24.56
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.47,1.9,5.69
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.06,0.03,0.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,15.62,6.12,29.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,12.19,4.23,23.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,3.43,1.88,5.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.47,0.41,5.89
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.98,0.11,5.15
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.49,0.3,0.74
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,9.68,3.42,18.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,8.97,2.95,17.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.71,0.46,1.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.02,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.39,5.43,29.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,14.26,4.69,28.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.13,0.74,1.65
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.03,0.02,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.23,1.54,22.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,7.41,0.42,19.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.82,1.13,2.77
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.03,0.02,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.67,8.0,44.08
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,21.01,6.91,41.65
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.66,1.09,2.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.02,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.53,14.18,65.16
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,34.02,13.13,63.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.51,1.05,2.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,31.9,11.3,58.53
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,31.9,11.3,58.53
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,14.01,4.11,28.26
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,13.37,3.72,27.3
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.64,0.4,0.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,15.05,3.22,33.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,15.05,3.22,33.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,9.19,1.39,21.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.07,0.66,19.61
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,1.12,0.72,1.61
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.04,0.03,0.06
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.75,1.76,17.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,5.54,0.43,13.94
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,2.21,1.33,3.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.95,2.07,6.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.95,2.07,6.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.04,0.03,0.06
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.21,2.21,7.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.59,1.17,5.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.62,1.02,2.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.86,1.48,5.21
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.08,0.98,4.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.78,0.5,1.16
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.63,1.37,4.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.96,0.96,3.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.66,0.42,1.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.64,0.8,2.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.64,0.8,2.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.32,0.64,2.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.32,0.64,2.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.01,0.01,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.71,2.44
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.17,0.58,2.14
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.21,0.14,0.3
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.01,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.46,0.81,2.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.0,0.51,1.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.46,0.3,0.65
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.35,1.37
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.71,0.35,1.37
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.89,0.43,1.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.84,0.39,1.56
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.05,0.03,0.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.64,0.29,1.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.56,0.25,1.14
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.06,0.04,0.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.02,0.0,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.24,0.6,2.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,1.18,0.53,2.06
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.08,0.05,0.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.28,3.04,18.38
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,8.65,2.63,17.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.63,0.4,0.93
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.38,2.79,16.53
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,7.79,2.42,15.66
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.59,0.38,0.88
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.68,1.01,5.02
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.68,1.01,5.02
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.44,12.63,36.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,22.44,12.63,36.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.31,17.54,52.85
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,31.31,17.54,52.85
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,7.74,2.92,14.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,7.74,2.92,14.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,50.24,28.15,84.82
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,50.24,28.15,84.82
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,77.53,45.03,124.08
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,77.53,45.03,124.08
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,70.37,40.1,118.15
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,70.37,40.1,118.15
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,63.51,35.36,112.46
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,63.51,35.36,112.46
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,35.06,17.49,62.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,35.06,17.49,62.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.62,8.14,34.61
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,18.62,8.14,34.61
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,21.66,9.21,40.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,21.66,9.21,40.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,14.91,6.36,28.58
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,14.91,6.36,28.58
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.74,3.52,19.83
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.74,3.52,19.83
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.54,2.39,16.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,7.54,2.39,16.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.43,1.74,11.1
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.43,1.74,11.1
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.21,1.68,8.12
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.21,1.68,8.12
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.18,1.96,7.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.18,1.96,7.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.78,1.3,5.33
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.78,1.3,5.33
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.93,0.8,3.81
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.93,0.8,3.81
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.67,0.68,3.23
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.67,0.68,3.23
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.32,0.53,2.49
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.32,0.53,2.49
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.93,0.31,1.88
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.93,0.31,1.88
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.29,1.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.74,0.29,1.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.7,0.33,1.33
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.7,0.33,1.33
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.2,0.84
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.45,0.2,0.84
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,19.8,10.16,34.7
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,19.8,10.16,34.7
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.69,9.53,32.87
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,18.69,9.53,32.87
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.55,0.83,2.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.55,0.83,2.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.58,7.22,20.53
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,12.58,7.22,20.53
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.91,9.45,28.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,16.91,9.45,28.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.45,2.37,7.18
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.45,2.37,7.18
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.06,15.13,46.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,27.06,15.13,46.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,43.21,24.99,70.62
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,43.21,24.99,70.62
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,37.72,21.14,64.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,37.72,21.14,64.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.49,17.48,58.29
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,32.49,17.48,58.29
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,17.01,7.17,30.15
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,17.01,7.17,30.15
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.6,3.15,16.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,8.6,3.15,16.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,9.9,3.52,19.66
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,9.9,3.52,19.66
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.67,2.01,13.75
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.67,2.01,13.75
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.86,1.15,10.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.86,1.15,10.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.5,1.41,6.65
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.5,1.41,6.65
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.49,1.13,4.73
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.49,1.13,4.73
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.86,0.79,3.62
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.86,0.79,3.62
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.77,0.75,3.53
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.77,0.75,3.53
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.45,2.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.25,0.45,2.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.85,0.3,1.83
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.85,0.3,1.83
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.72,0.28,1.45
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.72,0.28,1.45
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.57,0.26,1.02
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.57,0.26,1.02
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.37,0.15,0.73
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.37,0.15,0.73
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.1,0.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.26,0.1,0.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.1,0.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.25,0.1,0.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.15,0.05,0.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.15,0.05,0.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,10.13,5.03,17.95
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,10.13,5.03,17.95
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.7,4.27,15.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,8.7,4.27,15.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,0.9,5.24
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.6,0.9,5.24
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.23,12.36,34.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,22.23,12.36,34.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.09,17.04,52.11
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,31.09,17.04,52.11
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,7.39,2.57,14.9
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,7.39,2.57,14.9
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,49.55,27.16,83.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,49.55,27.16,83.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,76.34,43.92,116.22
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,76.34,43.92,116.22
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,69.57,38.84,115.43
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,69.57,38.84,115.43
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,63.06,33.95,114.67
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,63.06,33.95,114.67
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,34.54,17.03,63.75
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,34.54,17.03,63.75
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.54,8.22,34.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,18.54,8.22,34.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,21.76,9.5,39.96
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,21.76,9.5,39.96
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,15.29,6.21,28.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,15.29,6.21,28.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.62,4.15,20.81
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.62,4.15,20.81
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.35,2.54,15.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,7.35,2.54,15.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.41,1.38,12.1
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.41,1.38,12.1
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.18,1.6,8.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.18,1.6,8.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.12,2.06,7.14
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.12,2.06,7.14
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.35,5.18
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.79,1.35,5.18
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,0.84,3.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.97,0.84,3.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.69,0.7,3.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.69,0.7,3.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.33,0.52,2.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.33,0.52,2.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.93,0.34,1.94
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.93,0.34,1.94
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.3,1.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.74,0.3,1.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.34,1.27
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.71,0.34,1.27
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.19,0.87
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.44,0.19,0.87
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,19.6,9.93,34.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,19.6,9.93,34.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.47,9.31,32.52
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,18.47,9.31,32.52
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.81,2.55
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.54,0.81,2.55
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.46,6.64,20.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,12.46,6.64,20.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.64,8.74,28.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,16.64,8.74,28.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.35,2.29,7.22
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.35,2.29,7.22
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.45,13.89,45.05
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,26.45,13.89,45.05
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,42.45,22.63,69.17
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,42.45,22.63,69.17
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.9,19.37,62.94
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,36.9,19.37,62.94
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.6,16.25,56.99
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,31.6,16.25,56.99
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,16.2,7.44,28.38
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,16.2,7.44,28.38
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.32,3.29,15.89
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,8.32,3.29,15.89
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,9.72,3.84,19.7
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,9.72,3.84,19.7
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.4,1.83,13.2
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.4,1.83,13.2
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.73,1.11,9.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.73,1.11,9.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.53,1.67,6.68
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.53,1.67,6.68
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.46,1.02,4.57
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.46,1.02,4.57
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.84,0.74,3.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.84,0.74,3.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.78,0.72,3.43
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.78,0.72,3.43
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.23,0.46,2.41
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.23,0.46,2.41
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.83,0.27,1.67
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.83,0.27,1.67
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.26,1.4
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.71,0.26,1.4
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.25,1.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.56,0.25,1.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.37,0.15,0.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.37,0.15,0.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.11,0.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.25,0.11,0.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.1,0.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.25,0.1,0.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.15,0.06,0.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.15,0.06,0.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.87,4.76,17.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,9.87,4.76,17.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.46,4.04,15.06
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,8.46,4.04,15.06
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.1,0.57,1.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.1,0.57,1.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,30.71,15.38,52.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,30.71,15.38,52.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,49.16,25.02,83.11
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,49.16,25.02,83.11
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.65,5.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.16,1.65,5.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,78.9,40.16,133.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,78.9,40.16,133.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,113.31,56.68,192.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,113.31,56.68,192.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,114.78,58.4,193.97
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,114.78,58.4,193.97
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,116.18,60.05,195.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,116.18,60.05,195.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,0.49,0.29,0.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,116.81,61.18,193.81
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,84.83,42.17,143.69
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,31.98,19.01,50.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,0.46,0.28,0.72
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,81.97,42.54,137.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,56.09,26.84,97.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,25.88,15.7,40.28
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,0.49,0.31,0.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,95.13,50.77,157.09
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,65.45,32.13,112.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,29.68,18.63,45.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,0.43,0.27,0.68
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,73.91,38.74,126.15
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,49.84,23.89,88.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,24.07,14.85,38.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,0.43,0.26,0.65
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,62.63,31.81,105.24
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,41.05,18.91,72.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,21.58,12.9,32.7
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,0.45,0.27,0.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,53.94,26.1,94.31
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,33.27,13.85,60.91
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,20.66,12.25,33.4
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,27.14,11.67,48.15
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,27.14,11.67,48.15
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.11,0.07,0.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.65,11.28,47.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,22.61,8.72,41.23
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,4.04,2.55,6.14
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.33,0.21,0.5
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,33.67,15.88,57.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,21.94,8.47,39.96
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,11.73,7.41,17.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,17.94,5.46,34.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,17.94,5.46,34.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,14.27,4.58,27.99
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.27,4.58,27.99
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.52,4.54,26.53
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.52,4.54,26.53
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.54,4.5,24.65
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.54,4.5,24.65
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,11.14,3.22,22.62
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,11.14,3.22,22.62
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,0.29,0.17,0.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,13.98,5.1,26.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,10.16,2.76,21.23
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,3.81,2.34,5.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.93,0.56,1.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,22.1,10.01,39.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.94,2.56,20.95
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,12.12,7.45,18.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.57,2.13,18.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.57,2.13,18.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.19,0.11,0.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.35,26.97,90.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,43.53,20.99,75.2
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,9.83,5.98,15.26
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.19,0.12,0.3
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,52.49,26.35,89.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,42.6,20.33,73.88
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,9.88,6.01,15.34
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.63,0.28,1.18
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.63,0.28,1.18
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,17.3,7.37,33.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,17.3,7.37,33.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.7,12.04,52.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,27.7,12.04,52.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.81,0.81,3.39
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.81,0.81,3.39
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.32,19.27,83.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.32,19.27,83.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,63.6,27.04,124.19
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,63.6,27.04,124.19
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,64.37,27.98,121.76
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,64.37,27.98,121.76
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.11,28.88,119.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,65.11,28.88,119.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,47.47,20.29,86.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,47.47,20.29,86.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,32.2,13.4,59.83
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,32.2,13.4,59.83
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,36.51,17.07,65.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,36.51,17.07,65.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,29.6,12.42,58.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,29.6,12.42,58.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,24.87,8.96,45.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,24.87,8.96,45.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,20.51,7.28,39.96
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,20.51,7.28,39.96
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.13,0.08,0.18
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,21.92,9.09,40.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,16.82,5.78,33.07
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,5.11,3.31,7.39
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.04,0.03,0.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,16.08,5.85,31.23
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.32,4.71,28.69
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.76,1.14,2.54
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,13.87,4.69,27.6
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,13.87,4.69,27.6
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,12.06,3.55,25.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.06,3.55,25.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,9.82,2.41,20.56
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,9.82,2.41,20.56
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.06,0.05,0.08
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.69,3.11,20.8
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,9.36,2.09,19.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.33,1.02,1.69
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.13,0.1,0.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.69,3.92,21.08
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,8.82,1.71,17.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.87,2.21,3.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,8.36,1.65,19.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,8.36,1.65,19.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.11,0.07,0.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,8.52,1.87,18.48
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,7.46,1.22,16.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.07,0.65,1.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.17,0.1,0.25
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.4,2.4,19.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,7.35,1.1,15.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.07,1.28,3.15
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.18,0.1,0.28
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,7.98,1.67,16.7
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.68,0.89,14.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,1.31,0.78,2.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,25.49,10.61,48.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,25.13,10.36,47.54
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.36,0.24,0.52
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.02,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,23.92,9.71,45.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,23.4,9.36,44.57
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.51,0.34,0.73
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.16,0.59,1.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.16,0.59,1.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,32.8,15.94,55.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,32.12,15.58,54.68
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.68,0.36,1.14
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,53.25,26.15,90.83
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,51.25,25.01,87.59
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,2.0,1.13,3.24
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.31,1.67,5.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.31,1.67,5.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.04,0.02,0.07
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,84.89,41.68,144.8
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,81.7,39.88,139.63
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,3.19,1.81,5.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.03,0.02,0.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,119.96,58.25,204.16
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,117.41,56.89,199.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.55,1.35,4.28
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.06,0.04,0.11
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,123.62,60.68,210.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,118.92,58.01,203.25
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,4.7,2.66,7.62
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.09,0.05,0.16
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,127.13,63.02,217.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,120.36,59.09,206.48
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,6.77,3.93,10.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,0.52,0.3,0.83
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,120.99,61.6,201.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,86.94,41.56,146.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,34.04,20.04,54.56
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,0.36,0.22,0.57
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,77.91,40.24,130.51
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,57.1,27.75,97.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,20.81,12.49,32.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,0.35,0.22,0.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,86.71,47.06,144.67
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,65.46,33.91,111.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,21.25,13.14,33.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,0.32,0.2,0.5
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,69.9,36.51,115.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,52.05,25.52,87.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,17.85,11.0,28.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,0.29,0.17,0.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,56.29,28.7,92.52
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,41.81,20.03,70.76
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,14.48,8.67,21.76
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,0.31,0.18,0.5
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,47.21,22.86,84.2
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,33.12,14.6,61.75
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,14.08,8.26,22.45
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,27.51,11.58,48.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,27.51,11.58,48.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.04,0.02,0.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,24.16,9.82,43.52
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,22.81,8.98,41.47
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.35,0.84,2.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.11,0.06,0.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,26.32,10.96,47.99
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,22.4,8.52,42.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,3.93,2.45,5.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,17.71,6.42,32.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,17.71,6.42,32.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,13.94,4.93,27.58
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,13.94,4.93,27.58
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.3,4.49,26.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.3,4.49,26.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.47,3.92,24.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.47,3.92,24.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,0.26,0.18,0.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.43,6.2,27.35
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.98,3.26,21.14
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,4.47,2.95,6.2
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.38,0.24,0.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,14.47,5.53,26.35
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,10.06,2.7,20.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,4.41,2.83,6.34
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.3,0.19,0.45
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,13.5,4.7,25.18
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.7,2.42,19.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.77,2.28,5.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,0.73,0.44,1.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,13.92,5.37,26.01
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.8,2.03,18.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,5.12,3.34,7.35
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.16,0.09,0.24
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.1,26.36,90.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,44.62,21.28,76.86
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,8.48,5.08,13.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.16,0.1,0.25
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,52.13,25.72,88.81
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,43.65,20.64,75.48
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,8.47,5.08,13.33
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.66,0.31,1.21
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.66,0.31,1.21
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.01
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,17.91,7.8,34.97
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,17.61,7.62,34.51
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.3,0.18,0.47
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,28.74,12.72,55.27
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,28.23,12.42,54.47
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.5,0.3,0.8
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.86,0.87,3.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.86,0.87,3.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,45.67,20.21,87.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.87,19.73,86.57
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.8,0.48,1.27
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,65.25,28.35,127.61
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,64.14,27.67,125.86
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.12,0.67,1.75
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,66.4,29.36,127.78
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,65.22,28.66,125.91
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.18,0.7,1.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.01,0.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,67.5,30.34,127.94
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,66.27,29.6,125.96
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.23,0.73,1.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,47.8,21.01,86.73
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,47.8,21.01,86.73
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.02,0.02,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,34.04,14.33,62.58
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,32.82,13.55,60.72
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.22,0.78,1.86
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,37.69,16.12,67.3
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,37.69,16.12,67.3
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.04,0.03,0.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,31.72,13.07,57.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,29.6,11.65,54.68
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,2.13,1.41,3.16
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.08,0.05,0.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,29.33,12.32,53.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,25.16,9.72,47.47
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,4.16,2.6,6.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,21.78,8.23,43.94
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,21.78,8.23,43.94
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.05,0.03,0.07
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,19.67,7.2,37.24
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,17.61,5.86,34.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.06,1.33,3.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.01,0.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,15.59,4.85,30.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.61,4.22,28.58
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.98,0.62,1.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.02,0.01,0.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,15.14,4.41,28.34
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,14.33,3.92,27.08
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.81,0.49,1.25
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,11.66,2.78,24.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,11.66,2.78,24.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,9.71,2.14,20.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,9.71,2.14,20.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.05,0.03,0.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.13,2.83,20.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,9.16,2.08,19.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.97,0.74,1.21
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.1,0.07,0.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.63,3.64,20.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,8.52,2.02,18.34
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.11,1.62,2.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,8.14,1.44,16.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,8.14,1.44,16.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.08,0.05,0.13
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,8.17,1.75,17.23
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,7.47,1.34,16.13
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.7,0.42,1.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.06,0.04,0.08
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,8.27,2.1,18.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,7.52,1.64,16.91
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.75,0.46,1.14
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.18,0.11,0.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.13,1.79,17.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.79,1.02,14.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,1.34,0.79,2.13
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,26.35,10.99,49.72
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,25.52,10.46,48.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.83,0.53,1.26
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,24.66,10.0,46.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,23.78,9.44,45.41
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.88,0.56,1.32
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.78,1.58,6.91
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,3.78,1.58,6.91
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,61.98,30.23,106.28
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,61.98,30.23,106.28
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,121.23,60.41,207.5
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,121.23,60.41,207.5
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,10.89,4.56,19.91
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,10.89,4.56,19.91
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,194.56,96.95,333.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,194.56,96.95,333.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,224.3,110.13,383.42
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,224.3,110.13,383.42
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,281.55,140.71,481.3
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,281.55,140.71,481.3
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,336.43,170.02,575.11
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,336.43,170.02,575.11
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,3.61,2.36,5.35
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,532.12,305.17,841.45
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,296.19,151.32,492.35
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,235.93,153.86,349.11
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,2.55,1.64,3.79
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,322.5,175.76,523.66
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,177.31,82.19,307.68
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,145.19,93.57,215.98
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,2.23,1.43,3.31
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,347.04,184.53,563.64
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,212.85,98.19,363.66
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,134.2,86.34,199.99
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,2.32,1.51,3.43
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,280.63,151.8,461.64
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,151.95,68.25,271.47
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,128.68,83.56,190.18
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,2.23,1.41,3.31
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,225.22,117.66,374.17
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,112.94,46.36,207.11
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,112.28,71.3,167.05
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,2.21,1.39,3.35
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,188.53,96.26,318.08
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,88.29,33.22,165.93
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,100.23,63.05,152.15
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,71.25,28.93,131.78
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,71.25,28.93,131.78
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.42,0.27,0.62
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,73.32,31.5,131.47
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,58.24,21.72,109.29
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,15.08,9.79,22.18
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,1.22,0.8,1.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,100.84,49.08,172.22
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,57.05,20.66,107.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,43.79,28.41,64.4
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,43.96,14.25,83.93
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,43.96,14.25,83.93
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,33.75,10.28,68.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,33.75,10.28,68.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,31.22,9.3,64.36
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,31.22,9.3,64.36
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,27.96,8.02,58.63
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,27.96,8.02,58.63
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,23.73,5.39,49.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,23.73,5.39,49.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,1.4,0.92,2.02
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,40.88,17.79,73.26
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,22.58,5.78,46.78
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,18.31,12.0,26.47
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,4.45,2.93,6.45
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,80.0,44.04,128.46
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,21.69,5.78,44.12
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,58.32,38.22,84.34
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,21.54,6.54,45.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,21.54,6.54,45.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,1.0,0.64,1.48
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,175.32,91.65,291.43
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,121.24,56.77,211.06
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,54.08,34.88,80.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,1.03,0.66,1.53
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,172.79,89.93,287.82
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,118.76,55.09,207.54
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,54.03,34.84,80.29
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.18,1.11,3.68
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,2.18,1.11,3.68
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,38.62,16.75,72.12
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,38.62,16.75,72.12
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,83.78,37.98,150.52
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,83.78,37.98,150.52
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.27,3.19,10.57
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,6.27,3.19,10.57
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,134.07,60.78,240.88
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,134.07,60.78,240.88
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,139.84,60.18,262.21
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,139.84,60.18,262.21
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,194.35,87.95,349.5
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,194.35,87.95,349.5
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,246.27,114.4,432.65
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,246.27,114.4,432.65
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,240.69,116.64,403.62
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,240.69,116.64,403.62
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,156.73,72.5,270.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,156.73,72.5,270.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,189.31,89.9,318.31
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,189.31,89.9,318.31
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,144.0,67.23,254.4
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,144.0,67.23,254.4
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,109.8,45.57,199.97
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,109.8,45.57,199.97
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,88.39,37.26,158.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,88.39,37.26,158.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,2.09,1.51,2.79
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,159.35,93.0,250.4
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,74.45,31.68,136.85
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,84.91,61.32,113.55
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.72,0.52,0.96
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,89.93,45.55,151.24
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,60.7,24.44,112.14
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,29.24,21.11,39.1
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,59.22,23.65,109.36
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,59.22,23.65,109.36
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,47.16,17.31,87.97
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,47.16,17.31,87.97
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,38.03,13.84,72.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,38.03,13.84,72.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.75,0.58,0.94
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,51.43,24.3,88.19
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,35.15,11.69,67.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,16.28,12.61,20.39
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,1.62,1.26,2.05
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,67.07,36.52,106.44
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,31.79,9.18,62.28
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,35.28,27.33,44.18
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,29.18,8.39,61.75
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,29.18,8.39,61.75
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,1.41,0.98,1.92
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,41.68,17.74,75.21
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,27.29,7.63,55.65
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,14.39,10.1,19.57
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,2.46,1.78,3.33
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,58.99,30.88,96.99
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,26.68,7.6,53.44
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,32.33,23.29,43.55
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,1.95,1.31,2.68
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,40.1,16.39,71.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,25.94,6.92,51.43
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,14.16,9.47,19.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.18,0.13,0.24
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,105.8,49.35,184.25
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,100.08,45.18,176.66
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,5.72,4.17,7.59
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.32,0.23,0.43
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,101.7,47.35,177.07
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,94.02,41.76,166.88
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,7.68,5.59,10.19
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.76,1.49,7.22
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,3.76,1.49,7.22
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.08,0.05,0.13
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,69.84,33.93,118.35
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,63.56,30.21,108.37
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,6.27,3.71,9.98
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.21,0.13,0.31
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,138.17,69.45,235.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,123.27,60.19,212.75
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,14.89,9.26,22.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,10.69,4.23,20.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,10.69,4.23,20.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.33,0.21,0.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,220.25,110.71,375.02
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,196.51,95.95,339.15
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,23.74,14.76,35.87
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.31,0.19,0.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,251.92,123.31,424.58
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,228.36,109.36,387.11
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,23.56,13.95,37.47
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.49,0.3,0.73
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,319.74,161.26,543.31
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,284.72,139.49,490.41
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,35.01,21.76,52.9
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.66,0.42,0.96
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,384.97,197.76,657.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,338.93,168.47,589.76
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,46.03,29.28,67.74
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,3.89,2.51,5.87
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,554.77,314.44,880.23
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,300.42,150.58,496.78
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,254.35,163.86,383.45
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,2.09,1.34,3.14
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,302.06,164.64,491.97
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,180.29,86.5,309.15
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,121.77,78.14,182.82
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,1.6,1.03,2.41
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,312.58,171.27,509.55
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,216.01,109.29,363.84
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,96.57,61.98,145.7
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,1.71,1.1,2.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,251.3,135.65,412.27
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,156.68,74.42,271.9
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,94.61,61.24,140.37
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,1.5,0.95,2.22
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,191.26,97.67,317.13
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,115.74,49.38,205.29
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,75.52,48.28,111.85
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,1.49,0.93,2.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,155.53,77.55,271.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,87.7,35.16,169.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,67.82,42.39,102.39
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,72.53,28.21,134.28
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,72.53,28.21,134.28
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.14,0.09,0.21
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,62.89,24.86,115.71
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,57.85,21.64,108.29
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,5.04,3.22,7.42
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.41,0.26,0.6
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,70.48,30.12,126.61
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,55.85,20.77,105.05
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,14.62,9.36,21.56
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,42.73,14.85,81.18
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,42.73,14.85,81.18
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,33.42,10.75,68.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,33.42,10.75,68.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,31.28,9.8,64.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,31.28,9.8,64.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,28.48,8.55,58.55
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,28.48,8.55,58.55
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.98,0.67,1.32
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,40.42,17.52,70.56
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,23.73,5.79,47.84
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,16.7,11.73,22.72
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,1.71,1.15,2.41
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,41.72,18.88,72.76
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,22.44,5.87,45.58
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,19.28,13.01,27.19
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,1.38,0.9,2.05
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,39.43,17.34,69.53
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,21.19,5.67,42.75
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,18.24,11.67,26.78
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,3.48,2.37,4.93
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,47.14,23.4,81.07
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,21.66,6.28,45.01
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,25.48,17.11,36.06
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.89,0.57,1.33
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,173.17,90.34,288.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,122.8,58.11,212.97
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,50.37,32.23,75.6
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.92,0.59,1.37
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,170.35,88.46,284.53
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,120.43,56.5,209.65
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,49.92,31.96,74.88
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.19,1.12,3.76
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,2.19,1.12,3.76
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.09,0.06,0.13
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,45.53,21.14,82.91
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,38.75,16.4,73.39
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,6.78,4.74,9.52
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.14,0.1,0.19
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,94.61,45.46,170.27
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,84.62,38.55,156.27
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,9.99,6.9,14.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.2,3.16,10.66
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,6.2,3.16,10.66
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.22,0.15,0.31
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,150.35,72.24,270.6
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,134.48,61.27,248.36
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,15.87,10.97,22.24
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.34,0.24,0.48
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,164.45,76.1,300.05
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,139.06,58.35,264.41
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,25.4,17.75,35.64
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.32,0.23,0.45
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,218.57,104.94,393.61
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,195.19,88.77,360.84
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,23.39,16.16,32.77
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.3,0.21,0.42
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,270.34,132.52,483.11
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,248.89,117.87,453.08
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,21.46,14.65,30.03
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,244.54,122.01,417.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,244.54,122.01,417.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.21,0.15,0.3
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,170.39,83.95,290.49
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,159.18,76.06,275.05
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,11.21,7.89,15.44
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,194.08,94.28,329.23
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,194.08,94.28,329.23
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.37,0.27,0.49
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,165.39,82.26,276.39
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,144.93,67.33,248.95
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,20.46,14.93,27.43
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.74,0.52,1.03
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,148.23,75.94,251.15
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,110.74,50.07,198.81
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,37.49,25.88,52.34
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,89.51,40.12,160.65
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,89.51,40.12,160.65
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.84,0.61,1.12
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,109.56,56.37,182.19
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,75.38,31.55,136.59
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,34.18,24.82,45.61
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.42,0.3,0.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,76.54,35.13,132.74
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,60.13,23.36,110.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,16.41,11.77,22.2
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.38,0.27,0.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,72.41,31.74,125.91
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,58.6,22.14,106.58
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,13.81,9.6,19.33
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,45.28,15.83,86.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,45.28,15.83,86.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,37.14,11.54,70.64
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,37.14,11.54,70.64
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.55,0.42,0.69
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,46.56,20.17,81.99
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,34.71,11.07,67.17
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,11.84,9.09,14.81
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,1.2,0.92,1.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,57.69,30.37,95.4
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,31.84,10.51,63.07
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,25.85,19.84,32.32
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,28.93,8.43,58.83
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,28.93,8.43,58.83
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,0.99,0.67,1.36
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,35.66,13.55,66.22
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,27.02,7.61,54.34
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,8.63,5.93,11.89
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.89,0.64,1.21
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,37.84,15.73,69.38
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,26.16,7.31,53.53
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,11.66,8.39,15.85
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,2.0,1.32,2.77
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,40.39,16.74,70.83
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,25.86,7.05,50.68
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,14.53,9.68,20.16
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.24,0.17,0.33
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,112.08,54.2,195.07
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,101.01,46.38,179.86
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,11.08,7.82,15.21
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.33,0.23,0.45
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,106.49,51.03,185.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,94.99,42.89,169.85
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,11.5,8.14,15.72
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.0,1.74,11.51
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,6.0,1.74,11.51
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.75,13.04,46.45
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,27.75,13.04,46.45
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.54,20.93,74.54
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,44.54,20.93,74.54
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.74,6.6,43.63
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,22.74,6.6,43.63
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.64,30.85,109.85
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,65.64,30.85,109.85
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,106.75,54.09,173.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,106.75,54.09,173.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,2.52,1.73,3.61
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,291.58,186.01,434.8
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,126.8,72.97,199.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,164.78,113.05,235.8
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,1.68,1.13,2.42
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,174.13,104.44,265.56
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,78.18,39.95,127.51
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,95.95,64.48,138.04
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,1.36,0.9,1.96
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,179.44,102.98,274.41
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,97.48,48.48,155.96
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,81.96,54.5,118.43
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,1.51,1.02,2.14
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,152.83,89.71,233.54
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,69.36,33.42,115.08
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,83.46,56.29,118.46
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,1.46,0.96,2.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,122.01,70.82,191.63
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,48.64,22.6,85.18
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,73.37,48.22,106.45
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,1.44,0.94,2.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,103.87,58.64,163.08
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,38.21,15.67,66.98
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,65.67,42.97,96.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,31.57,12.96,57.93
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,31.57,12.96,57.93
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.25,0.17,0.36
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.43,15.43,62.67
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,26.5,9.46,49.88
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,8.93,5.97,12.79
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.72,0.49,1.04
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,52.4,26.07,87.83
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,26.49,8.73,50.69
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,25.91,17.35,37.14
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,20.43,6.08,39.26
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,20.43,6.08,39.26
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,15.36,3.79,33.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,15.36,3.79,33.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.04,3.04,31.08
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,14.04,3.04,31.08
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.35,2.06,28.47
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.35,2.06,28.47
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,10.27,1.13,22.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.27,1.13,22.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.8,0.56,1.13
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,20.5,9.18,35.95
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.94,1.86,21.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,10.57,7.31,14.84
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,2.56,1.78,3.6
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,43.3,25.54,66.69
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.64,2.22,19.43
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,33.66,23.28,47.27
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,9.71,2.77,20.8
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,9.71,2.77,20.8
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.65,0.44,0.94
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,78.87,44.73,123.69
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,43.32,20.83,72.59
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,35.55,23.9,51.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.67,0.45,0.96
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,78.66,44.36,123.81
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,43.2,20.53,72.84
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,35.45,23.83,50.98
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.62,2.03,12.56
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.62,2.03,12.56
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.86,13.75,49.89
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,29.86,13.75,49.89
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,47.78,22.01,79.84
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,47.78,22.01,79.84
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,25.02,7.66,47.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,25.02,7.66,47.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,70.32,32.39,117.5
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,70.32,32.39,117.5
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,113.47,55.95,184.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,113.47,55.95,184.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,141.2,76.72,221.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,141.2,76.72,221.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,97.21,50.33,155.91
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,97.21,50.33,155.91
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,122.31,63.54,189.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,122.31,63.54,189.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,93.13,50.13,150.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,93.13,50.13,150.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,68.68,33.11,116.68
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,68.68,33.11,116.68
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,54.36,24.51,93.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,54.36,24.51,93.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,1.71,1.26,2.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,117.55,73.72,175.34
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,48.01,22.26,84.45
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,69.53,51.45,90.88
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.59,0.44,0.77
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,64.01,35.15,101.82
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,40.06,17.43,70.53
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,23.94,17.72,31.3
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,39.76,17.3,69.48
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,39.76,17.3,69.48
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.64,12.24,56.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,31.64,12.24,56.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,25.54,10.23,46.9
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,25.54,10.23,46.9
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.6,0.47,0.74
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,36.29,18.56,60.26
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,23.41,8.48,44.32
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,12.87,10.09,15.94
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,1.29,1.02,1.6
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,48.83,28.28,75.86
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,20.93,6.43,41.32
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,27.88,21.86,34.54
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,19.3,5.96,39.23
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,19.3,5.96,39.23
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,1.12,0.8,1.49
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,29.75,13.92,51.21
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,18.25,5.61,36.04
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,11.5,8.31,15.17
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,1.99,1.47,2.61
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,44.11,25.19,69.36
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,18.07,5.86,35.27
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,26.04,19.31,34.07
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,1.54,1.06,2.05
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,28.52,12.71,48.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,17.37,5.06,33.52
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,11.15,7.65,14.94
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.15,0.11,0.19
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,58.41,29.93,94.38
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,53.75,26.46,88.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,4.66,3.47,6.05
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.26,0.19,0.34
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,58.0,29.65,94.05
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,51.78,25.02,85.98
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,6.22,4.63,8.07
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.06,0.04,0.09
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.85,4.67,19.47
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,6.42,1.94,12.68
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,4.43,2.73,6.79
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.14,0.09,0.21
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,38.9,20.43,63.54
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,28.62,13.82,48.52
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,10.29,6.61,15.02
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.23,0.15,0.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.02,32.56,101.3
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,45.62,22.03,77.35
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,16.4,10.54,23.95
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.22,0.14,0.34
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,40.74,17.54,73.14
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,24.12,7.28,47.62
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,16.62,10.27,25.52
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.34,0.22,0.49
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,91.46,48.02,149.39
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,67.27,32.48,114.07
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,24.19,15.54,35.32
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.45,0.29,0.63
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,140.24,77.33,222.72
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,108.77,56.72,177.97
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,31.46,20.61,44.75
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,2.71,1.84,3.95
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,307.01,192.97,455.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,129.7,72.69,197.69
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,177.3,120.28,257.73
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,1.39,0.93,2.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,161.48,97.34,245.89
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,80.59,43.01,128.65
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,80.88,54.33,117.24
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.98,0.65,1.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,159.91,95.87,242.75
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,101.13,56.68,157.18
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,58.78,39.19,85.57
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,1.1,0.74,1.58
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,132.81,79.69,204.43
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,71.88,38.67,117.25
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,60.92,41.02,87.2
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.97,0.65,1.4
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,100.5,56.22,156.17
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,51.34,23.54,85.38
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,49.17,32.68,70.79
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,0.97,0.63,1.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,82.2,45.6,134.88
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,38.06,16.78,70.56
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,44.15,28.82,64.32
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,32.65,12.77,59.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,32.65,12.77,59.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,0.08,0.05,0.12
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,29.05,11.21,52.95
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,26.09,9.25,48.7
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,2.96,1.96,4.25
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,0.24,0.16,0.35
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,33.66,14.41,59.09
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,25.06,8.72,46.74
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,8.61,5.69,12.34
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,19.49,5.7,38.73
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,19.49,5.7,38.73
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,15.35,3.93,33.51
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,15.35,3.93,33.51
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.31,3.61,31.39
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,14.31,3.61,31.39
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.96,3.21,28.64
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.96,3.21,28.64
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,0.52,0.39,0.67
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,19.23,7.93,34.09
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.47,1.47,22.43
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,8.76,6.46,11.66
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,0.96,0.67,1.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,20.7,9.51,36.03
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.94,1.97,21.2
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,10.74,7.53,14.83
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,0.78,0.52,1.16
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,19.92,9.25,34.65
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.44,2.2,19.66
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,10.48,7.01,14.99
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,2.03,1.4,2.8
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,24.46,12.81,41.43
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,9.62,2.61,20.88
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,14.79,10.2,20.55
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.59,0.39,0.85
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,77.93,44.61,122.12
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,44.44,22.22,73.56
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,33.49,22.39,48.56
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.6,0.4,0.87
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,77.55,44.1,122.02
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,44.43,21.95,74.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,33.13,22.15,48.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.07,0.05,0.1
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.13,5.98,20.77
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.65,2.02,13.28
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,5.48,3.96,7.48
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.11,0.08,0.15
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,38.44,20.13,65.6
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,30.43,14.43,54.69
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,8.01,5.7,10.92
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.18,0.12,0.24
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,61.09,31.99,104.26
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,48.36,22.94,86.91
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,12.73,9.05,17.36
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.27,0.2,0.38
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,45.41,22.39,77.74
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,24.89,7.56,49.73
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,20.51,14.83,28.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.26,0.18,0.35
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,90.0,47.13,153.6
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,71.25,33.79,128.04
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,18.75,13.34,25.57
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.24,0.17,0.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,132.66,70.8,226.17
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,115.59,58.89,202.94
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,17.07,11.91,23.23
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,145.15,81.39,236.13
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,145.15,81.39,236.13
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.17,0.12,0.22
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,107.99,60.08,171.84
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,99.42,53.84,160.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,8.57,6.24,11.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,126.44,69.55,198.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,126.44,69.55,198.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.29,0.21,0.37
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,110.8,63.09,170.5
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,95.07,51.23,150.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,15.73,11.88,20.45
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.57,0.4,0.77
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,97.84,57.16,153.97
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,69.27,36.75,115.4
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,28.58,20.41,38.57
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,54.35,26.17,91.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,54.35,26.17,91.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.69,0.52,0.89
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,76.1,42.94,118.93
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,48.11,22.05,82.54
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,27.99,20.89,36.39
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.34,0.25,0.45
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,52.67,26.75,86.81
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,39.21,16.83,69.02
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,13.46,9.92,17.79
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.32,0.23,0.43
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,50.04,24.65,83.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,38.66,16.54,67.44
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,11.38,8.11,15.61
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,30.17,11.49,56.11
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,30.17,11.49,56.11
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,24.78,8.23,45.36
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,24.78,8.23,45.36
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.43,0.34,0.54
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,32.55,15.15,55.04
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,23.18,7.88,43.45
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,9.36,7.27,11.59
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.94,0.74,1.17
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,41.73,23.33,66.5
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,21.3,7.47,41.2
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,20.43,15.87,25.3
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,19.3,6.21,39.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,19.3,6.21,39.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,0.78,0.55,1.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,24.85,10.35,44.56
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,17.98,5.48,35.41
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,6.87,4.87,9.15
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.73,0.54,0.96
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,26.81,12.07,46.71
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,17.39,5.07,34.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,9.41,7.0,12.38
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,1.56,1.08,2.11
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,28.63,12.95,47.89
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,17.18,5.1,32.52
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,11.45,7.86,15.37
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.19,0.14,0.25
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,63.37,34.21,103.19
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,54.6,27.83,91.47
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,8.78,6.38,11.72
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.26,0.19,0.34
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,61.77,32.94,100.98
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,52.65,26.29,88.85
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,9.12,6.64,12.13
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.02,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.32,0.01,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.32,0.01,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.02,1.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.51,0.02,1.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.06,0.4
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.19,0.06,0.4
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.75,0.03,1.97
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.75,0.03,1.97
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.29,0.0,3.48
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.29,0.0,3.48
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.38,0.22,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,27.9,14.63,47.36
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.91,0.45,6.91
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,24.99,14.18,40.46
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.23,0.13,0.37
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,17.11,8.58,29.85
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.69,0.76,8.21
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,13.42,7.81,21.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.21,0.13,0.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,16.66,8.43,29.01
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.91,0.76,8.57
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,12.75,7.67,20.43
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.21,0.12,0.33
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,15.72,7.9,27.91
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,4.13,1.04,9.59
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,11.58,6.86,18.33
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.18,0.11,0.28
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,12.81,6.05,23.02
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.93,0.77,8.6
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,8.88,5.28,14.43
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.15,0.08,0.25
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.64,4.84,18.97
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.68,0.86,7.56
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,6.96,3.98,11.4
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.73,0.47,6.3
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.73,0.47,6.3
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.34,0.73,4.88
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.52,0.23,3.65
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.81,0.5,1.23
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.06,0.04,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.59,1.45,6.99
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.22,0.0,3.41
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,2.36,1.45,3.58
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.21,0.73
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.41,0.21,0.73
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.63
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.63
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.61
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.61
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.58
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.58
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.57
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.57
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.26,0.15,0.38
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.74,2.27,5.61
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.41,0.23,0.59
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,3.34,2.04,5.03
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.82,0.48,1.22
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,11.01,6.71,16.57
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.41,0.22,0.59
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,10.64,6.49,16.02
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.25,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.45,0.25,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.09,0.05,0.15
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,6.67,3.24,11.82
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.68,0.33,3.8
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,4.99,2.91,8.02
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.1,0.06,0.16
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,6.69,3.25,11.85
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.7,0.34,3.84
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,4.98,2.91,8.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.02,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.34,0.01,0.89
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.34,0.01,0.89
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.54,0.02,1.42
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.54,0.02,1.42
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.18,0.06,0.39
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.18,0.06,0.39
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.8,0.03,2.08
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.8,0.03,2.08
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.0,3.7
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.39,0.0,3.7
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.55,0.89,7.93
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.55,0.89,7.93
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.29,1.66,10.74
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.29,1.66,10.74
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.18,1.55,10.44
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.18,1.55,10.44
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.82,2.09,11.96
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.82,2.09,11.96
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.05,1.91,12.31
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.05,1.91,12.31
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.04,1.97,11.37
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.04,1.97,11.37
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.16,0.1,0.23
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,10.78,5.31,18.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.53,1.33,9.5
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,6.25,3.98,9.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.05,0.03,0.08
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.54,1.92,8.48
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.38,0.55,5.27
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,2.15,1.37,3.22
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.86,0.0,4.9
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.86,0.0,4.9
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.59,0.29,1.01
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.59,0.29,1.01
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.29,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.51,0.29,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.08,0.06,0.11
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.28,1.59,3.13
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.49,0.28,0.78
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.8,1.31,2.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.17,0.13,0.23
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.35,3.12,5.8
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.46,0.28,0.73
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,3.9,2.84,5.08
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.42,0.27,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.42,0.27,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.17,0.1,0.26
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.23,1.4,3.36
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.49,0.31,0.73
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.74,1.09,2.63
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.31,0.19,0.46
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,4.47,2.84,6.71
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.43,0.27,0.66
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,4.04,2.57,6.06
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.23,0.13,0.35
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.21,1.37,3.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.59,0.38,0.88
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,1.62,0.99,2.46
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.02
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.84,1.0,5.63
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.37,0.69,4.94
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.47,0.31,0.68
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.0,1.14,5.79
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,2.32,0.69,4.8
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.68,0.45,0.99
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.81,0.43,1.43
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.11
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.76,0.41,1.32
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.02,0.01,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.98,1.03,3.43
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.32,0.01,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.67,1.02,2.6
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.04,0.02,0.06
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.65,5.47
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.5,0.02,1.33
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,2.66,1.63,4.14
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.04,0.02,0.07
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.05,1.6,5.37
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.2,0.07,0.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.85,1.53,4.95
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.06,0.03,0.08
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.66,2.43,8.07
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.74,0.03,1.96
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,3.92,2.4,6.11
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.07,0.05,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.21,3.24,10.67
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.27,0.0,3.45
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,4.95,3.24,7.22
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.41,0.23,0.69
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,30.03,15.63,51.67
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.92,0.54,6.73
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,27.1,15.08,44.94
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.2,0.11,0.32
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,15.25,7.51,26.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.63,0.85,7.84
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,11.62,6.66,19.01
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.16,0.09,0.25
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,13.09,6.56,22.93
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.87,1.03,8.14
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.23,5.53,14.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.16,0.09,0.25
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,12.52,6.15,21.81
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.91,1.04,8.19
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,8.61,5.1,13.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.12,0.07,0.2
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,9.87,4.46,18.32
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.86,0.9,8.4
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,6.01,3.56,9.92
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.1,0.06,0.17
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.42,3.47,15.67
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.67,0.78,7.89
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,4.75,2.69,7.78
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.69,0.49,6.52
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.69,0.49,6.52
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.75,0.4,3.99
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.47,0.24,3.57
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.27,0.16,0.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.94,0.48,4.23
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.14,0.0,3.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.79,0.48,1.21
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.22,0.7
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.41,0.22,0.7
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.22,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.39,0.22,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.6
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.6
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.13,0.08,0.18
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.66,1.76,3.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.59
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,2.27,1.5,3.26
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.29,0.19,0.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.6,2.32,5.27
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.41,0.26,0.61
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,3.19,2.07,4.66
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.26,0.15,0.37
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.77,2.35,5.63
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.41,0.26,0.6
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.36,2.09,5.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.63,0.44,0.92
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.12,3.34,7.45
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.44,0.29,0.68
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,4.69,3.09,6.82
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.09,0.05,0.14
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,6.57,3.22,11.64
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.65,0.36,3.65
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,4.93,2.86,7.99
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.09,0.06,0.15
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,6.57,3.21,11.64
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.68,0.37,3.72
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,4.89,2.84,7.92
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.57,0.32,0.93
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.11
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.52,0.3,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.46,2.22
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.35,0.01,0.98
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.77,0.45,1.24
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.77,0.73,3.53
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.55,0.02,1.56
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.22,0.71,1.97
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.12,1.19,3.49
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.18,0.06,0.4
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.94,1.13,3.09
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,1.07,5.2
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.81,0.03,2.3
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.79,1.04,2.9
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.07,0.95,6.84
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.42,0.0,4.13
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.65,0.95,2.72
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.49,0.88,7.8
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.49,0.88,7.8
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.02,0.01,0.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.02,2.14,11.92
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.24,1.67,10.72
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.78,0.48,1.2
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.19,1.56,10.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.19,1.56,10.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,7.28,2.89,13.63
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.8,1.97,11.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,1.47,0.93,2.21
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.05,0.03,0.08
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.58,3.59,16.2
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.03,2.06,12.23
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,2.55,1.53,3.97
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.9,1.99,11.66
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.9,1.99,11.66
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.06,0.04,0.09
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,7.12,3.0,13.82
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.61,1.44,10.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.5,1.56,3.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.58,1.32,7.19
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.4,0.58,5.39
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.18,0.73,1.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.82,0.58,6.25
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.87,0.0,4.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.96,0.58,1.46
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.58,0.29,1.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.58,0.29,1.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.5,0.27,0.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.5,0.27,0.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.06,0.05,0.08
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.79,1.21,2.45
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.48,0.27,0.75
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.3,0.94,1.71
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.13,0.1,0.17
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.31,2.32,4.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.45,0.27,0.71
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.84,2.05,3.73
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.42,0.25,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.42,0.25,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.11,0.06,0.18
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.5,0.91,2.28
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.48,0.29,0.71
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.02,0.62,1.56
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.1,0.06,0.17
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.87,1.16,2.87
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.44,0.25,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.45,0.89,2.22
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.23,0.13,0.35
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.24,1.34,3.4
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.56,0.35,0.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,1.66,1.0,2.55
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.2,1.21,6.29
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.36,0.7,5.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.84,0.51,1.29
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.23,1.26,6.26
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,2.32,0.7,4.87
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.91,0.56,1.39
